Report on Survey of Domestic Bioindustry based on 2015

2017. 1.

MINISTRY OF TRADE, INDUSTRY & ENERGY

Korea Biotechnology Industry Organization

Table of Contents

I. Survey Overview	1

1. Survey Overview	2

2. Background and Purpose	4

3. Methodology	5

4. Contents	6

5. Terminology	7

[Special Notes on Statistical Data]	15

II. Key Findings	16

1. General Status of Bioindustry	17

A. Bioindustry's Distribution per Place	17

B. Bioindustry's Distribution per Size of Workers	19

C. Bioindustry's Distribution per Existence of Other Businesses	21

D. Bioindustry's Financial Analysis	22

E. Type of Biobusiness Being Promoted in Bioindustry	23

2. Manpower Status of Bioindustry	25

A. Manpower Status of 2015	25

B. Recent Trend of Bioindustry Manpower Status	30

3. Investment Status of Bioindustry	34

A. Bioindustry's Investment Status of 2015	34

B. Recent Trend of Investment Status	37

4. Cooperation with Other Organizations	43

A. Cooperation Types	43

B. Cooperation Stages	50

C. Cooperating Organizations	54

5. Supply and Demand Status of Bioindustry	60

A. Bioindustry's Supply and Demand Status of 2015	60

Table of Contents

B. Recent Trend of Supply and Demand Status	63

6. Domestic Sales of Bioindustry	67

A. Domestic Sales Status of 2015	67

B. Recent Trend of Domestic Sales Status	69

7. Export Status of Bioindustry	73

A. Export Status of 2015	73

B. Recent Trend of Export Status	75

8. Import Status of Bioindustry	79

A. Import Status of 2015	79

B. Recent Trend of Import Status	81

III. Statistical Tables	85

Appendix : Explanation on Classification Scheme	173

List of Tables

[Table 1-1] Classification Scheme of Bioindustry	10

[Table 1-2] Classification Scheme of Biotechnology	13

[Table 2-1] Bioindustry's Distribution per Place	18

[Table 2-2] Biotechnology Industry’s Financial Standing Analysis by Category	22

[Table 2-3] 2015 Bioindustry's Manpower Distribution	26

[Table 2-4] 2015 Bioindustry's Distribution of Academic Degree	27

[Table 2-5] 2015 Bioindustry's Manpower Distribution by Area	29

[Table 2-6] 2013~2015 Bioindustry's Change in Manpower	30

[Table 2-7] 2013~2015 Bioindustry's Trend in Academic Degree of Manpower	31

[Table 2-8] 2011~2015 Bioindustry's Change in Manpower	32

[Table 2-9] 2011~2015 Bioindustry's Trend in Academic Degree of Manpower	33

[Table 2-10] 2015 Bioindustry's Size of Investment	35

[Table 2-11] 2015 Bioindustry's Size of Investment by Area	36

[Table 2-12] 2013~2015 Bioindustry's Trend of Investment	37

[Table 2-13] 2013~2015 Bioindustry's Trend in Overall Size of Investment	38

[Table 2-14] 2013~2015 Bioindustry's Trend of R&D and Facility Investment Cost	39

[Table 2-15] 2011~2015 Bioindustry's Trend of Investment	40

[Table 2-16] 2011~2015 Bioindustry's Trend in Overall Size of Investment	41

[Table 2-17] 2011~2015 Bioindustry's Trend of R&D and Facility Investment Cost	42

[Table 2-18] No. of Cooperation Cases by Bioindustrial Category and Cooperation

Type	47

[Table 2-19] No. of Partners by Bioindustrial Category and Cooperation Type	49

[Table 2-20] No. of Cooperation Cases by Cooperation Stage	51

[Table 2-21] No. of Cooperation Cases by Bioindustrial Category and Cooperation

Stage	51

[Table 2-22] No. of Partners by Cooperation Stage	53

[Table 2-23] No. of Partners by Bioindustrial Category and Cooperation Stage	53

[Table 2-24] No. of Cooperation Cases by Cooperating Organization	55

[Table 2-25] No. of Cooperation Cases by Bioindustrial Category and Cooperating

Organization	55

[Table 2-26] No. of Partners by Bioindustrial Category and Cooperating

Organization	57

[Table 2-27] Domestic and Overseas Cooperative Relationships and Cooperating

Organizations	58

[Table 2-28] Cooperating Organizations by Scale of Workers	59

[Table 2-29] 2013~2015 Bioindustry's Trend of Supply and Demand	60

[Table 2-30] 2015 Bioindustry's Status of Production and Domestic Demand	61

[Table 2-31] 2015 Bioindustry's Status of Production and Domestic Demand by

Area	62

[Table 2-32] 2013~2015 Bioindustry's Trend of Production and Domestic Demand	63

[Table 2-33] 2013~2015 Bioindustry's Trend of Supply and Demand by Category	64

[Table 2-34] 2011~2015 Bioindustry's Trend of Supply and Demand	65

[Table 2-35] 2011~2015 Bioindustry's Trend of Supply and Demand by Category	66

[Table 2-36] 2015 Main Bioproduct's Size of Domestic Sales	68

[Table 2-37] 2011~2015 Bioindustry's Trend of Domestic Sales	69

[Table 2-38] 2011~2015 Bioindustry's Trend of Domestic Sales by Category	70

[Table 2-39] 2011~2015 Bioindustry's Trend of Domestic Sales	71

[Table 2-40] 2011~2015 Bioindustry's Trend of Domestic Sales by Category	72

[Table 2-41] 2015 Main Bioproduct's Export	74

[Table 2-42] 2013~2015 Bioindustry's Trend of Export	75

[Table 2-43] 2013~2015 Bioindustry's Trend of Export by Category	76

[Table 2-44] 2011~2015 Bioindustry's Trend of Export	77

[Table 2-45] 2011~2015 Bioindustry's Trend of Export by Category	78

[Table 2-46] 2015 Main Bioproduct's Import	80

[Table 2-47] 2013~2015 Bioindustry's Trend of Import	81

[Table 2-48] 2013~2015 Bioindustry's Trend of Import by Category	82

[Table 2-49] 2011~2015 Bioindustry's Trend of Import	83

[Table 2-50] 2011~2015 Bioindustry's Trend of Import by Category	84

List of Figures

[Figure 2-1] Bioindustry's Distribution per Place	17

[Figure 2-2] Bioindustry's Distribution per Size of Workers	19

[Figure 2-3] Bioindustry's Size of Workers	20

[Figure 2-4] Bioindustry's Existence of Other Businesses	21

[Figure 2-5] Type of Biobusiness Being Promoted in Bioindustry	23

[Figure 2-6] Bioindustry's Sales Period	24

[Figure 2-7] 2015 Bioindustry's Distribution of Manpower	25

[Figure 2-8] Bioindustry's Manpower Proportion of 2015	26

[Figure 2-9] Bioindustry's Academic Degree Proportion of Workers of 2015	27

[Figure 2-10] Bioindustry's Academic Degree Proportion of 2015	28

[Figure 2-11] 2013~2015 Bioindustry's Trend of Manpower	30

[Figure 2-12] 2013~2015 Bioindustry's Trend in Academic Degree of Manpower	31

[Figure 2-13] 2011~2015 Bioindustry's Trend of Manpower	32

[Figure 2-14] 2011~2015 Bioindustry's Trend in Academic Degree of Manpower	33

[Figure 2-15] 2015 Total Investment cost and Investment in Bioindustry	34

[Figure 2-16] 2013~2015 Bioindustry Investment Trend	37

[Figure 2-17] 2011~2015 Bioindustry Investment Trend	40

[Figure 2-18] Cooperative Relationship with Other Organizations	43

[Figure 2-19] No. of Companies Holding Cooperative Relationships by Bioindustrial

Category	44

[Figure 2-20] Types of Cooperative Relationship with Other Organizations	45

[Figure 2-21] No. of Cooperation Cases by Cooperative Relationship Type	46

[Figure 2-22] No. of Partners by Cooperative Relationship Type	48

[Figure 2-23] No. of Cooperation Cases by Cooperation Stage	50

[Figure 2-24] No. of Partners by Cooperation Stage	52

[Figure 2-25] No. of Cooperation Cases by Cooperating Organization	54

[Figure 2-26] No. of Partners by Cooperating Organization	56

[Figure 2-27] 2015 Bioindustry's Size of Production and Domestic Demand	61

[Figure 2-28] 2013~2015 Bioindustry's Trend of Production and Domestic Demand	63

[Figure 2-29] 2011~2015 Bioindustry's Trend of Supply and Demand	65

[Figure 2-30] 2015 Bioindustry's Size of Domestic Sales by Category	67

[Figure 2-31] 2013~2015 Bioindustry's Trend of Domestic Sales	69

[Figure 2-32] 2011~2015 Bioindustry's Trend of Domestic Sales	71

[Figure 2-33] 2015 Bioindustry's Size of Export by Category	73

[Figure 2-34] 2013~2015 Bioindustry's Trend of Export	75

[Figure 2-35] 2011~2015 Bioindustry's Trend of Export	77

[Figure 2-36] 2015 Bioindustry's Size of Import by Category	79

[Figure 2-37] 2013~2015 Bioindustry's Trend of Import	81

[Figure 2-38] 2011~2015 Bioindustry's Trend of Import	83

I. Survey Overview

1		Survey Overview

A. Data Sources

○ Division of Bio-nano, Ministry of Trade, Industry and Energy

I. Overview

(www.motie.go.kr)

○ Statistical Sources : Korea Biotechnology Industry Organization

(www.koreabio.org)

B. Type of Statistics and Authorized Number

○ Type of Statistics : General·Survey Statistics

○ Authorized Number: No. 11515

○ Authorized Date : October 30th, 2003

C. Survey Period

○ Survey Baseline Date: December 31, 2015

○ Targeted Survey Period : January 1, 2015 ~ December 31, 2015

○ Conducting Survey Period : May 27, 2016 ~ November 18, 2016

D. Scope

○ Based on ‘classification scheme of bioindustry (KS J 1009, recognized by Korean Agency for Technology and Standards, Ministry of Trade, Industry and Energy on January 2008)’ which established the scope and definition of the domestic biotechnology and bioindustry in the survey baseline year, the scope of the survey refers to domestic businesses engaged in the activities related to biotechnology. The activities related to biotechnology refers to the following.

- Using biotechnology as the main technology in the research and development phases, although it uses non-biotechnology in the production phase

- Using biotechnology in the manufacturing, production and service (including research and development) phases

- Producing machine, equipment, or plant that are used in the biotechnological process of the research and development phase or the production phase

- Selling the above products after importing

※ The survey includes companies resulted in sales through the activities stated above as well as companies pushing forward the research development in the survey baseline year.

E. Survey Targets

○ The survey primarily selected bioindustry's fact-finding companies of 2014 among domestic companies falling into the range of the survey as survey targets. The survey then selected corresponding companies using the bio cluster-related companies per geography of December, 2015, other registered company data of Korea Biotechnology Industry Organization, and company yearbooks.

F. Survey Units

○ The survey units refers to companies that sell products or services which went through the production process of value-adding after the assembled capital equipment or raw materials were bought under the control of the entrepreneur.

○ The survey units include public enterprises (state-owned enterprises, public enterprises), public - private companies, the private companies (private enterprises, collective enterprises, partnership, joint venture, anonymous company, Co., Ltd., Co., Ltd., co-operatives).

○ In case the company has more than two businesses, the survey unit included the sum of the corresponding business' results and received the responses based on the bioindustry results among the overall industrial activities.

G. Methodology and Approach

○ Survey Methodology : Via mail, fax, e-mail, telephone, face-to-face interview

○ Survey Approach : Researcher → Research Company → Korea Biotechnology Industry Organization → Ministry of Trade, Industry and Energy

H. Announcement of Results

○ Announcement Period : Once a year

○ Form of Announcement : Publishment of the Report on Fact Finding Survey of Domestic Bioindustry

2		Background and Purpose

○ Ministry of Trade, Industry and Energy and Korea Biotechnology Industry Organization have been conducting fact finding survey of domestic bioindustry since 2003 to build groundwork for economic analysis, international comparison and establishment of related nurturing policies through analyzing overall status of bioindustry and its actual condition.

○ The 'Report on Fact Finding Survey of Domestic Bioindustry' that started its survey conduct from May, 2016 aims to increase the successful rate as complete enumeration survey and to grasp more accurate status of domestic bioindustry.

○ This survey aims to analyze bioindustry's economic feasibility through grasping sales and financial status and to establish bio-related nurturing policies through studying accurate actual condition of domestic bioindustry.

○ Ministry of Trade, Industry and Energy and Korea Biotechnology Industry Organization aims to contribute to the development of domestic bioindustry through the results of this survey.

3		Methodology

Target		Company representatives or managers in Bioindustry such as Biopharmaceutical·Biochemical·Biofood·Bioenvironmental· Bioelectronics
Area		Nation-wide(17 areas including Seoul and 6 Metropolitan cities)
Methodology		Research was conduced via mail, fax, e-mail, telephone, face-to-face interview by researcher
Data-mining tool		Structured Questionnaire
Size of population		1,034 Companies (Among primarily selected 1,067 companies, 33 closed-down)
Size of valid sample		978 Companies(94.6% of the population)

* Classification of 'No Response' in last 3 years of our survey

Year	Size of population	Valid response cases		No response cases	Type of No response
					Refusal	Not in the office	Not connected	Shutdown (during surveyed year)
2013	1,037	971	(94%)	66	13	24	18	11
2014	1,035	975	(94%)	60	15	19	20	6
2015	1,034	978	(95%)	56	16	13	22	5

4		Contents

Category	Main Contents of the Survey
Company Information	- Name of Company, Name of Representative - Business Registration Number, Corporate-parent (Group) Name - Phone, Establishment Date - Address - Respondent Information
General Status	- Capital, Capital Ratio of Net Worth - Number of Workers - Existence of exclusive business, type of company, place of business - Items in the income statement (sales, cost of goods sold, selling expenses & administrative expenses, tax, etc)
Status of Bio Industry	- Core business - Manpower status - R&D cost and Facility Investment cost - Cooperation with Other Organizations - Phase of Growth - Period Resulted in Sales - Product, Service, Commerce Technology (Resulted in Sales, Export·Import)

5		Terminology

A. General Status

○ Selected Companies

① Venture Company : Refers to companies that are selected for meeting the requirements of the venture capital investment, investment in research and development, and companies developing new technologies and technology assessment companies according to ‘Act on Special Measures for the Promotion of Venture Businesses’.

② INNO-BIZ : Refers to companies that are selected for Small and Medium Business Administration's 'Fostering Business for technology-innovative (INNO-BIZ) Small and Medium Businesses'.

③ Listed Company : Refers to companies that meet the listing requirements which are being able to sell the issued stocks in the Kosdaq market or the stock market.

○ Capital : Refers to the current amount of capital that is paid by the corporation (headquarter) until December 31, 2013.

○ Capital Ratio of Net Worth : Refers to the ratio of equity capital (total amount of capital-liabilities) on the total capital (=total amount of capital+liabilities=total assets).

B. Manpower Status

○ Received responses from three groups among bioindustry workers:　research, production, and others including sales/administrative.

① Research : Refers to research and development manpower in bioindustry.

② Production : Refers to manpower engaged in production, facilities and quality management in bioindustry. (excluding manpower in research center)

③ Others including sales/administrative : Refers to all manpower except research and production manpower in bioindustry.

C. R&D and Sales

○ R&D Cost : Refers to company's total cost spent in research activities to develop new products or new technology for the past year of 2015. It refers to sales cost in income statement and manufacturing statement, ordinary development expense and investment cost for management, land and equipment acquisition cost related to R&D in balance sheet.

① R&D Cost : Includes self R&D cost (labor costs, material costs and other expenses), commissioned research and development costs, cost for technology implementation

② Facility Investment Cost related to R&D : Includes machinery, land and building acquisition cost related to R&D

○ Resulting in Sales

① Selling complete product that was produced in the business

② Selling complete product which was outsourced by other businesses using raw material or half-finished products

③ Refers to providing services and sales resulting from transfer of technology. It includes all the results of domestic sales and export activities.

D. Classification Scheme of Bioindustry and Biotechnology

1) Classification Scheme of Bioindustry

○ In case of classification scheme of bioindustry, the Korean Agency for Technology and Standards established national standard KS J 1009(Bioindustry Classification Code) on January 31, 2008 by reflecting the business results of Ministry of Trade, Industry and Energy's ‘Building groundwork for standardization of biotechnology and industrial products’ and the second	detail topic ‘Building standard classification scheme of bioindustry/biotechnology and analyzing structure of the bioindustry’.

<Overview of Bioindustry's Classification Scheme>

■ Purpose of Classification

◦ To clarify the scope of bioindustry

- Defined companies that uses biotechnology in the research and development,  manufacturing, production, and service phases

◦ To propose standardized evidences that can be used for bioindustry-related statistics and institutions without confusion

- Creating industrial statistics such as company profits created from using biotechnology

◦ To build groundwork for analysis such as economic structure, industrial structure, and correlation with other industries

◦ To secure the connectivity with the classification scheme of international bioindustry

- Creating groundwork for comparing and analyzing the statistical data of the international bioindustry

■ Target and Standard of Classification

◦ Industrial activities conducted by companies using biotechnology

◦ Characteristics of products (produced goods or provided service) which use biotechnology in the research and development, production and service phases

- The function and the market of the products

■ Classification Scheme

◦ Consisted of 8 upper classifications and 51 middle classifications

- The upper classifications are categorized by KS J 1009(Bioindustry Classification Code)

- The middle classifications are categorized by goods sold using biotechnology or provided service using biotechnology. These are categorized according to their correlation with industrial activities of corresponding upper classification.

>> <Table 1-1> Classification Scheme of Bioindustry
Code	Name of Industrial Classification
1	Biopharmaceutical Industry
1010	Antibiotics
1020	Anticancer medications
1030	Vaccines
1040	Hormones
1050	Immunotherapeutics
1060	Hemotherapeutics
1070	Growth factors
1080	New therapeutics(ex. gene therapeutics, cell therapy, cloned organs, etc)
1090	Diagnostic kits
1100	Animal medications
1000	Other biopharmaceuticals
2	Biochemical Industry
2010	Biopolymers
2020	Industrial enzymes and reagents
2030	Enzymes and reagents for research
2040	Biocosmetics and home & personal care chemicals
2050	Biological agrochemicals and fertilizers
2000	Other biochemicals
3	Biofood Industry
3010	Functional health foods
3020	Amino acids
3030	Food additives
3040	Fermented foods
3050	Feed additives
3000	Other biofoods
4	Bioenvironmental Industry
4010	Microbial treatment agents
4020	Microbe-immobilized materials and equipments
4030	Bioenvironmental agents and systems
4040	Measuring apparatus for environmental pollution(service for pollution assessment)
4000	Other bioenvironmental productions and services

>> <Table 1-1> Classification Scheme of Bioindustry(Cont'd)
Code	Name of Industrial Classification
5	Bioelectronics Industry
5010	DNA chips
5020	Protein chips
5030	Cell chips
5040	Biosensors
5050	BioMEMS
5000	Other bioelectronics
6	Biochemical Industry
6010	Bioreactors
6020	Biomedical and diagnostic apparatuses
6030	Bioprocess and analysis equipments
6040	Plant and process design
6000	Other Bioprocesses and equipments
7	Bioenergy and bioresource Industry
7010	Biofuel
7020	Artifical seeds and seedlings
7030	Experimental animals
7040	Transgenic animals and plants
7000	Other bioenergy and bioresources
8	Bioassay, bioinformatics and R&D service Industry
8010	Bioinformatics services
8020	Gene analysis services
8030	Protein analysis services
8040	R&D services (ex. drug development services, etc)
8050	Biosafety and efficacy evaluation services
8060	Diagnosis and preservation services
8000	Other bioassays, bioinformatics services

※ Refer to <Appendix 1> for the explanation on classification scheme

2) Classification Scheme of Biotechnology

○ In case of the classification scheme of biotechnology, it provides 13 sectors biotechnology classification code according to KS J 1009(Bioindustry Classification Code) which is recognized as national standard by the Korean Agency for Technology and Standards in January 31, 2008. This reflected the business results of Ministry of Trade, Industry and Energy's ‘Building groundwork for standardization of biotechnology and industrial products’ and the second	detail topic ‘Building standard classification scheme of bioindustry/biotechnology and analyzing structure of the bioindustry’.

<Overview of Biotechnology's Classification Scheme>

■ Purpose of Classification

◦ To define the scope of the domestic bioindustry

◦ To analyze the usage condition of biotechnology in the domestic industry

■ Target and Standard of Classification

◦ To establish the classification scheme of biotechnology used in industries

◦ To emphasize the technology used in the current bioindustry and the research development field

◦ To reflect the development vision of the future bioindustry and biotechnology

■ Classification Scheme

◦ Consisted of 2 classifications (Upper․Middle). There are 13 upper classifications and 68 middle classifications.

◦ The upper classification includes the technological scope of the corresponding middle classifications. It is consisted of items that can easily implement and respond to specific details of technology.

◦ The middle classification limits the technological scope of the upper classification. It is consisted of items that can encompass related new technologies into the list-based definitions.

◦ Each of the 68 middle classification has corresponding list-based definition which explains the definition and the scope of the middle classification's technology. This list-based definition is consisted of items that allows duplication among middle classifications and focuses on technological names used in industry and the research and development field.

>> <Table 1-2> Classification Scheme of Biotechnology
Code	Name of Technological Classification
A	Genetic engineering
A1	Gene manipulation
A2	Gene expression and regulation
A3	Gene application
A4	Gene therapy
A0	Genetic engineering, n.e.s.
B	Protein engineering
B1	Protein structure analysis
B2	Protein function analysis
B3	Complex protein engineering
B4	Peptide engineering
B5	Protein application
B0	Protein engineering, n.e.s.
C	Other macromolecule engineering
C1	Lipid engineering
C2	Carbohydrate engineering
C0	Macromolecule engineering, n.e.s.
D	Cell and tissue engineering
D1	Stem cell therapy
D2	Bioenvironment regulation
D3	Functional biomaterial development
D4	Cell engineering
D5	Tissue engineering
D0	Cell and tissue engineering, n.e.s.
E	Systems biology and bioinformatics
E1	Gene sequence analysis
E2	Functional genomics
E3	Proteomics
E4	Bioinformatics
E0	Systems biology and bioinformatics, n.e.s.
F	Metabolic engineering
F1	Metabolite production
F2	Applications of metabolic engineering
F3	Understanding the metabolism and metabolic pathways
F0	Metabolic engineering, n.e.s.
G	Bioprocess
G1.	Fermentation engineering
G2.	Cell culture engineering
G3.	Biotransformation
G4.	Bioseparation engineering
G5.	Industrialization
G0.	Bioprocess, n.e.s.

>> <Table 1-2> Classification Scheme of Biotechnology(Cont'd)
Code	Name of Technological Classification
H	Bioresource production and utilization
H1	Plant resource utilization technology
H2	Animal resource utilization technology
H3	Microbial resource utilization technology
H4	Insect resource utilization technology
H5	Marine/fresh water organism technology
H6	Food engineering
H7	Biomaterializing technology
H8	Biodiversity conservation
H0	Bioresource production and utilization, n.e.s.
I	Environmental biotechnology and bioenergy technology
I1	Clean technology
I2	Environmental pollution control and management technology
I3	Bioenergy technology
I0	Environmental biotechnology and bioenergy technology, n.e.s.
J	Nanobiotechnology
J1	Nano-biodevice fabrication
J2	Nanobiomaterial technology
J3	Nano drug delivery system
J4	BioNEMS(Nanoelectromechanical systems, nano-LOC(lab-on-a-chip)
J0	Nanobiotechnology, n.e.s.
K	Bioelectronics
K1	Biosensor fabrication
K2	Bioelectronic device fabrication
K3	Biochip fabrication
K4	Microfluidics
K0	Bioelectronics, n.e.s.
L	Biosafety and efficacy evaluation
L1	Safety evaluation
L2	Safety management
L3	Environmental assessment
L4	Biohazard management
L5	Efficacy evaluation
L0	Biosafety and efficacy evaluation, n.e.s.
M	Other biotechnology
M1	Combinatorial biology
M2	Drug delivery
M3	Immunotherapy technology
M0	Biotechnology, n.e.s.

※ Refer to <Appendix 1> for the explanation on classification scheme

【Special Notes on Statistical Data】

1) The missing values (no response, unsureness and none of the above) were excluded from the statistical calculation. (Statistical analysis was conducted based on 100% data with the missing value excluded.)

2) The sum of detail items and the total sum may not be identical as all the statistical values are rounded values.

3) This report calculates down to one place of decimals and related symbols are as the following:

「-」: none of the above

「0.0」: less than the unit

4) Any inquiries on this report should be contacted to the Bio Industry Policy unit of the Korea Biotechnology Industry Organization. (Phone : 031-628-0040, 0019)

II. Key Findings

II. Key Findings

1

General Status of Bioindustry

A. Bioindustry's Distribution per Place

Headquarters and biobusinesses of domestic bioindustry are mostly located in Seoul and Gyeonggi province. There are 313 headquarters in Seoul, and 313 biobusinesses in Gyeonggi.

<Figure 2-1> Bioindustry's Distribution per Place         (Unit : number of companies)

* Place of biobusinesses were analyzed according to the following order:

factory > research center > headquarter.

<Table 2-1> Bioindustry's Distribution per Place          (Unit : number of companies)

Industrial Category	Total	Seoul	Busan	Daegu	In cheon	Gwang ju	Dae jeon	Ulsan	Sejong
Total	978	185	14	23	22	10	81	9	6
Biopharmaceutical industry	330	84	3	7	9	1	19	1	1
Biochemical industry	206	24	2	3	4	2	34	3	3
Biofood industry	197	22	7	4	4	2	7	-	2
Bioenvironmental industry	76	5	1	6	3	2	4	2	-
Bioelectronics industry	22	7	-	1	1	1	2	-	-
Bioprocess and equipment industry	71	20	-	1	1	1	7	-	-
Bioenergy and bioresource industry	26	1	1	-	-	-	2	3	-
Bioassay, bioinformatics and R&D service industry	50	22	-	1	-	1	6	-	-

Industrial Category	Gyeonggi	Gangwon	Chungbuk	Chungnam	Jeonbuk	Jeonnam	Gyeongbuk	Gyeongnam	Jeju
Total	313	55	72	57	26	28	34	29	14
Biopharmaceutical industry	137	11	28	18	5	1	2	2	1
Biochemical industry	48	13	14	14	5	10	15	8	4
Biofood industry	45	18	19	18	8	10	10	14	7
Bioenvironmental industry	25	8	5	1	4	3	3	4	-
Bioelectronics industry	5	4	-	1	-	-	-	-	-
Bioprocess and equipment industry	31	1	1	4	-	2	2	-	-
Bioenergy and bioresource industry	8	-	3	-	3	2	1	1	1
Bioassay, bioinformatics and R&D service industry	14	-	2	1	1	-	1	-	1

* The result analyzed the results of 1 core business that was selected for each company.

TOP3 provinces for domestic bioindustry's businesses are as the following:
Biopharmaceutical Industry: Gyeonggi 41.5% > Seoul 25.5% > Chungbuk 8.5%
Biochemical Industry : Gyeonggi  23.3% > Daejeon 16.5% > Seoul 11.7%
Biofood Industry : Gyeonggi  22.8% > Seoul 11.2% > Chungbuk 9.6%
Bioenvironmental Industry : Gyeonggi 32.9% > Gangwon 10.5% > Seoul 6.6%
Bioelectronics Industry : Seoul 31.8% > Gyeonggi 22.7% > Gangwon 18.2%

Bioprocess and equipment industry : Gyeonggi 43.7% > Seoul 28.2% >

Dajeon 9.9%
Bioenergy and bioresource Industry : Gyeonggi 30.8% >

Ulsan, Chungbuk, Jeonbuk 11.5%

Bioassay, bioinformatics and R&D service Industry : Seoul 44.0% > Gyeonggi

28.0% > Daejeon 12.0%

B. Bioindustry's Distribution per Size of Workers

There are 574 companies (59.4%) that belongs to 'less than 1~50 workers' among total size of workers. (Excluded 11 no response cases)

There are 46 companies (4.8%) that have more than 1,000 workers.

<Figure 2-2> Bioindustry's Distribution per Size of Workers

<Figure 2-3> Bioindustry's Size of Workers              (Unit : number of companies)

* Companies that did not have information on the size of workers were excluded from the statistical data.

C. Bioindustry's Distribution on the Existence of Other Businesses

Bioindustry's existence of other businesses refers to the existence of factories, research centers or stores in other location.

Companies that do not have factories, research center or stores in other location are categorized as 'exclusive business'. Companies that have factories, research centers or stores in other location are categorized as 'plural businesses'.

Among 974 bioindustry companies, 518 companies (53.2%) are 'exclusive business' and 456 companies (46.8%) are 'plural businesses' according to the survey.

<Figure 2-4> Bioindustry's Existence of Other Businesses                   (Unit : %)

* Excluded samples that could not classify their operation status as either exclusive or plural

D. Bioindustry's Financial Analysis

The total capital of bioindustry is surveyed as 15.3 billion won and the ratio of net worth is 54%.

Companies in biochemical industry had higher average amount of capital reaching 35.4 billion won. Companies in biopharmaceutical, bioelectronics industry had higher value compared to other bioindustries with ratio of net worth reaching 62%, 58% each.

<Table 2-2> Biotechnology Industry’s Financial Standing Analysis by Category

(Unit : %, million Won)

Industrial Category	No. of companies	Capital			Ratio of Net worth
		Minimum	Maximum	Average	Minimum	Maximum	Average
Total	978	5	1,500,000	15,325	-432	1,782	54
Biopharmaceutical industry	330	15	815,317	13,843	-220	1,782	62
Biochemical industry	206	30	1,500,000	35,436	-432	126	48
Biofood industry	197	10	516,625	12,661	-194	301	51
Bioenvironmental industry	76	30	10,846	1,379	19	99	55
Bioelectronics industry	22	10	7,305	2,828	24	91	58
Bioprocess and equipment industry	71	5	41,277	2,277	7	96	51
Bioenergy and bioresource industry	26	53	167,456	14,517	-84	98	38
Bioassay, bioinformatics and R&D service industry	50	5	13,908	2,029	-103	100	51

E. Type of Biobusiness Being Promoted in Bioindustry

The result for type of forwarded biobusiness includes responses from 926 companies out of 978 total participants, of which 52 were non-responses.

Among 926 companies, 281 companies (30.3%) belonged to the phase of 'before sales' in 2015, and among 645 companies that resulted in sales, 343 companies which are almost half the number belonged to 'below BEP'.

<Figure 2-5> Type of Biobusiness Being Promoted in Bioindustry

Among 644 companies that resulted in sales in 2015, 11 companies (1.7%) had their first sales in 2015. (Excluded 1 no response case)

There are 283 companies (43.9%) that resulted in sales for more than 10 years.

<Figure 2-6> Bioindustry's Sales Period

2

Manpower Status of Bioindustry

A. Manpower Status of 2015

1) Manpower Status per Category

Among 978 domestic bioindustry companies in 2015, there was an increase of 1,885 workers compared to 2014, reaching 39,686 and there are average of 40.6 workers per company.

Manpower of bioindustry is consisted of 12,782 research workers (32.2%), 13,567 production workers (34.2%), 13,340 sales/administrative workers (33.6%).

<Figure 2-7> 2015 Bioindustry's Distribution of Manpower

<Table 2-3> 2015 Bioindustry's Manpower Distribution

(Unit : number of companies, workers, %)

Industrial Category		No. of Companies	Research workers	Production workers	Sales/administrative workers	Total	Distribution Ratio
Total	No. of Employees	978	12,782	13,564	13,340	39,686	100.0
	Distribution Ratio	100.0	32.2	34.2	33.6	100.0
Biopharmaceutical industry		330	6,157	7,147	7,514	20,818	52.5
Biochemical industry		206	2,168	1,453	1,394	5,015	12.6
Biofood industry		197	1,659	3,029	1,831	6,519	16.4
Bioenvironmental industry		76	357	369	488	1,214	3.1
Bioelectronics industry		22	303	576	306	1,185	3.0
Bioprocess and equipment industry		71	428	510	576	1,514	3.8
Bioenergy and bioresource industry		26	371	409	369	1,149	2.9
Bioassay, bioinformatics and R&D service industry		50	1,339	71	862	2,272	5.7

<Figure 2-8> Bioindustry's Manpower Proportion of 2015              (Unit : %)

2) Manpower Status per Academic Degree

Among bioindustry manpower in 2015, workers with bachelor's degree were the largest in number, reaching 16,718 people (42.1%). Workers with master's degree ranked second with 8,140 workers (20.5%), and workers with doctor's degree the last with 2,342 workers (5.9%).

<Figure 2-9> Bioindustry's Academic Degree Proportion of Workers of 2015

<Table 2-4> 2015 Bioindustry's Distribution of Academic Degree

(Unit : number of people, %)

Industrial Category		Doctor	Master	Bachelor	Others	Total	Distribution Ratio
Total	No. of Employees	2,342	8,140	16,718	12,486	39,686	100.0
	Distribution Ratio	5.9	20.5	42.1	31.5	100.0
Biopharmaceutical industry		1252	4,336	8,658	6,572	20,818	52.5
Biochemical industry		345	1,321	2,126	1,223	5,015	12.6
Biofood industry		341	1,131	2,461	2,586	6,519	16.4
Bioenvironmental industry		43	181	708	282	1,214	3.1
Bioelectronics industry		47	185	413	540	1,185	3.0
Bioprocess and equipment industry		78	238	656	542	1,514	3.8
Bioenergy and bioresource industry		61	157	438	493	1,149	2.9
Bioassay, bioinformatics and R&D service industry		175	591	1258	248	2,272	5.7

Portion of elite manpower such as workers with masters or doctors degree is relatively high in bioassay, bioinformatics and R&D service industry(33.7%) and in biochemical industry(33.2%).

<Figure 2-10> Bioindustry's Academic Degree Proportion of 2015         (Unit : %)

3) Manpower Distribution by Area

Gyeonggi area held 34.4% of total bioindustry's manpower in 2015, which account for 13,634 workers in numbers. Followed areas that ranked high of possession of bioindustry's manpower are Chungbuk (5,626 people), Seoul(4,745 people), Incheon(3,546 people).

< Talbe 2-5 > 2015 Bioindustry's Manpower Distribution by Area

(Unit : number of people, %)

Area		Doctor	Master	Bachelor	Others	Total	Distribution Ratio
Total	No. of Employees	2,342	8,140	16,718	12,486	39,686	100.0
	Distribution Ratio	5.9	20.5	42.1	31.5	100.0
Seoul		376	1106	2,568	695	4,745	12.0
Busan		14	37	57	62	170	0.4
Daegu		18	65	231	249	563	1.4
Incheon		151	812	1,317	1266	3,546	8.9
Gwangju		3	19	36	5	63	0.2
Daejeon		306	640	874	366	2,186	5.5
Ulsan		15	85	237	204	541	1.4
Sejong		11	69	213	136	429	1.1
Gyeonggi		772	3,007	5,061	4,794	13,634	34.4
Gangwon		133	349	935	903	2,320	5.8
Chungbuk		218	988	2,733	1,687	5,626	14.2
Chungnam		95	327	677	807	1,906	4.8
Jeonbuk		122	419	1,087	699	2,327	5.9
Jeonnam		31	53	184	134	402	1.0
Gyeongbuk		27	54	187	149	417	1.1
Gyeongnam		24	82	252	257	615	1.5
Jeju		26	28	69	73	196	0.5

B. Recent Trend of Bioindustry Manpower Status

1) 2013~2015 Bioindustry's trend of manpower status

① Bioindustry's Trend of manpower status

The manpower of bioindustry in 2015 had an increase of 1,885 workers(5.0%) compared to 2014, reaching 39,686 workers.

<Table 2-6> 2013~2015 Bioindustry's Change in Manpower

(Unit : number of people, %)

Classification	2013	2014	2015	Annual Average Rate of change
No. of Employees	36,684	37,801	39,686	4.0
Rate of Change	-2.4	3.0	5.0

<Figure 2-11> 2013~2015 Bioindustry's Trend of Manpower

(Unit : number of people)

② Bioindustry's Trend in Academic Degree of Manpower

Compared to 2014, the proportion of bioindustry workers with bachelor's degree in 2015 increased slightly from 41.4% to 42.1% (0.7%p).

<Table 2-7> 2013~2015 Bioindustry's Trend in Academic Degree of

Manpower                                      (Unit : number of people, %)

Degree	2013		2014		2015		Variation from the year before
	No. of Employees	Distribution Ratio	No. of Employees	Distribution Ratio	No. of Employees	Distribution Ratio	No. of Employees	Rate of Change
Total	36,684	100.0	37,801	100.0	39,686	100.0	1,885	5.0
Doctor	2,082	5.7	2,189	5.8	2,342	5.9	153	7.0
Master	7,408	20.2	7,833	20.7	8,140	20.5	307	3.9
Bachelor	15,160	41.3	15,655	41.4	16,718	42.1	1,063	6.8
Others	12,034	32.8	12,124	32.1	12,486	31.5	362	3.0

<Figure 2-12> 2013~2015 Bioindustry's Trend in Academic Degree of Manpower

(Unit : number of people)

2) 2011~2015 Bioindustry's Trend in Academic Degree of Manpower

① Bioindustry's Trend of Manpower status

Since 2013, Bioindustry Manpower continued to increase.

<Table 2-8> 2011~2015 Bioindustry's Change in Manpower (%)

(Unit : number of people, %)

Classification	2011	2012	2013	2014	2015	Annual Average Rate of Change
No. of Employees	35,718	37,570	36,684	37,801	39,686	2.7
Rate of Change	11.1	5.2	-2.4	3.0	5.0

<Figure 2-13> 2011~2015 Bioindustry's Trend of Manpower

(Unit : number of people)

② Bioindustry's Trend in Academic Degree of Manpower

In 2011 to 2015, number of employees with either bechelor, master, and doctor degree continued to increase.

<Table 2-9> 2011 ~ 2015 Bioindustry's Trend in Academic Degree of Manpower

(Unit : number of people, %)

Degree	2011		2012		2013		2014		2015		Variation from the year before
	No. of Employees	Distribution Ratio	No. of Employees	Distribution Ratio	No. of Employees	Distribution Ratio	No. of Employees	Distribution Ratio	No. of Employees	Distribution Ratio	No. of Employees	Rate of Change
Total	35,718	100.0	37,570	100.0	36,684	100.0	37,801	100.0	39,686	100.0	1,885	5.0
Doctor	1,864	5.2	1,956	5.2	2,082	5.7	2,189	5.8	2,342	5.9	153	7.0
Master	6,738	18.9	7,146	19.0	7,408	20.2	7,833	20.7	8,140	20.5	307	3.9
Bachelor	13,602	38.1	14,665	39.0	15,160	41.3	15,655	41.4	16,718	42.1	1,063	6.8
Others	13,514	37.8	13,803	36.7	12,034	32.8	12,124	32.1	12,486	31.5	362	3.0

<Figure 2-14> 2011~2015 Bioindustry's Trend in Academic Degree of Manpower

(Unit : number of people)

3

Investment Status of Bioindustry

A. Bioindustry's Investment Status of 2015

The total amount of investment bioindustry companies made for the past year of 2015 reached 5 trillion and 661.8 billion won, and the investment cost on bioindustry turned out to be 30.5% of the total investment fee reaching 1 trillion and 724.5 billion won.

The R&D cost in bioindustry turned out to be 26.9% of the total R&D cost reaching 1 trillion and 312.6 billion won, and the facility investment cost in bioindustry took 53.0% of the total facility investment cost reaching  412.0 billion won.

<Figure 2-15> 2015 Total Investment cost and Investment in Bioindustry

(Unit: million Won)

Among bioindustries, the total investment was highest in biopharmaceutical industry reaching 1 trillion and 349.9 billion won(78.3%) and then the following highest industries were biofood industry reaching 99.7 billion won(5.8%) and biochemcial industry reaching 136.6 billion won(7.9%). These three core bioindustries took 92.0% of bioindustry's the total investment cost.

Among bioindustries, the total R&D cost was highest in biopharmaceutical industry reaching 996.4 billion won(75.9%) and then the following highest industries were biochemcial industry reaching 118.2 billion won(9.0%) and biofood industry reaching 86.5 billion won(6.6%). These three core bioindustries took 91.5% of bioindustry's the total R&D cost.

Among bioindustry companies, the average amount of R&D cost was highest in biopharmaceutical industry reaching 3.0 billion won and then the following highest industries were bioelectronics industry with 1.0 billion won, bioenergy and bioresource, bioassay, bioinformatics and  R&D service industry with 0.7 billion won.

Among bioindustries, the total facility investment cost was highest in biopharmaceutical industry reaching 353.5 billion won(85.8%) and then the following highest industries were biofood industry reaching 13.2 billion won(3.2%) and biochemcial industry reaching 18.5 billion won(4.5%). These three bioindustries took 93.5% of bioindustry's the total facility investment cost.

Among bioindustry companies, the average amount of facility investment cost was highest in biopharmaceutical industry reaching 1.1 billion won and then the following highest industries were bioassay, bioinformatics and  R&D service industry with 0.4 billion won, Bioprocess and equipment industry , Bioenergy and bioresource industry with 0.2 billion won.

<Table 2-10> 2015 Bioindustry's Size of Investment (Unit : number of companies, million Won)

Industrial Category	No. of companies	R&D Investment		Facility Investment		Total Investment
		Total	Average	Total	Average	Total	Average
Total	978	1,312,560	1,342.1	411,962	421.2	1,724,522	1,763.3
Biopharmaceutical industry	330	996,423	3,019.5	353,457	1,071.1	1,349,880	4,090.5
Biochemical industry	206	118,190	573.7	18,457	89.6	136,647	663.3
Biofood industry	197	86,500	439.1	13,219	67.1	99,719	506.2
Bioenvironmental industry	76	9,183	120.8	1,793	23.6	10,976	144.4
Bioelectronics industry	22	22,764	1,034.7	1,087	49.4	23,851	1,084.1
Bioprocess and equipment industry	71	21,038	296.3	1,553	21.9	22,591	318.2
Bioenergy and bioresource industry	26	21,064	810.2	4,056	156.0	25,120	966.2
Bioassay, bioinformatics and R&D service industry	50	37,398	748.0	18,340	366.8	55,738	1,114.8

Size of overall R&D investment was highest in Incheon and Gyeonggi area, while that of facility investment was highest in Incheon area.

Average size of R&D investment was highest in Incheon area where it reached 16.3 billion won, while that of facility investment was highest in Incheon to reach 10.4 billion won.

< Table 2-11 > 2015 Bioindustry's Size of Investment by Area

(Unit : number of companies, million Won)

Area	No. of companies	R&D Investment		Facility Investment		Total Investment
		Total	Average	Total	Average	Total	Average
Total	978	1,312,560	1,342.1	411,962	421.2	1,724,522	1,763.3
Seoul	185	98,379	531.8	11,184	60.5	109,563	592.2
Busan	14	1,639	117.1	515	36.8	2,154	153.9
Daegu	23	2,988	129.9	337	14.7	3,325	144.6
Incheon	22	359,530	16,342.3	228,994	10408.8	588,524	26,751.1
Gwangju	10	503	50.3	160	16.0	663	66.3
Daejeon	81	128,402	1,585.2	28,605	353.1	157,007	1,938.4
Ulsan	9	33,745	3,749.4	12,917	1435.2	46,662	5,184.7
Sejong	6	22,667	3,777.8	1,700	283.3	24,367	4,061.2
Gyeonggi	313	360,156	1,150.7	58,870	188.1	419,026	1,338.7
Gangwon	55	31,618	574.9	9,547	173.6	41,165	748.5
Chungbuk	72	174,956	2,429.9	42,705	593.1	217,661	3,023.1
Chungnam	57	21,642	379.7	8,401	147.4	30,043	527.1
Jeonbuk	26	63,405	2,438.7	2,570	98.8	65,975	2,537.5
Jeonnam	28	2,036	72.7	3,238	115.6	5,274	188.4
Gyeongbuk	34	3,799	111.7	840	24.7	4,639	136.4
Gyeongnam	29	4,480	154.5	505	17.4	4,985	171.9
Jeju	14	2,615	186.8	874	62.4	3,489	249.2

B. Recent Trend of Investment Status

1) 2013~2015 Bioindustry's Trend of Investment

The total investment cost in bioindustry decreased from 1 trillion and 834.4 billion won in 2014 to 1 trillion and 724.5 billion won in 2015.

<Table 2-12> 2013~2015 Bioindustry's Trend of Investment

(Unit : one hundred million Won, %)

Classification		2013	2014	2015	Annual Average Rate of Change
Total Investment	Amount	13,763	18,344	17,245	11.9
	Rate of Change	-11.2	33.3	-6.0
R&D Investment	Amount	11,547	12,486	13,126	36.3
	Rate of Change	14.6	8.1	5.1
Facility Investment	Amount	2,216	5,858	4,120	-39.4
	Rate of Change	-59.1	164.3	-29.7

<Figure 2-16> 2013~2015 Bioindustry Investment Trend (Unit : one hundred million Won)

In comparison to 2014, overall size of investment for 2015 increased the most in bioassay, bioinformatics and  R&D service industry and biochemical industry by 25.4%, 22.8% each; however, its size decreased by 9.4% biopharmaceutical  industry.

<Table 2-13> 2013~2015 Bioindustry's Trend in Overall Size of Investment

(Unit : million Won, %)

Industrial Category	2013		2014		2015		Variation from the year before	Annual Average Rate of Change
	Investment Amount	Distribution Ratio	Investment Amount	Distribution Ratio	Investment Amount	Distribution Ratio
Total	1,376,336	100.0	1,834,358	100.0	1,724,522	100.0	-6.0	11.9
Biopharmaceutical industry	1,020,871	74.2	1,490,557	81.3	1,349,880	78.3	-9.4	15.0
Biochemical industry	110,416	8.0	111,254	6.1	136,647	7.9	22.8	11.2
Biofood industry	123,621	9.0	109,002	5.9	99,719	5.8	-8.5	-10.2
Bioenvironmental industry	12,596	0.9	11,254	0.6	10,976	0.6	-2.5	-6.7
Bioelectronics industry	22,579	1.6	24,199	1.3	23,851	1.4	-1.4	2.8
Bioprocess and equipment industry	20,038	1.5	21,025	1.1	22,591	1.3	7.4	6.2
Bioenergy and bioresource industry	22,938	1.7	22,635	1.2	25,120	1.5	11.0	4.6
Bioassay, bioinformatics and R&D service industry	43,277	3.1	44,432	2.4	55,738	3.2	25.4	13.5

In comparison to 2014, R&D cost for 2015 increased by 21.6% in biochemical industry, 6.3% in bioprocess and equipment  industry, 5.3% in biopharmaceutical industry. However, R&D cost decreased the most in 3 industry areas such as biofood industry (by 9.6%), bioenvironmental industry(by 3.8%), and bioelectronics industry (by 0.5%).

Bioassay, bioinformatics and  R&D service industry showed the highest increase in the facility investment cost of 2015 compared to 2014, reaching 141.6%. Bioenergy and bioresource  industry also showed a high rate with 69.8% increase. However, facility investment cost decreased the most in 3 industry areas such as biopharmaceutical industry (by 35.0%), bioassay, bioelectronics industry (by 18.3%), biofood industry (by 0.7%).

<Table 2-14> 2013~2015 Bioindustry's Trend of R&D and Facility Investment Cost

(Unit : million Won, %)

Industrial Category	2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	R&D	Facility	R&D	Facility	R&D	Facility	R&D	Facility	R&D	Facility
Total	1,154,719	221,617	1,248,594	585,764	1,312,560	411,962	5.1	-29.7	6.6	36.3
Biopharmaceutical industry	847,459	173,412	946,385	544,172	996,423	353,457	5.3	-35.0	8.4	42.8
Biochemical industry	95,247	15,169	97,220	14,034	118,190	18,457	21.6	31.5	11.4	10.3
Biofood industry	108,190	15,431	95,696	13,306	86,500	13,219	-9.6	-0.7	-10.6	-7.4
Bioenvironmental industry	10,717	1,879	9,550	1,704	9,183	1,793	-3.8	5.2	-7.4	-2.3
Bioelectronics industry	20,769	1,810	22,868	1,331	22,764	1,087	-0.5	-18.3	4.7	-22.5
Bioprocess and equipment industry	18,584	1,454	19,788	1,237	21,038	1,553	6.3	25.5	6.4	3.3
Bioenergy and bioresource industry	20,798	2,140	20,246	2,389	21,064	4,056	4.0	69.8	0.6	37.7
Bioassay, bioinformatics and R&D service industry	32,955	10,322	36,841	7,591	37,398	18,340	1.5	141.6	6.5	33.3

2) 2011~2015 Bioindustry's Trend of Investment

Total size of investment in bioindustry increased compared to its previous year in 2011 and 2012, while it decreased in 2013 by 11.2%, but increased in 2014 by 33.3%.

<Table 2-15> 2011~2015 Bioindustry's Trend of Investment

(Unit : one hundred million Won, %)

Classification		2011	2012	2013	2014	2015	Annual Average Rate of Change
Total Investment	Amount	12,907	15,495	13,763	18,344	17,245	7.5
	Rate of Change	27.4	20.1	-11.2	33.3	-6.0
R&D Investment	Amount	9,302	10,079	11,547	12,486	13,126	9.0
	Rate of Change	21	8.4	14.6	8.1	5.1
Facility Investment	Amount	3,605	5,417	2,216	5,858	4,120	3.4
	Rate of Change	47.2	50.3	-59.1	164.3	-29.7

<Figure 2-17> 2011~2015 Bioindustry Investment Trend (Unit : one hundred million Won)

For investment in bioindustry since 2011, the investment in biopharmaceutical industry accounts for approx. 70% or more of total investment and the proportion has been increasing gradually to 78.3% as of 2015.

However, investment size portion of biochemical industry and biofood industry within total industry, of which is 2nd and 3rd largest in volume, is in decreasing trend.

<Table 2-16> 2011~2015 Bioindustry's Trend in Overall Size of Investment

(Unit : million Won, %)

Industrial Category	2011		2012		2013		2014		2015		Variation from the year before	Annual Average Rate of Change
	Investment Amount	Distribution Ratio	Investment Amount	Distribution Ratio	Investment Amount	Distribution Ratio	Investment Amount	Distribution Ratio	Investment Amount	Distribution Ratio
Total	1,290,750	100.0	1,549,548	100.0	1,376,336	100.0	1,834,358	100.0	1,724,522	100.0	-6.0	7.5
Biopharmaceutical industry	903,350	70.0	1,142,819	73.8	1,020,871	74.2	1,490,557	81.3	1,349,880	78.3	-9.4	10.6
Biochemical industry	120,875	9.4	134,810	8.7	110,416	8.0	111,254	6.1	136,647	7.9	22.8	3.1
Biofood industry	144,887	11.2	139,888	9.0	123,621	9.0	109,002	5.9	99,719	5.8	-8.5	-8.9
Bioenvironmental industry	14,358	1.1	15,197	1.0	12,596	0.9	11,254	0.6	10,976	0.6	-2.5	-6.5
Bioelectronics industry	20,298	1.6	22,563	1.5	22,579	1.6	24,199	1.3	23,851	1.4	-1.4	4.1
Bioprocess and equipment industry	22,634	1.8	23,210	1.5	20,038	1.5	21,025	1.1	22,591	1.3	7.4	0.0
Bioenergy and bioresource industry	26,666	2.1	20,037	1.3	22,938	1.7	22,635	1.2	25,120	1.5	11.0	-1.5
Bioassay, bioinformatics and R&D service industry	37,682	2.9	51,024	3.3	43,277	3.1	44,432	2.4	55,738	3.2	25.4	10.3

In comparison to 2014, overall size of r&d investment increased the most in 2015 in biochemical industry (by 21.6%), bioprocess and equipment industry (by 6.3%), biopharmaceutical industry(by 5.3%).  However, it decreased in biofood industry (by 9.6%), bioenvironmental industry (by 3.8%).

In comparison to 2014, overall size of facility investment increased the most in 2015 in bioassay, bioinformatics and R&D service industry (by 141.6%), bioenergy and biosource industry (by 69.8%). However, it decreased in biopharmaceutical industry (by 35.0%), bioelectronics industry (by 18.3%), and in biofood industry (by 0.7%).

<Table 2-17> 2011~2015 Bioindustry's Trend of R&D and Facility Investment Cost

(Unit : one hundred million Won, %)

Industrial Category	2011		2012		2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	R&D	Facility	R&D	Facility	R&D	Facility	R&D	Facility	R&D	Facility	R&D	Facility	R&D	Facility
Total	9,302	3,605	10,079	5,417	11,547	2,216	12,486	5,858	13,126	4,120	5.1	-29.7	9.0	3.4
Biopharmaceutical industry	6,292	2,741	6,670	4,758	8,475	1,734	9,464	5,442	9,964	3,535	5.3	-35.0	12.2	6.6
Biochemical industry	966	243	1,137	211	952	152	972	140	1,182	185	21.6	31.5	5.2	-6.6
Biofood industry	1,136	313	1,231	168	1,082	154	957	133	865	132	-9.6	-0.7	-6.6	-19.4
Bioenvironmental industry	114	30	120	32	107	19	96	17	92	18	-3.8	5.2	-5.3	-12.1
Bioelectronics industry	182	21	209	16	208	18	229	13	228	11	-0.5	-18.3	5.8	-15.2
Bioprocess and equipment industry	200	27	212	20	186	15	198	12	210	16	6.3	25.5	1.3	-12.9
Bioenergy and bioresource industry	180	87	184	16	208	21	202	24	211	41	4.0	69.8	4.0	-17.4
Bioassay, bioinformatics and R&D service industry	233	144	314	196	330	103	368	76	374	183	1.5	141.6	12.6	6.2

4

Cooperation with Other Organizations

A. Cooperation Types

1) Cooperative Relationship with Other Organizations

Of 978 companies in total, 282 companies, 28.9%, have cooperative relationships with other organizations as of 2015.

< Figure 2-18 > Cooperative Relationship with Other Organizations

By bioindustrial categories, cooperative relationship was established in larger numbers in the order of biopharmaceutical, biochemical and biofood industries. The total number of cooperative relationships in the three industrial categories put together is 218, which is 80.9% of 275 companies holding cooperative relationships.

< Figure 2-19 > No. of Companies Holding Cooperative Relationships by Bioindustrial Category

2) Types of Cooperative Relationship with Other Organizations

Based on 282 companies, the most frequently found type of cooperative relationship was joint R&D contract at 81.9%. It was followed by technical tie-up and licensing (2 3.8%), domestic and international technical manpower exchange (11.3%) and joint investment (4.6%).

< Figure 2-20 > Types of Cooperative Relationship with Other Organizations

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

3) Number of Cooperation Cases by Cooperative Relationship Type

The total number of cooperative relationships of 282 companies is 1,119 which is broken down into 1,003 cooperative relationships in Korea (89.6%) and 116 abroad (10.4%).

The number of joint R&D contracts is 798 in Korea and 58 in abroad (856 in total). This is the most frequently found cooperative relationship type.

< Figure 2-21 > No. of Cooperation Cases by Cooperative Relationship Type
(Unit : Cases)

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

* Numbers in brackets are based on 2014 results.

The number of cooperation cases by bioindustrial category and cooperation type is 443 in biopharmaceutical industry. This accounts for 39.6% of 1,119 cases in total.

The number of cooperation cases in biofood and biochemical industries are 254 (22.7%) and 182 (16.3%) respectively. Number of cooperation cases by above mentioned 3 industries covers about 78.6% of total cases.

< Table 2-18 > No. of Cooperation Cases by Bioindustrial Category and Cooperation Type

(Unit : Cases)

Industrial Category	2014		2015		Cooperation Type
	Total	%	Total	%	Joint Investment	Joint R&D Contract	Technical Tie-up and Licensing	Technical Manpower Exchange
Total	1,060	(100.0%)	1,119	(100.0%)	39	856	153	71
Biopharmaceutical industry	401	(37.8%)	443	(39.6%)	35	302	95	11
Biochemical industry	173	(16.3%)	182	(16.3%)	1	147	24	10
Biofood industry	238	(22.5%)	254	(22.7%)	2	236	8	8
Bioenvironmental industry	28	(2.6%)	25	(2.2%)	1	14	9	1
Bioelectronics industry	74	(7.0%)	58	(5.2%)	-	35	2	21
Bioprocess and equipment industry	45	(4.2%)	38	(3.4%)	-	31	4	3
Bioenergy and bioresource industry	33	(3.1%)	33	(2.9%)	-	20	8	5
Bioassay, bioinformatics and R&D service industry	68	(6.4%)	86	(7.7%)	-	71	3	12

4) Number of Partners by Cooperative Relationship Type

As for cooperation types, 231 companies have established joint R&D contract relationships and the count of cooperation was found to be 856. It is identified that a company holding a joint R&D contract relationship has conducted an average of 3.7 cooperation cases arithmetically.

< Figure 2-22 > No. of Partners by Cooperative Relationship Type (Unit : Cases, Count)

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

* Numbers in brackets are based on 2014 results.

The number of companies holding cooperative relationships was the largest at 131 in biopharmaceutical industry. It was followed by biochemical and biofood industries.

< Table 2-19 > No. of Partners by Bioindustrial Category and Cooperation

Type                                            (Unit: Count)

Industrial Category	2014		2015		Cooperation Type
	Companies in Total	%	Companies in Total	%	Joint Investment	Joint R&D Contract	Technical Tie-up and Licensing	Technical Manpower Exchange
Total	330	(100.0%)	343	(100.0%)	13	231	67	32
Biopharmaceutical industry	121	(36.7%)	131	(38.2%)	9	79	35	8
Biochemical industry	75	(22.7%)	77	(22.4%)	1	55	14	7
Biofood industry	66	(20.0%)	69	(20.1%)	2	53	8	6
Bioenvironmental industry	16	(4.8%)	16	(4.7%)	1	9	5	1
Bioelectronics industry	8	(2.4%)	8	(2.3%)	-	6	1	1
Bioprocess and equipment industry	17	(5.2%)	16	(4.7%)	-	12	2	2
Bioenergy and bioresource industry	9	(2.7%)	10	(2.9%)	-	6	1	3
Bioassay, bioinformatics and R&D service industry	18	(5.5%)	16	(4.7%)	-	11	1	4

B. Cooperation Stages

1) Number of Cooperation Cases by Cooperation Stage

As per cooperation stage, 1,119 cooperation cases, the largest, were completed in the stage of basic research, which is 33.6% of 1,119 cases in total. It was followed by 354 cases in experiment stage (31.6%).

In commercialization stage, the final stage, 79 cases (7.1%) were completed, which is a relatively smaller number. This indicates that the companies cooperate frequently with other organizations in basic research and experiment stages, the initial stages.

Compared to its previous year, portion of cooperation cases in basic research stage and experiment stage slightly increased.

< Figure 2-23 > No. of Cooperation Cases by Cooperation Stage  (Unit : Cases)

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

< Table 2-20 >  No. of Cooperation Cases by Cooperation Stage (Unit : Cases)

Classification	Cooperative Relationships in Total	Domestic					Overseas
		Total	Joint Investment	Joint R&D	Technical Tie-up	Technical Manpower Exchange	Total	Joint Investment	Joint R&D	Technical Tie-up	Technical Manpower Exchange
Total of 2014	1,060	948	26	754	106	62	112	11	62	33	6
Total of 2015	1,119	1,003	30	798	112	63	116	9	58	41	8
Basic Research Stage	354	339	21	246	35	37	15	1	9	4	1
Experiment Stage	376	343	6	284	34	19	33	5	19	8	1
Prototype Stage	172	132	-	115	17	-	40	-	16	22	2
Product Development Stage	138	125	2	102	16	5	13	1	9	2	1
Commercialization Stage	79	64	1	51	10	2	15	2	5	5	3

By industry classification, no. of cooperations cases were most frequent in experiment stage for biopharmaceutical industry, biofood industry, and bioassay, bioinformatics and r&d service industry, while it occurred more frequent in basic research stage in other industry areas.

< Table 2-21 > No. of Cooperation Cases by Bioindustrial Category and

Cooperation Stage                         (Unit : Cases)

Industrial Category	Companies in Total	Companies with Cooperative Relationships	Cooperation Stage
			Basic Research Stage	Experiment Stage	Prototype Stage	Product Development Stage	Commercialization Stage	Total
Total	978	282	354	376	172	138	79	1,119	(100.0%)
Biopharmaceutical industry	330	100	122	155	96	51	19	443	(39.6%)
Biochemical industry	206	65	46	44	21	33	38	182	(16.3%)
Biofood industry	197	63	68	117	23	38	8	254	(22.7%)
Bioenvironmental industry	76	14	10	5	4	1	5	25	(2.2%)
Bioelectronics industry	22	6	43	3	7	3	2	58	(5.2%)
Bioprocess and equipment industry	71	14	8	10	7	9	4	38	(3.4%)
Bioenergy and bioresource industry	26	8	10	9	10	1	3	33	(2.9%)
Bioassay, bioinformatics and R&D service industry	50	12	47	33	4	2	-	86	(7.7%)

2) Number of Partners by Cooperation Stage

The number of companies with cooperative relationships by stage including those that made multiple responses is 693. By stage, 216 companies (31.2%) are in the stage of basic research.

When cooperation case and company number percentages are compared, the percentage of company count is lower than the rate of cooperation cases in basic research and experiment stages. This indicates that the average cooperation cases per company are larger in the initial stages of cooperation than the later stages.

< Figure 2-24 > No. of Partners by Cooperation Stage  (Unit : Cases, Count)

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

< Table 2-22 > No. of Partners by Cooperation Stage  (Unit : Cases, Count)

Classification		Total	Basic Research	Experimental	Prototype	Product Development	Commercialization
No. of cases	Domestic	1,003	339	343	132	125	64
	Overseas	116	15	33	40	13	15
Total		1,119	354	376	172	138	79
Percentage		100.0	31.6	33.6	15.4	12.3	7.1
No. of companies	Domestic	617	195	197	88	95	42
	Overseas	76	15	19	19	10	13
Total		693	210	216	107	105	55
Percentage		100.0	30.3	31.2	15.4	15.2	7.9

As for the number of partners by bioindustrial category and cooperation stage, there was a total of 559 partners in biopharmaceutical, biochemical and biofood industries(80.7% of all partners).

In biopharmaceutical and biofood industries, the percentage of experiment stage was found to be high.

< Table 2-23 > No. of Partners by Bioindustrial Category and Cooperation

Stage                                                 (Unit : Count)

Industrial Category	2014		2015		Cooperation Stage
	Companies in Total	%	Companies in Total	%	Basic Research	Experimental	Prototype	Product Development	Commercialization
Total	673	(100.0%)	693	(100.0%)	210	216	107	105	55
Biopharmaceutical industry	249	(37.0%)	278	(40.1%)	81	95	50	36	16
Biochemical industry	132	(19.6%)	132	(19.0%)	38	34	17	26	17
Biofood industry	150	(22.3%)	149	(21.5%)	43	51	19	28	8
Bioenvironmental industry	26	(3.9%)	22	(3.2%)	7	5	4	1	5
Bioelectronics industry	25	(3.7%)	24	(3.5%)	11	3	5	3	2
Bioprocess and equipment industry	33	(4.9%)	30	(4.3%)	5	7	6	8	4
Bioenergy and bioresource industry	25	(3.7%)	25	(3.6%)	9	9	3	1	3
Bioassay, bioinformatics and R&D service industry	33	(4.9%)	33	(4.8%)	16	12	3	2	-

C. Cooperating Organizations

1) Number of Cooperation Cases by Cooperating Organization

By cooperating organization, the number of cooperation cases with Business Entities was the largest at 429, which is 38.3% of 1,119 cases in total. It was followed by cooperation cases with Universities (391), research institutes (234) and medical institutes (65).

< Figure 2-25 > No. of Cooperation Cases by Cooperating Organization (Unit : Cases)

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

< Table 2-24 > No. of Cooperation Cases by Cooperating Organization (Unit : Cases)

Classification	Cooperative Relationships in Total	Domestic					Overseas
		Total	Joint Investment	Joint R&D	Technical Tie-up	Technical Manpower Exchange	Total	Joint Investment	Joint R&D	Technical Tie-up	Technical Manpower Exchange
Total	1,119	1,003	30	798	112	63	116	9	58	41	8
Business Entities	429	347	10	265	55	17	82	9	39	30	4
Small and Medium-scale Venture Companies	298	242	8	173	44	17	56	5	26	21	4
Middle-standing Companies	80	75	1	69	5	-	5	-	3	2	-
Large Enterprises	51	30	1	23	6	-	21	4	10	7	-
Research Institutes	234	221	2	188	14	17	13	-	5	8	-
Government-invested Research Institutes	185	174	1	154	10	9	11	-	3	8	-
Private Research Institutes	49	47	1	34	4	8	2	-	2	-	-
Universities	391	374	18	287	42	27	17	-	11	2	4
Medical Institutes	65	61	-	58	1	2	4	-	3	1	-

By bioindustrial category, the number of cooperation cases in biopharmaceutical and biofood industry were the largest with business entities. However, the cases of cooperation with in biochemical industries was relatively larger with research Institutes.

< Table 2-25 > No. of Cooperation Cases by Bioindustrial Category and

Cooperating Organization                      (Unit : Cases)

Industrial Category	Companies in Total	Companies with Cooperative Relationships	Cooperating Organization
			Business Entities	Research Institutes	Universities	Medical Institutes	Total
Total	978	282	429	234	391	65	1,119	(100.0%)
Biopharmaceutical industry	330	100	192	54	156	41	443	(39.6%)
Biochemical industry	206	65	57	71	54	-	182	(16.3%)
Biofood industry	197	63	110	31	105	8	254	(22.7%)
Bioenvironmental industry	76	14	9	3	13	-	25	(2.2%)
Bioelectronics industry	22	6	10	21	23	4	58	(5.2%)
Bioprocess and equipment industry	71	14	9	13	12	4	38	(3.4%)
Bioenergy and bioresource industry	26	8	12	11	7	3	33	(2.9%)
Bioassay, bioinformatics and R&D service industry	50	12	30	30	21	5	86	(7.7%)

2) Number of Partners by Cooperating Organization

The number of bio-companies holding cooperative relationships with universities is 197. It was found that an average of 2 cooperation cases was completed per each of these companies.

< Figure 2-26 > No. of Partners by Cooperating Organization (Unit : Cases, Count)

* Based on 282 companies with cooperative relationships.

Multiple responses accepted.

* Numbers in brackets are based on 2014 results.

By bioindustrial category, the number of partners in biopharmaceutical industry was the largest with business entities. However, the partners of cooperation in biochemical and biofood industries were relatively larger with universities.

< Table 2-26 > No. of Partners by Bioindustrial Category and Cooperating

Organization                                          (Unit : Cases)

Industrial Category	Companies in Total	Companies with Cooperative Relationships	Cooperating Organization
			Business Entities	Research Institutes	Universities	Medical Institutes	Total
Total	978	282	195	122	197	36	550	(100.0%)
Biopharmaceutical industry	330	100	96	36	70	20	222	(40.4%)
Biochemical industry	206	65	31	36	39	-	106	(19.3%)
Biofood industry	197	63	34	22	47	6	109	(19.8%)
Bioenvironmental industry	76	14	6	3	10	-	19	(3.5%)
Bioelectronics industry	22	6	5	5	5	4	19	(3.5%)
Bioprocess and equipment industry	71	14	7	8	9	3	27	(4.9%)
Bioenergy and bioresource industry	26	8	9	4	7	2	22	(4.0%)
Bioassay, bioinformatics and R&D service industry	50	12	7	8	10	1	26	(4.7%)

< Table 2-27 > Domestic and Overseas Cooperative Relationships and Cooperating Organizations                            (Unit : Cases, Count, %)

Classification			Total	Venture Companies	Middle-standing Companies	Large Enterprises	Government-invested Research Institutes	Private Research Institutes	Universities	Medical Institutes
Joint investment	Total Investments	Domestic	30	8	1	1	1	1	18	-
		Overseas	9	5	-	4	-	-	-	-
		Subtotal	39	13	1	5	1	1	18	-
	No. of Companies	Domestic	13	4	1	1	1	1	5	-
		Overseas	7	5	-	2	-	-	-	-
		Subtotal	20	9	1	3	1	1	5	-
Joint R&D contract	Total Investments	Domestic	798	173	69	23	154	34	287	58
		Overseas	58	26	3	10	3	2	11	3
		Subtotal	856	199	72	33	157	36	298	61
	No. of Companies	Domestic	364	76	15	14	75	20	134	30
		Overseas	35	14	2	4	3	2	8	2
		Subtotal	399	90	17	18	78	22	142	32
Technical tie-up and Licensing	Total Investments	Domestic	112	44	5	6	10	4	42	1
		Overseas	41	21	2	7	8	-	2	1
		Subtotal	153	65	7	13	18	4	44	2
	No. of Companies	Domestic	71	23	4	5	8	4	26	1
		Overseas	20	12	2	2	1	-	2	1
		Subtotal	91	35	6	7	9	4	28	2
Technical manpower change	Total Investments	Domestic	63	17	-	-	9	8	27	2
		Overseas	8	4	-	-	-	-	4	-
		Subtotal	71	21	-	-	9	8	31	2
	No. of Companies	Domestic	33	6	-	-	4	3	18	2
		Overseas	7	3	-	-	-	-	4	-
		Subtotal	40	9	-	-	4	3	22	2
Cooperation Cases in Total			1,119	298	80	51	185	49	391	65
Percentage			100.0	26.6	7.1	4.6	16.5	4.4	34.9	5.8
Companies in Total			550	143	24	28	92	30	197	36
Percentage			100.0	26.0	4.4	5.1	16.7	5.5	35.8	6.5

3) Cooperating Organizations by Scale of Workers

The number of cooperation cases between a small and medium-scale venture company with 1 - 299 workers and a same small and medium-scale venture company (with 1 - 299 workers) is large at 257.

The numbers of cooperation cases between a bioindustrial company with 1 - less than 50 workers and a university is large at 191.

< Table 2-28 > Cooperating Organizations by Scale of Workers   (Unit : Count)

Classification		Cooperative Relationships in Total	Business Entities				Research Institutes			Universities	Medical Institutes
			Total	Venture Companies	Middle-standing Companies	Large Enterprises	Total	Government-invested Research Institutes	Private Research Institutes
Total	Total	1,119	429	298	80	51	234	185	49	391	65
	1 – less than 50 workers	492	165	128	15	22	114	92	22	191	22
	50 – 299	383	152	129	11	12	63	44	19	139	29
	300 - 999	89	18	18	-	-	35	30	5	29	7
	1,000 or more	155	94	23	54	17	22	19	3	32	7
Domestic	Total	1,003	347	242	75	30	221	174	47	374	61
	1 – less than 50 workers	436	124	98	14	12	103	81	22	187	22
	50 – 299	338	124	108	7	9	61	44	17	128	25
	300 - 999	86	15	15	-	-	35	30	5	29	7
	1,000 or more	143	84	21	54	9	22	19	3	30	7
Overseas	Total	116	82	56	5	21	13	11	2	17	4
	1 – less than 50 workers	56	41	30	1	10	11	11	-	4	-
	50 –299	45	28	21	4	3	2	-	2	11	4
	300 - 999	3	3	3	-	-	-	-	-	-	-
	1,000 or more	12	10	2	-	8	-	-	-	2	-

※ 1-less than 50 workers : 574 companies. 50-299 : 272 companies. 300–999 : 75 companies. 1,000 or more : 46 companies.

5

Supply and Demand Status of Bioindustry

A. Bioindustry's Supply and Demand Status of 2015

Total size of supply in 2015 bioindustry reached 9.9 trillion won, and portion of production within total supply is 85.7% in portion, and its amount is 8.5 trillion won.  Size of import is 1.4 trillion won (14.3% in portion).  Total size of supply increased by 5.3% compared to last year.

Total size of domestic demand is 5.6 trillion won, which occupies 56.9% of total supply and its portion slightly decreased compared to last year; however, total size of export is 4.3 trillion won and it occupies 43.1% of total supply.

<Table 2-29> 2013~2015 Bioindustry's Trend of Supply and Demand

(Unit : one hundred million Won)

Year	Supply				Total	Demand
	Production		Import			Domestic Demand		Export
	Amount	Distribution Ratio	Amount	Distribution Ratio		Amount	Distribution Ratio	Amount	Distribution Ratio
2013	75,108	84.4	13,872	15.6	88,980	57,337	64.4	31,642	35.6
2014	76,070	84.5	14,006	15.5	90,076	56,024	62.2	34,052	37.8
2015	84,607	85.7	14,087	14.3	98,694	56,181	56.9	42,513	43.1
Annual Average Rate of Change	6.1		0.8		5.3	-1.0		15.9

The production size of domestic bioindustry in 2015 reached 8 trillion and 460.7 billion won. Among them, the domestic sales took 49.8% with 4 trillion and 209.4 billion won and the export took, 50.2% with 4 trillion and 251.3 billion won.

The size of domestic demand due to domestic sales and import reached  5 trillion and 618.1 billion won. Among them, the domestic sales took 74.9% with 4 trillion and 209.4 billion won and the import took 25.1% with 1 trillion and 408.7 billion won.

<Figure 2-27> 2015 Bioindustry's Size of Production and Domestic Demand

The production size of biopharmaceutical industry reached 3 trillion and 425.1 billion won which is 40.5% of the total industry, and biofood industry took 38.0% with 3 trillion and 217.4 billion won.

The biopharmaceutical industry reaching 2 trillion and 751.4 billion won which is 49.0% and the biofood industry reaching 1 trillion and 327.5 billion won which is 23.6% took 72.6% of the bioindustry's domestic demand market.

<Table 2-30> 2015 Bioindustry's Status of Production and Domestic Demand

Industrial Category	Production				Domestic Demand
	Domestic Sales	Export	Total	Distribution Ratio	Domestic Sales	Import	Total	Distribution Ratio
Total	4,209,360	4,251,346	8,460,706	100.0	4,209,360	1,408,699	5,618,059	100.0
Biopharmaceutical industry	1,530,701	1,894,416	3,425,116	40.5	1,530,701	1,220,685	2,751,386	49.0
Biochemical industry	436,206	135,203	571,409	6.8	436,206	87,710	523,916	9.3
Biofood industry	1,291,411	1,925,962	3,217,373	38.0	1,291,411	36,076	1,327,487	23.6
Bioenvironmental industry	30,311	303	30,614	0.4	30,311	119	30,430	0.5
Bioelectronics industry	30,774	129,425	160,199	1.9	30,774	770	31,544	0.6
Bioprocess and equipment industry	89,044	73,548	162,592	1.9	89,044	53,781	142,825	2.5
Bioenergy and bioresource industry	600,073	46,741	646,814	7.6	600,073	8,194	608,267	10.8
Bioassay, bioinformatics and R&D service industry	200,840	45,749	246,589	2.9	200,840	1,364	202,204	3.6

(Unit : million Won, %)

Size of supply and domestic demand in Gyeonggi area occupies 49.5%, 31.4% each in total industry and is the highest compared to other areas.

< Table 2-31 > 2015 Bioindustry's Status of Production and Domestic

Demand by Area                        (Unit : million Won, %)

Area	Production				Domestic Demand
	Domestic Sales	Export	Total	Distribution Ratio	Domestic Sales	Import	Total	Distribution Ratio
Total	4,209,360	4,251,346	8,460,706	100.0	4,209,360	1,408,699	5,618,059	100.0
Seoul	238,744	54,431	293,175	3.5	238,744	864,970	1,103,714	19.6
Busan	1,011	-	1,011	0.0	1,011	-	1,011	0.0
Daegu	8,899	1,209	10,108	0.1	8,899	-	8,899	0.2
Incheon	39,083	664,891	703,974	8.3	39,083	132,872	171,955	3.1
Gwangju	3,434	977	4,411	0.1	3,434	-	3,434	0.1
Daejeon	188,203	120,768	308,971	3.7	188,203	60,509	248,712	4.4
Ulsan	371,010	20,814	391,824	4.6	371,010	-	371,010	6.6
Sejong	22,920	170	23,090	0.3	22,920	1,859	24,779	0.4
Gyeonggi	1,600,425	2,586,695	4,187,120	49.5	1,600,425	163,492	1,763,917	31.4
Gangwon	78,762	135,545	214,307	2.5	78,762	5,416	84,178	1.5
Chungbuk	1,051,395	352,288	1,403,683	16.6	1,051,395	155,612	1,207,007	21.5
Chungnam	78,827	15,076	93,903	1.1	78,827	15,805	94,632	1.7
Jeonbuk	313,390	259,741	573,131	6.8	313,390	1,697	315,087	5.6
Jeonnam	157,216	1,163	158,379	1.9	157,216	-	157,216	2.8
Gyeongbuk	37,116	10,060	47,176	0.6	37,116	-	37,116	0.7
Gyeongnam	15,287	27,239	42,526	0.5	15,287	6,466	21,753	0.4
Jeju	3,638	281	3,919	0.0	3,638	-	3,638	0.1

B. Recent Trend of Supply and Demand Status

1) 2013~2015 Trend of Supply and Demand Status

Bioindustry's trend of production from 2013 to 2015 continues to increase. Total size of domestic demand increased up to 2015 by 0.3% compared to its previous year.

For the average variation rate per year since 2013, the supply and demand marked 5.3%, production 6.1%, and domestic demand -1.0%.

<Table 2-32> 2013~2015 Bioindustry's Trend of Production and Domestic Demand

(Unit : one hundred million Won, %)

Classification		2013	2014	2015	Annual Average Rate of Change
Supply and Demand (Production+Import)	Investment Amount	88,980	90,076	98,694	5.3
	Distribution Ratio	3.8	1.2	9.6
Production (Domestic Sales+Export)	Investment Amount	75,108	76,070	84,607	6.1
	Distribution Ratio	5.1	1.3	11.2
Domestic Demand (Domestic Sales+Import)	Investment Amount	57,337	56,024	56,181	-1.0
	Distribution Ratio	3.7	-2.3	0.3

<Figure 2-28> 2013~2015 Bioindustry's Trend of Production and Domestic Demand

(Unit : one hundred million Won)

The production sector increased by 11.2% in 2015 compared to 2014, and Bioprocess and equipment industry industry reached the highest growth rate with 29.5%.

Total supply of biopharmaceutical industry and biofood industry, which occupies the largest portion in the total industry, increased by 19.3% and 5.9%.

The domestic demand sector decreased by 0.3% in 2015 compared to 2014.

Domestic demand of biopharmaceutical industry equal to 2014, while that of biofood industry decreased by 5.4%, which are 2 industries that occupy largest portion in total industry.

<Table 2-33> 2013~2015 Bioindustry's Trend of Supply and Demand by Category

(Unit : one hundred million Won, %)

Industrial Category	Production					Domestic Demand
	2012	2013	2014	Variation from the year before	Annual Average Rate of Change	2012	2013	2014	Variation from the year before	Annual Average Rate of Change
Total	75,108	76,070	84,607	11.2	6.1	57,337	56,024	56,181	0.3	-1.0
Biopharmaceutical industry	27,635	28,709	34,251	19.3	11.3	28,490	27,514	27,514	0.0	-1.7
Biochemical industry	5,622	5,484	5,714	4.2	0.8	5,147	4,972	5,239	5.4	0.9
Biofood industry	30,211	30,392	32,174	5.9	3.2	13,666	14,032	13,275	-5.4	-1.4
Bioenvironmental industry	301	306	306	0.0	0.9	303	306	304	-0.7	0.2
Bioelectronics industry	1,517	1,543	1,602	3.8	2.8	373	363	315	-13.1	-8.0
Bioprocess and equipment industry	1,216	1,255	1,626	29.5	15.6	1294	1203	1428	18.7	5.1
Bioenergy and bioresource industry	6,659	6,217	6,468	4.0	-1.4	6,504	5,870	6,083	3.6	-3.3
Bioassay, bioinformatics and R&D service industry	1,947	2,161	2,466	14.1	12.5	1,560	1,764	2,022	14.6	13.8

Domestic Demand

2) 2011~2015 Trend of Supply and Demand

Bioindustry's trend of supply and demand from 2011 to 2015 can be summarized as follows: Bioindustry's supply continues to increase upto 2015, while demand increased upto 2013 but slightly decreased in 2014 by 2.3%.

Due to such tendency, growth range of total supply and demand is in increasing trend as of 2015, so average growth rate of total supply and demand since 2011 was 5.5%, and that of production was 7.2%, while that of demand was 1.9%.

<Table 2-34> 2011~2015 Bioindustry's Trend of Supply and Demand

(Unit : one hundred million Won, %)

Classification		2011	2012	2013	2014	2015	Annual Average Rate of Change
Supply and Demand (Production+Import)	Investment Amount	79,574	85,756	88,980	90,076	98,694	5.5
	Distribution Ratio	10.6	7.8	3.8	1.2	9.6
Production (Domestic Sales+Export)	Investment Amount	63,963	71,445	75,108	76,070	84,607	7.2
	Distribution Ratio	10.5	11.7	5.1	1.3	11.2
Domestic Demand (Domestic Sales+Import)	Investment Amount	52,081	55,281	57,337	56,024	56,181	1.9
	Distribution Ratio	9.6	6.1	3.7	-2.3	0.3

<Figure 2-29> 2011~2015 Bioindustry's Trend of Supply and Demand

(Unit : one hundred million Won)

<Table 2-35> 2011~2015 Bioindustry's Trend of Supply and Demand by Category

(Unit : one hundred million Won, %)

Industrial Category	Production							Domestic Demands
	2011	2012	2013	2014	2015	Variation from the year before	Annual Average Rate of Change	2010	2011	2012	2013	2014	Variation from the year before	Annual Average Rate of Change
Total	63,964	71,445	75,108	76,070	84,607	11.2	7.2	52,081	55,281	57,337	56,024	56,181	0.3	1.9
Biopharmaceutical industry	24,607	27,087	27,635	28,709	34,251	19.3	8.6	27,367	28,194	28,490	27,514	27,514	0.0	0.1
Biochemical industry	4,305	5,030	5,622	5,484	5,714	4.2	7.3	4,354	4,749	5,147	4,972	5,239	5.4	4.7
Biofood industry	25,978	28,579	30,211	30,392	32,174	5.9	5.5	10,989	13,019	13,666	14,032	13,275	-5.4	4.8
Bioenvironmental industry	1,092	275	301	306	306	0.0	-27.2	1,066	277	303	306	304	-0.7	-26.9
Bioelectronics industry	1,164	1,238	1,517	1,543	1,602	3.8	8.3	239	242	373	363	315	-13.1	7.2
Bioprocess and equipment industry	811	1,219	1,216	1,255	1,626	29.5	19.0	2,496	1,308	1,294	1,203	1,428	18.7	-13.0
Bioenergy and bioresource industry	4,387	6,122	6,659	6,217	6,468	4.0	10.2	4,237	5,959	6,504	5,870	6,083	3.6	9.5
Bioassay, bioinformatics and R&D service industry	1,620	1,895	1,947	2,161	2,466	14.1	11.1	1,333	1,533	1,560	1,764	2,022	14.6	11.0

6

Domestic Sales of Bioindustry

A. Domestic Sales Status of 2015

The size of bioindustry's domestic sales in 2015 reached 4 trillion and 209.4 billion won and biopharmaceutical industry took the largest proportion among them with 1 trillion and 530.7 billion won(36.4%).

The following largest industries were biofood industry with 1 trillion and 291.4 billion won(30.7%) and bioenergy and bioresource industry with 600.1 billion won(14.3%).

Biopharmaceutical industry, biofood industry, bioenergy and bioresource industry took 77.4%(78.9% in 2014) of the total market for the bioindustry's domestic sales in 2015.

<Figure 2-30> 2015 Bioindustry's Size of Domestic Sales by Category

[Table 2-36] shows the domestic bioproducts or bioservices that have more than 1.0% domestic sales among 51 domestic bioproducts and bioservices, according to the size. Feed additive‘s size of domestic sales took 15.8% of the total bioindustry with 665.8 billion won.

The following largest bioproducts or bioservices were Other biopharmaceuticals(13.5%), Biofuel(9.6%), Functional health foods(7.6%), Hemotherapeutics(7.5%). Among the TOP5 products, 2 items belonged to biofood industry.

<Table 2-36> 2015 Main Bioproduct's Size of Domestic Sales     (Unit : million Won, %)

Ranking	Code	Product Name	Domestic Sales	Distribution Ratio
1	3050	Feed additives	665,750	15.8
2	1000	Other biopharmaceuticals	567,339	13.5
3	7010	Biofuel	402,803	9.6
4	3010	Functional health foods	319,109	7.6
5	2040	Hemotherapeutics	315,392	7.5
6	1030	Vaccines	289,707	6.9
7	1060	Biocosmetics and home & personal care chemicals	266,156	6.3
8	3030	Food additives	166,587	4.0
9	7020	Artificial seeds and seedlings	126,731	3.0
10	1040	Hormones	113,401	2.7
11	1100	Animal medications	101,869	2.4
12	8050	Biosafety and efficacy evaluation services	92,781	2.2
13	3040	Fermented foods	89,762	2.1
14	1080	New therapeutics	54,908	1.3
15	1020	Anticancer medications	48,078	1.1
16	8020	Gene analysis services	47,212	1.1
17	7000	Other bioenergy and bioresources	44,854	1.1

B. Recent Trend of Domestic Sales Status

1) 2013~2015 Trend of Domestic Sales Status

The size of bioindustry's domestic sales in 2015 increased by 7.6 billion won(0.2%) with 4 trillion and 209.4 billion won compared to 4 trillion and 201.8 billion won in 2014.

<Table 2-37> 2011~2015 Bioindustry's Trend of Domestic Sales

(Unit : one hundred million Won, %)

Classification		2013	2014	2015	Annual Average Rate of Change
Domestic Sales	Amount of money	43,465	42,018	42,094	-1.6
	Rate of Change	6.1	-3.3	0.2

<Figure 2-31> 2013~2015 Bioindustry's Trend of Domestic Sales

(Unit : one hundred million Won)

The growth size of biopharmaceutical industry increased by 0.1% with 19.6 billion won compared to 2014.

Domestic sales volume of bioprocess and equipment industry increased as compared to 2014 by 35.8%, while that of bioassay, bioinformatics and R&D service industry increased by 14.8%, and their portion in total market also increased.

However, domestic sales volume of biofood industry decreased (by 80.7 billion won), while that of bioelectronics industry also decreased by 4.8 billion won.

<Table 2-38> 2011~2015 Bioindustry's Trend of Domestic Sales by Category

(Unit : million Won, %)

Industrial Category	2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	Domestic Sales	Distribution Ratio	Domestic Sales	Distribution Ratio	Domestic Sales	Distribution Ratio	Domestic Sales	Rate of Change
Total	4,346,527	100.0	4,201,792	100.0	4,209,360	100.0	7,568	0.2	-1.6
Biopharmaceutical industry	1,627,163	37.4	1,528,742	36.4	1,530,701	36.4	1,959	0.1	-3.0
Biochemical industry	451,091	10.4	416,107	9.9	436,206	10.4	20,099	4.8	-1.7
Biofood industry	1,338,933	30.8	1,372,073	32.7	1,291,411	30.7	-80,662	-5.9	-1.8
Bioenvironmental industry	30,093	0.7	30,412	0.7	30,311	0.7	-101	-0.3	0.4
Bioelectronics industry	35,814	0.8	35,550	0.8	30,774	0.7	-4,776	-13.4	-7.3
Bioprocess and equipment industry	72,391	1.7	65,549	1.6	89,044	2.1	23,495	35.8	10.9
Bioenergy and bioresource industry	637,245	14.7	578,470	13.8	600,073	14.3	21,603	3.7	-3.0
Bioassay, bioinformatics and R&D service industry	153,797	3.5	174,888	4.2	200,840	4.8	25,952	14.8	14.3

2) 2011~2015 Trend of Domestic Sales

Since 2011, the average variation rate per year for the past 5 years showed  3.7%.

Total size of domestic sales continued to increase up to 2013 but slightly decreased in 2014 by 3.3%  compared to its previous year, but total size remains above 4 trillion won.

<Table 2-39> 2011~2015 Bioindustry's Trend of Domestic Sales

(Unit : one hundred million Won, %)

Classification		2011	2012	2013	2014	2015	Annual Average Rate of Change
Domestic Sales	Amount of money	36,469	40,970	43,465	42,018	42,094	3.7
	Rate of Change	9.0	12.3	6.1	-3.3	0.2

<Figure 2-32> 2011~2015 Bioindustry's Trend of Domestic Sales

(Unit : one hundred million Won)

<Table 2-40> 2011~2015 Bioindustry's Trend of Domestic Sales by Category

(Unit : million Won, %)

Industrial Category	2011		2012		2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	Domestic Sales	Distribution Ratio	Domestic Sales	Distribution Ratio	Domestic Sales	Distribution Ratio	Domestic Sales	Distribution Ratio	Domestic Sales	Distribution Ratio	Domestic Sales	Rate of Change
Total	3,646,896	100	2,907,448	100	4,346,527	100	4,201,792	100	4,209,360	100	7,568	0.2	3.7
Biopharmaceutical industry	1,506,329	41.3	1,577,524	54.3	1,627,163	37.4	1,528,742	36.4	1,530,701	36.4	1,959	0.1	0.4
Biochemical industry	355,684	9.8	406,185	14.0	451,091	10.4	416,107	9.9	436,206	10.4	20,099	4.8	5.2
Biofood industry	1,065,834	29.2	1,250,255	43.0	1,338,933	30.8	1,372,073	32.7	1,291,411	30.7	-80,662	-5.9	4.9
Bioenvironmental industry	106,381	2.9	27,446	0.9	30,093	0.7	30,412	0.7	30,311	0.7	-101	-0.3	-26.9
Bioelectronics industry	23,738	0.7	23,987	0.8	35,814	0.8	35,550	0.8	30,774	0.7	-4,776	-13.4	6.7
Bioprocess and equipment industry	43,895	1.2	76,691	2.6	72,391	1.7	65,549	1.6	89,044	2.1	23,495	35.8	19.3
Bioenergy and bioresource industry	413,275	11.3	582,984	20.1	637,245	14.7	578,470	13.8	600,073	14.3	21,603	3.7	9.8
Bioassay, bioinformatics and R&D service industry	131,760	3.6	151,952	5.2	153,797	3.5	174,888	4.2	200,840	4.8	25,952	14.8	11.1

7

Export Status of Bioindustry

A. Export Status of 2015

The size of bioindustry's export in 2015 reached 4 trillion and 251.3 billion won.

Biofood industry took the largest proportion with 1 trillion and 926.0 billion won(45.3%) and the following largest industry was biopharmaceutical industry with 1 trillion and 894.4 billion won(44.6%) according to the bioindustry's size of export by category.

<Figure 2-33> 2015 Bioindustry's Size of Export by Category

[Table 2-41] shows domestic bioproducts or bioservices that have more than 1.0% export amount among 51 domestic bioproducts and bioservices, according to the size. 14 products showed more than 1.0% of exports.

Feed additives ranked the highest amount of export with 1 trillion and  453.7 billion won(34.2%) and the following largest were Other biopharmaceuticals(13.4%), Immunotherapeutics(12.1%), Food additives(8.9%), and Vaccines(5.5%). Among the TOP5 products, 3 items belonged to biopharmaceutical and 2 items belonged to biofood industry.

<Table 2-41> 2015 Main Bioproduct's Export                     (Unit : million Won, %)

Ranking	Code	Product Name	Domestic Sales	Distribution Ratio
1	3050	Feed additives	1,453,657	34.2
2	1000	Other biopharmaceuticals	568,214	13.4
3	1050	Immunotherapeutics	514,228	12.1
4	3030	Food additives	377,648	8.9
5	1030	Vaccines	235,257	5.5
6	1090	Diagnostic kits	203,730	4.8
7	5040	Biosensors	128,121	3.0
8	1060	Hemotherapeutics	95,309	2.2
9	1010	Anticancer medications	81,907	1.9
10	1040	Hormones	80,065	1.9
11	1020	Antibiotics	79,960	1.9
12	3020	Amino acids	52,368	1.2
13	2030	Enzymes and reagents for research	43,074	1.0
14	2040	Biocosmetics and home & personal care chemicals	41,556	1.0

B. Recent Trend of Export Status

1) 2013~2015 Trend of Export

The amount of bioindustry's export in 2015 increased by 846.2 billion won(24.8%) with 4 trillion and 251.3 billion won compared to 3 trillion and 405.2 billion won in 2014.

<Table 2-42> 2013~2015 Bioindustry's Trend of Export (Unit : one hundred million Won, %)

Classification		2013	2014	2015	Annual Average Rate of Change
Export	Amount	31,642	34,052	42,513	15.9
	Rate of Change	3.8	7.6	24.8

<Figure 2-34> 2013~2015 Bioindustry's Trend of Export  (Unit : one hundred million Won)

Biopharmaceutical industry export recorded the highest increase to 1 trillion 894.4 billion won by 552.2 billion won (41.1%) from 2014.

<Table 2-43> 2013~2015 Bioindustry's Trend of Export by Category

(Unit : million Won, %)

Industrial Category	2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	Amount of Export	Distribution Ratio	Amount of Export	Distribution Ratio	Amount of Export	Distribution Ratio	Amount of Export	Rate of Change
Total	3,164,248	100.0	3,405,174	100.0	4,251,346	100.0	846,172	24.8	15.9
Biopharmaceutical industry	1,136,385	35.9	1,342,190	39.4	1,894,416	44.6	552,225	41.1	29.1
Biochemical industry	111,110	3.5	132,339	3.9	135,203	3.2	2,865	2.2	10.3
Biofood industry	1,682,131	53.2	1,667,157	49.0	1,925,962	45.3	258,805	15.5	7.0
Bioenvironmental industry	12	0.0	192	0.0	303	0.0	111	58.0	402.6
Bioelectronics industry	115,882	3.7	118,782	3.5	129,425	3.0	10,643	9.0	5.7
Bioprocess and equipment industry	49,177	1.6	59,997	1.8	73,548	1.7	13,551	22.6	22.3
Bioenergy and bioresource industry	28,690	0.9	43,272	1.3	46,741	1.1	3,469	8.0	27.6
Bioassay, bioinformatics and R&D service industry	40,861	1.3	41,244	1.2	45,749	1.1	4,505	10.9	5.8

2) 2011~2015 Trend of Export

Total size of export continued to increase since 2011, and had large increase in 2015.

Since 2011, bioindustry's export showed continuous growth with 11.5% increase of average variation rate per year.

<Table 2-44> 2011~2015 Bioindustry's Trend of Export

(Unit : one hundred million Won, %)

Classification		2011	2012	2013	2014	2015	Annual Average Rate of Change
Export	Amount	27,494	30,475	31,642	34,052	42,513	11.5
	Rate of Change	12.6	10.8	3.8	7.6	24.8

<Figure 2-35> 2011~2015 Bioindustry's Trend of Export (Unit : one hundred million Won)

<Table 2-45> 2011~2015 Bioindustry's Trend of Export by Category

(Unit : million Won, %)

Industrial Category	2011		2012		2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	Amount of Export	Distribution Ratio	Amount of Export	Distribution Ratio	Amount of Export	Distribution Ratio	Amount of Export	Distribution Ratio	Amount of Export	Distribution Ratio	Domestic Sales	Rate of Change
Total	2,749,355	100.0	3,047,521	100.0	3,164,248	100.0	3,405,174	100.0	4,251,346	100.0	846,172	24.8	11.5
Biopharmaceutical industry	954,412	34.7	1,131,198	37.1	1,136,385	35.9	1,342,190	39.4	1,894,416	44.6	552,225	41.1	18.7
Biochemical industry	74,783	2.7	96,766	3.2	111,110	3.5	132,339	3.9	135,203	3.2	2,865	2.2	16.0
Biofood industry	1,531,965	55.7	1,607,654	52.8	1,682,131	53.2	1,667,157	49.0	1,925,962	45.3	258,805	15.5	5.9
Bioenvironmental industry	2,782	0.1	18	0.0	12	0.0	192	0.0	303	0.0	111	58.0	-42.5
Bioelectronics industry	92,623	3.4	99,841	3.3	115,882	3.7	118,782	3.5	129,425	3.0	10,643	9.0	8.7
Bioprocess and equipment industry	37,199	1.4	45,256	1.5	49,177	1.6	59,997	1.8	73,548	1.7	13,551	22.6	18.6
Bioenergy and bioresource industry	25393	0.9	29,254	1.0	28,690	0.9	43,272	1.3	46,741	1.1	3,469	8.0	16.5
Bioassay, bioinformatics and R&D service industry	30,198	1.1	37,534	1.2	40,861	1.3	41,244	1.2	45,749	1.1	4,505	10.9	10.9

8

Import Status of Bioindustry

A. Import Status of 2015

The size of bioindustry's import in 2015 reached 1 trillion and 408.7 billion won.

Biopharmaceutical industry showed the highest proportion among the total import amount with 1 trillion and 220.7 billion won(86.7%) according to the bioindustry's size of import by category.

<Figure 2-36> 2015 Bioindustry's Size of Import by Category

Among 51 domestic bioproducts and bioservices, there is 13 products that have more than 1.0% import amount.

Among bioproducts, vaccines ranked the highest import amount among the total imports with 270.7 billion won(19.2%) and then the following highest products were hormones with 231.8 billion won(16.5%), other biopharmaceuticals with 215.7 billion won(15.3%), hemotherapeutics with 199.6 billion won(14.2%), and anticancer medications with 170.1 billion won(12.1%)

8 products among 14 belonged to biopharmaceutical industry according to the size of imports, and it took 85.0% among the total import amount.

<Table 2-46> 2015 Main Bioproduct's Import        (Unit : million Won, %)

Ranking	Code	Product Name	Domestic Sales	Distribution Ratio
1	1030	Vaccines	270,708	19.2
2	1040	Hormones	231,750	16.5
3	1000	Other biopharmaceuticals	215,701	15.3
4	1060	Hemotherapeutics	199,641	14.2
5	1020	Anticancer medications	170,144	12.1
6	1050	Immunotherapeutics	62,733	4.5
7	6030	Bioprocess and analysis equipments	50,519	3.6
8	2030	Enzymes and reagents for research	44,189	3.1
9	1090	Diagnostic kits	30,714	2.2
10	2000	Other biochemicals	21,927	1.6
11	2020	Industrial enzymes and reagents	16,984	1.2
12	3010	Functional health foods	16,651	1.2
13	1010	Antibiotics	16,243	1.2

B. Recent Trend of Import Status

1) 2013~2015 Bioindustry's Trend of Import

The amount of bioindustry's import in 2015 increased by 8.1 billion won(0.6%) with 1 trillion and 408.7 billion won compared to 1 trillion and 400.6 billion won in 2014.

The average variation rate per year for 2013~2015 is 0.8%.

<Table 2-47> 2013~2015 Bioindustry's Trend of Import

(Unit : one hundred million Won, %)

Classification		2013	2014	2015	Annual Average Rate of Change
Import	Amount	13,872	14,006	14,087	0.8
	Rate of Change	-3.1	1.0	0.6

<Figure 2-37> 2013~2015 Bioindustry's Trend of Import  (Unit : one hundred million Won)

<Table 2-48> 2013~2015 Bioindustry's Trend of Import by Category

(Unit : million Won, %)

Industrial Category	2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	Amount of Import	Distribution Ratio	Amount of Import	Distribution Ratio	Amount of Import	Distribution Ratio	Amount of Import	Rate of Change
Total	1,387,198	100.0	1,400,645	100.0	1,408,699	100.0	8,054	0.6	0.8
Biopharmaceutical industry	1,221,854	88.1	1,222,661	87.3	1,220,685	86.7	-1,976	-0.2	0.0
Biochemical industry	63,609	4.6	81,114	5.8	87,710	6.2	6,596	8.1	17.4
Biofood industry	27,639	2.0	31,140	2.2	36,076	2.6	4,935	15.8	14.2
Bioenvironmental industry	226	0.0	226	0.0	119	0.0	-107	-47.3	-27.5
Bioelectronics industry	1,471	0.1	760	0.1	770	0.1	10	1.3	-27.6
Bioprocess and equipment industry	57,026	4.1	54,737	3.9	53,781	3.8	-956	-1.7	-2.9
Bioenergy and bioresource industry	13,142	0.9	8,525	0.6	8,194	0.6	-331	-3.9	-21.0
Bioassay, bioinformatics and R&D service industry	2,231	0.2	1,482	0.1	1,364	0.1	-118	-8.0	-21.8

2) 2011~2015 Bioindustry's Trend of Import

Domestic bioindustry's import decreased in 2012 and 2013, but increased again in 2014 and 2015. Its average increase rate of import per year marked –2.5% since 2011.

<Table 2-49> 2011~2015 Bioindustry's Trend of Import (Unit : one hundred million Won, %)

Classification		2011	2012	2013	2014	2015	Annual Average Rate of Change
Import	Amount	15,612	14,311	13,872	14,006	14,087	-2.5
	Rate of Change	11.1	-8.3	-3.1	1.0	0.6

<Figure 2-38> 2011~2015 Bioindustry's Trend of Import

(Unit : one hundred million Won)

<Table 2-50> 2011~2015 Bioindustry's Trend of Import by Category

(Unit : one hundred million Won, %)

Industrial Category	2011		2012		2013		2014		2015		Variation from the year before		Annual Average Rate of Change
	Amount of Import	Distribution Ratio	Amount of Import	Distribution Ratio	Amount of Import	Distribution Ratio	Amount of Import	Distribution Ratio	Amount of Import	Distribution Ratio	Domestic Sales	Rate of Change
Total	1,561,182	100	1,431,097	100	1,387,198	100	1,400,645	100	1,408,699	100	8,054	0.6	-2.5
Biopharmaceutical industry	1,230,328	78.8	1,241,893	86.8	1,221,854	88.1	1,222,661	87.3	1,220,685	86.7	-1,976	-0.2	-0.2
Biochemical industry	79,718	5.1	68,726	4.8	63,609	4.6	81,114	5.8	87,710	6.2	6,596	8.1	2.4
Biofood industry	33,073	2.1	51,680	3.6	27,639	2.0	31,140	2.2	36,076	2.6	4,935	15.8	2.2
Bioenvironmental industry	239	0.0	230	0.0	226	0.0	226	0.0	119	0.0	-107	-47.3	-16.0
Bioelectronics industry	150	0.0	248	0.0	1,471	0.1	760	0.1	770	0.1	10	1.3	50.5
Bioprocess and equipment industry	205,724	13.2	54,113	3.8	57,026	4.1	54,737	3.9	53,781	3.8	-956	-1.7	-28.5
Bioenergy and bioresource industry	10,436	0.7	12,897	0.9	13,142	0.9	8,525	0.6	8,194	0.6	-331	-3.9	-5.9
Bioassay, bioinformatics and R&D service industry	1514	0.1	1310	0.1	2231	0.2	1,482	0.1	1,364	0.1	-118	-8.0	-2.6

III. Statistical Tables

III. Statistical Tables

Content

< Table 1 > General Status of Company

< Table 1-1 > Distribution by Geography(Ⅰ-7)

< Table 1-2 > Existence of other business within the company(Ⅱ-4-1)	< Table 1-3 > Distribution by Type of Company[Duplication](Ⅱ-4-2)	< Table 1-4 > Distribution by Establishment Year	(Ⅰ-6)	< Table 1-5 > Distribution by total number of workers' size(Ⅱ-3)	< Table 1-6 > Size of Capital(Ⅱ-1)

< Table 1-7 > Ratio of Net Worth(Ⅱ-2)

< Table 2 > Manpower Status of Bioindustry

< Table 2-1 > Manpower Size of Researchers(Ⅲ-2)	< Table 2-2 > Manpower Size of Production Workers(Ⅲ-2)	< Table 2-3 > Manpower Size of Others such as sales/administrative(Ⅲ-2)

< Table 3 > Investment Status of Bioindustry(Ⅲ-3)

< Table 4 > Cooperation in Bioindustry

< Table 4-1 > Domestic Scale of Joint Investment Cooperation (Ⅲ-4)

< Table 4-2 > Overseas Scale of Joint Investment Cooperation (Ⅲ-4)

< Table 4-3 > Domestic Scale of Joint R&D Contract Cooperation (Ⅲ-4)

< Table 4-4 > Overseas Scale of Joint R&D Contract Cooperation (Ⅲ-4)

< Table 4-5 > Domestic Scale of Technical Tie-up (Licensing) Cooperation (Ⅲ-4)

< Table 4-6 > Overseas Scale of Technical Tie-up (Licensing) Cooperation (Ⅲ-4)

< Table 4-7 > Domestic Scale of Domestic/ International Technical Manpower

Exchange Cooperation (Ⅲ-4)

< Table 4-8 > Overseas Scale of Domestic/ International Technical Manpower

Exchange Cooperation (Ⅲ-4)

< Table 5 > Size of Sales and Import in Bioindustry

< Table 5-1 > Size of Domestic Sales and Export by Category among Classification Scheme of Bioindustry (Ⅲ-6)

< Table 5-2 > Size of Import by Category among Classification Scheme of Bioindustry(Ⅲ-7)

< Table 1 > General Status of Company

< Table 1-1 > Distribution by Geography(Ⅰ-7)

	Total	Seoul	Busan	Daegu	Incheon	Gwangju	Daejeon	Ulsan	Sejong	Gyeonggi	Gangwon	Chungbuk	Chungnam	Jeonbuk	Jeonnam	Gyeongbuk	Gyeongnam	Jeju
Number of companies	978	185	14	23	22	10	81	9	6	313	55	72	57	26	28	34	29	14
▣ Sales Situation
No sales	281	52	5	8	9	3	18	2	2	106	12	14	17	6	9	7	6	5
Sales below break-even - 1 year	10	4	-	-	-	-	1	-	-	4	1	-	-	-	-	-	-	-
Sales below break-even - 2~3 years	63	10	1	1	2	2	9	1	1	14	6	6	1	2	2	3	2	-
Sales below break-even - 4~5 years	96	15	-	7	2	1	11	-	1	25	5	2	10	5	2	5	4	1
Sales below break-even - 6~9 years	91	16	2	2	1	1	10	1	-	24	10	6	1	3	4	4	5	1
Sales below break-even - 10 or more years	82	7	3	1	-	1	8	-	2	28	7	7	8	3	3	1	2	1
Sales below break-even - Unknown	1	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-
Sales below break-even - 1 year	1	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-
Sales below break-even - 2~3 years	15	1	-	1	2	1	-	-	-	5	1	2	-	-	-	-	2	-
Sales below break-even - 4~5 years	27	5	-	1	1	-	2	-	-	5	1	2	3	-	1	4	-	2
Sales above break-even - 6~9 years	58	5	1	1	2	-	8	2	-	12	2	8	3	1	4	4	4	1
Sales above break-even - 10 or more years	201	48	2	1	2	1	11	3	-	75	7	22	11	5	2	4	4	3
Sales - Unknown	52	22	-	-	1	-	3	-	-	15	3	2	2	1	1	2	-	-
▣ Main type of industry
Biopharmaceutical industry	330	84	3	7	9	1	19	1	1	137	11	28	18	5	1	2	2	1
Biochemical industry	206	24	2	3	4	2	34	3	3	48	13	14	14	5	10	15	8	4
Biofood industry	197	22	7	4	4	2	7	-	2	45	18	19	18	8	10	10	14	7
Bioenvironmental industry	76	5	1	6	3	2	4	2	-	25	8	5	1	4	3	3	4	-
Bioelectronics industry	22	7	-	1	1	1	2	-	-	5	4	-	1	-	-	-	-	-
Bioprocess and equipment industry	71	20	-	1	1	1	7	-	-	31	1	1	4	-	2	2	-	-
Bioenergy and bioresource industry	26	1	1	-	-	-	2	3	-	8	-	3	-	3	2	1	1	1
Bioassay, bioinformatics and R&D service industry	50	22	-	1	-	1	6	-	-	14	-	2	1	1	-	1	-	1
□ No sales
Biopharmaceutical industry	101	25	1	2	5	-	2	-	-	46	1	8	6	2	1	-	1	1
Biochemical industry	47	5	-	1	-	-	12	1	1	11	1	3	3	3	2	2	1	1
Biofood industry	60	10	2	2	2	-	-	-	1	18	6	2	7	-	3	2	3	2
Bioenvironmental industry	23	2	1	3	2	-	1	-	-	7	3	1	-	-	1	2	-	-
Bioelectronics industry	7	4	-	-	-	1	-	-	-	1	1	-	-	-	-	-	-	-
Bioprocess and equipment industry	22	5	-	-	-	1	-	-	-	12	-	-	1	-	2	1	-	-
Bioenergy and bioresource industry	11	1	1	-	-	-	1	1	-	5	-	-	-	1	-	-	1	-
Bioassay, bioinformatics and R&D service industry	10	-	-	-	-	1	2	-	-	6	-	-	-	-	-	-	-	1
□ Sales below break-even - 1 year
Biopharmaceutical industry	5	2	-	-	-	-	-	-	-	3	-	-	-	-	-	-	-	-
Biofood industry	1	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-	-
Bioenvironmental industry	1	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-
Bioelectronics industry	1	-	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	19	5	-	-	1	-	2	-	-	7	2	2	-	-	-	-	-	-
Biochemical industry	20	2	-	-	-	2	4	-	1	4	1	-	1	-	1	3	1	-
Biofood industry	10	-	1	-	-	-	1	-	-	1	3	2	-	-	1	-	1	-
Bioenvironmental industry	3	-	-	-	1	-	-	-	-	-	-	1	-	1	-	-	-	-
Bioelectronics industry	3	-	-	1	-	-	-	-	-	2	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	4	2	-	-	-	-	2	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	3	-	-	-	-	-	-	1	-	-	-	1	-	1	-	-	-	-
Bioassay, bioinformatics and R&D service industry	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	23	3	-	1	-	1	1	-	-	12	2	-	2	-	-	1	-	-
Biochemical industry	22	4	-	1	1	-	5	-	1	2	1	1	3	-	-	2	1	-
Biofood industry	19	2	-	2	-	-	-	-	-	5	1	-	3	3	-	1	1	1
Bioenvironmental industry	10	1	-	2	-	-	1	-	-	1	-	1	-	1	1	-	2	-
Bioelectronics industry	3	-	-	-	-	-	1	-	-	-	1	-	1	-	-	-	-	-
Bioprocess and equipment industry	10	3	-	1	1	-	1	-	-	4	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	4	-	-	-	-	-	1	-	-	-	-	-	-	1	1	1	-	-
Bioassay, bioinformatics and R&D service industry	5	2	-	-	-	-	1	-	-	1	-	-	1	-	-	-	-	-

	Total	Seoul	Busan	Daegu	Incheon	Gwangju	Daejeon	Ulsan	Sejong	Gyeonggi	Gangwon	Chungbuk	Chungnam	Jeonbuk	Jeonnam	Gyeongbuk	Gyeongnam	Jeju
Number of companies	978	185	14	23	22	10	81	9	6	313	55	72	57	26	28	34	29	14
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	24	6	-	1	-	-	5	-	-	7	2	3	-	-	-	-	-	-
Biochemical industry	24	2	1	1	-	-	2	-	-	7	4	1	-	-	2	3	1	-
Biofood industry	24	3	1	-	1	-	2	-	-	4	2	1	1	2	2	1	3	1
Bioenvironmental industry	9	1	-	-	-	1	1	1	-	4	-	-	-	-	-	-	1	-
Bioelectronics industry	1	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-
Bioprocess and equipment industry	2	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-
Bioenergy and bioresource industry	1	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	6	4	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	28	3	1	-	-	-	3	-	1	12	1	2	3	2	-	-	-	-
Biochemical industry	12	1	1	-	-	-	2	-	-	3	-	1	2	-	1	-	1	-
Biofood industry	24	1	1	-	-	1	2	-	1	4	3	2	3	1	2	1	1	1
Bioenvironmental industry	6	-	-	-	-	-	-	-	-	3	3	-	-	-	-	-	-	-
Bioelectronics industry	1	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	6	1	-	-	-	-	1	-	-	4	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	5	1	-	1	-	-	-	-	-	1	-	2	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	1	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	1	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	6	1	-	1	-	-	-	-	-	2	1	1	-	-	-	-	-	-
Biochemical industry	3	-	-	-	1	-	-	-	-	2	-	-	-	-	-	-	-	-
Biofood industry	3	-	-	-	-	1	-	-	-	-	-	1	-	-	-	-	1	-
Bioenvironmental industry	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-
Bioelectronics industry	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	1	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	9	1	-	1	1	-	-	-	-	4	-	1	1	-	-	-	-	-
Biochemical industry	11	2	-	-	-	-	2	-	-	-	1	1	2	-	-	3	-	-
Biofood industry	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1
Bioenvironmental industry	1	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	2	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1
Bioassay, bioinformatics and R&D service industry	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	11	2	-	-	1	-	2	1	-	3	-	-	-	-	-	1	1	-
Biochemical industry	17	-	-	-	1	-	2	-	-	3	1	4	1	-	2	1	1	1
Biofood industry	14	-	1	-	-	-	2	-	-	2	1	4	1	-	1	-	2	-
Bioenvironmental industry	5	-	-	1	-	-	1	-	-	-	-	-	-	1	1	1	-	-
Bioelectronics industry	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	6	1	-	-	-	-	1	-	-	3	-	-	1	-	-	-	-	-
Bioenergy and bioresource industry	1	-	-	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	3	1	-	-	-	-	-	-	-	1	-	-	-	-	-	1	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	75	17	1	1	1	-	3	-	-	34	2	10	6	-	-	-	-	-
Biochemical industry	37	7	-	-	-	-	3	2	-	11	2	3	2	2	1	-	2	2
Biofood industry	36	6	1	-	1	-	-	-	-	10	2	5	2	2	1	3	2	1
Bioenvironmental industry	15	-	-	-	-	1	-	1	-	9	-	2	1	1	-	-	-	-
Bioelectronics industry	4	2	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-
Bioprocess and equipment industry	16	8	-	-	-	-	2	-	-	4	-	1	-	-	-	1	-	-
Bioenergy and bioresource industry	4	-	-	-	-	-	-	-	-	3	-	1	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	14	8	-	-	-	-	3	-	-	3	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	29	19	-	-	-	-	1	-	-	7	-	1	-	1	-	-	-	-
Biochemical industry	13	1	-	-	1	-	2	-	-	5	2	-	-	-	1	1	-	-
Biofood industry	2	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-
Bioenvironmental industry	2	1	-	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-
Bioprocess and equipment industry	4	-	-	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	2	1	-	-	-	-	-	-	-	1	-	-	-	-	-	-	-	-

< Table 1-2 > Existence of other business within the company(Ⅱ-4-1)

(Unit : number of firms)

	Total	Exclusive business	Plural businesses	Unknown
Number of companies	978	518	456	4
▣ Sales Situation
No sales	281	139	142	-
Sales below break-even - 1 year	10	7	3	-
Sales below break-even - 2~3 years	63	35	28	-
Sales below break-even - 4~5 years	96	63	33	-
Sales below break-even - 6~9 years	91	55	36	-
Sales below break-even - 10 or more years	82	49	33	-
Sales below break-even - Unknown	1	-	1	-
Sales below break-even - 1 year	1	1	-	-
Sales below break-even - 2~3 years	15	8	7	-
Sales below break-even - 4~5 years	27	14	13	-
Sales above break-even - 6~9 years	58	34	24	-
Sales above break-even - 10 or more years	201	81	119	1
Sales - Unknown	52	32	17	3
▣ Main type of industry
Biopharmaceutical industry	330	147	180	3
Biochemical industry	206	108	98	-
Biofood industry	197	104	93	-
Bioenvironmental industry	76	48	28	-
Bioelectronics industry	22	16	6	-
Bioprocess and equipment industry	71	49	21	1
Bioenergy and bioresource industry	26	12	14	-
Bioassay, bioinformatics and R&D service industry	50	34	16	-
□ No sales
Biopharmaceutical industry	101	46	55	-
Biochemical industry	47	20	27	-
Biofood industry	60	23	37	-
Bioenvironmental industry	23	15	8	-
Bioelectronics industry	7	6	1	-
Bioprocess and equipment industry	22	16	6	-
Bioenergy and bioresource industry	11	6	5	-
Bioassay, bioinformatics and R&D service industry	10	7	3	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	5	2	3	-
Biofood industry	1	1	-	-
Bioenvironmental industry	1	1	-	-
Bioelectronics industry	1	1	-	-
Bioassay, bioinformatics and R&D service industry	2	2	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	19	9	10	-
Biochemical industry	20	13	7	-
Biofood industry	10	6	4	-
Bioenvironmental industry	3	1	2	-
Bioelectronics industry	3	2	1	-
Bioprocess and equipment industry	4	2	2	-
Bioenergy and bioresource industry	3	1	2	-
Bioassay, bioinformatics and R&D service industry	1	1	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	23	15	8	-
Biochemical industry	22	14	8	-
Biofood industry	19	12	7	-
Bioenvironmental industry	10	7	3	-
Bioelectronics industry	3	2	1	-
Bioprocess and equipment industry	10	8	2	-
바이오에너지 및 자원산업	4	3	1	-
Bioassay, bioinformatics and R&D service industry	5	2	3	-

	Total	Exclusive business	Plural businesses	Unknown
Number of companies	978	518	456	4
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	24	14	10	-
Biochemical industry	24	13	11	-
Biofood industry	24	17	7	-
Bioenvironmental industry	9	6	3	-
Bioelectronics industry	1	-	1	-
Bioprocess and equipment industry	2	1	1	-
Bioenergy and bioresource industry	1	1	-	-
Bioassay, bioinformatics and R&D service industry	6	3	3	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	28	7	21	-
Biochemical industry	12	9	3	-
Biofood industry	24	16	8	-
Bioenvironmental industry	6	6	-	-
Bioelectronics industry	1	1	-	-
Bioprocess and equipment industry	6	6	-	-
Bioassay, bioinformatics and R&D service industry	5	4	1	-
□ Sales below break-even - Unknown
Biofood industry	1	-	1	-
□ Sales below break-even - 1 year
Biofood industry	1	1	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	6	-	6	-
Biochemical industry	3	2	1	-
Biofood industry	3	3	-	-
Bioenvironmental industry	1	1	-	-
Bioelectronics industry	1	1	-	-
Bioprocess and equipment industry	1	1	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	9	3	6	-
Biochemical industry	11	7	4	-
Biofood industry	2	1	1	-
Bioenvironmental industry	1	-	1	-
Bioenergy and bioresource industry	2	1	1	-
Bioassay, bioinformatics and R&D service industry	2	2	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	11	6	5	-
Biochemical industry	17	7	10	-
Biofood industry	14	10	4	-
Bioenvironmental industry	5	2	3	-
Bioelectronics industry	1	1	-	-
Bioprocess and equipment industry	6	5	1	-
Bioenergy and bioresource industry	1	-	1	-
Bioassay, bioinformatics and R&D service industry	3	3	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	75	27	48	-
Biochemical industry	37	16	21	-
Biofood industry	36	12	24	-
Bioenvironmental industry	15	7	8	-
Bioelectronics industry	4	2	2	-
Bioprocess and equipment industry	16	9	6	1
Bioenergy and bioresource industry	4	-	4	-
Bioassay, bioinformatics and R&D service industry	14	8	6	-
□ Sales - Unknown
Biopharmaceutical industry	29	18	8	3
Biochemical industry	13	7	6	-
Biofood industry	2	2	-	-
Bioenvironmental industry	2	2	-	-
Bioprocess and equipment industry	4	1	3	-
Bioassay, bioinformatics and R&D service industry	2	2	-	-

<Table  1-3 > Distribution by Type of Company[Duplication](Ⅱ-4-2)

(Unit : number of firms)

	Total	Venture companies	INNO-BIZ	Kosdaq-listed companies	Listed companies	Not applicable/ Unknown
Number of companies	978	338	324	99	87	397
▣ Sales Situation
No sales	281	78	76	20	36	123
Sales below break-even - 1 year	10	4	2	1	1	5
Sales below break-even - 2~3 years	63	23	15	2	3	31
Sales below break-even - 4~5 years	96	41	31	7	4	42
Sales below break-even - 6~9 years	91	40	37	8	5	31
Sales below break-even - 10 or more years	82	31	35	10	7	25
Sales below break-even - Unknown	1	1	1	-	-	-
Sales below break-even - 1 year	1	-	1	-	-	-
Sales below break-even - 2~3 years	15	6	2	1	1	7
Sales below break-even - 4~5 years	27	9	4	2	-	16
Sales above break-even - 6~9 years	58	32	29	8	4	14
Sales above break-even - 10 or more years	201	61	79	34	21	77
Sales - Unknown	52	12	12	6	5	26
▣ Main type of industry
Biopharmaceutical industry	330	92	83	58	43	139
Biochemical industry	206	77	79	13	21	81
Biofood industry	197	64	63	12	18	78
Bioenvironmental industry	76	29	38	-	1	34
Bioelectronics industry	22	13	7	2	-	7
Bioprocess and equipment industry	71	26	30	7	1	32
Bioenergy and bioresource industry	26	10	6	2	3	10
Bioassay, bioinformatics and R&D service industry	50	27	18	5	-	16
□ No sales
Biopharmaceutical industry	101	25	20	12	14	44
Biochemical industry	47	13	17	1	8	18
Biofood industry	60	12	10	4	12	29
Bioenvironmental industry	23	9	13	-	-	9
Bioelectronics industry	7	1	2	-	-	5
Bioprocess and equipment industry	22	9	9	2	-	11
Bioenergy and bioresource industry	11	4	3	-	2	4
Bioassay, bioinformatics and R&D service industry	10	5	2	1	-	3
□ Sales below break-even - 1 year
Biopharmaceutical industry	5	1	1	1	1	3
Biofood industry	1	-	-	-	-	1
Bioenvironmental industry	1	1	1	-	-	-
Bioelectronics industry	1	1	-	-	-	-
Bioassay, bioinformatics and R&D service industry	2	1	-	-	-	1
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	19	5	6	2	2	9
Biochemical industry	20	7	2	-	1	12
Biofood industry	10	4	4	-	-	4
Bioenvironmental industry	3	1	1	-	-	2
Bioelectronics industry	3	2	-	-	-	1
Bioprocess and equipment industry	4	1	2	-	-	2
Bioenergy and bioresource industry	3	2	-	-	-	1
Bioassay, bioinformatics and R&D service industry	1	1	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	23	11	7	3	3	9
Biochemical industry	22	5	6	2	1	11
Biofood industry	19	9	6	-	-	9
Bioenvironmental industry	10	6	6	-	-	4
Bioelectronics industry	3	2	-	1	-	1
Bioprocess and equipment industry	10	5	3	-	-	4
Bioenergy and bioresource industry	4	1	1	-	-	3
Bioassay, bioinformatics and R&D service industry	5	2	2	1	-	1

	Total	Venture companies	INNO-BIZ	Kosdaq-listed companies	Listed companies	Not applicable/ Unknown
Number of companies	978	338	324	99	87	397
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	24	9	8	3	2	9
Biochemical industry	24	12	12	4	2	6
Biofood industry	24	11	7	-	1	9
Bioenvironmental industry	9	2	4	-	-	5
Bioelectronics industry	1	1	1	-	-	-
Bioprocess and equipment industry	2	1	2	1	-	-
Bioenergy and bioresource industry	1	1	1	-	-	-
Bioassay, bioinformatics and R&D service industry	6	3	2	-	-	2
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	28	11	12	7	6	4
Biochemical industry	12	4	5	-	1	5
Biofood industry	24	9	13	2	-	6
Bioenvironmental industry	6	2	1	-	-	4
Bioelectronics industry	1	1	1	-	-	-
Bioprocess and equipment industry	6	1	2	-	-	4
Bioassay, bioinformatics and R&D service industry	5	3	1	1	-	2
□ Sales below break-even - Unknown
Biofood industry	1	1	1	-	-	-
□ Sales below break-even - 1 year
Biofood industry	1	-	1	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	6	3	1	1	1	2
Biochemical industry	3	1	-	-	-	2
Biofood industry	3	1	-	-	-	2
Bioenvironmental industry	1	-	1	-	-	-
Bioelectronics industry	1	1	-	-	-	-
Bioprocess and equipment industry	1	-	-	-	-	1
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	9	2	-	2	-	5
Biochemical industry	11	5	3	-	-	6
Biofood industry	2	-	-	-	-	2
Bioenvironmental industry	1	1	1	-	-	-
Bioenergy and bioresource industry	2	1	-	-	-	1
Bioassay, bioinformatics and R&D service industry	2	-	-	-	-	2
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	11	3	2	4	1	5
Biochemical industry	17	12	12	1	2	2
Biofood industry	14	8	8	1	-	3
Bioenvironmental industry	5	1	2	-	1	2
Bioelectronics industry	1	1	-	-	-	-
Bioprocess and equipment industry	6	4	3	1	-	2
Bioenergy and bioresource industry	1	-	-	1	-	-
Bioassay, bioinformatics and R&D service industry	3	3	2	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	75	15	19	18	13	34
Biochemical industry	37	17	20	5	2	12
Biofood industry	36	9	13	5	5	11
Bioenvironmental industry	15	6	8	-	-	6
Bioelectronics industry	4	3	3	1	-	-
Bioprocess and equipment industry	16	3	7	2	-	8
Bioenergy and bioresource industry	4	1	1	1	1	1
Bioassay, bioinformatics and R&D service industry	14	7	8	2	-	5
□ Sales - Unknown
Biopharmaceutical industry	29	7	7	5	-	15
Biochemical industry	13	1	2	-	4	7
Biofood industry	2	-	-	-	-	2
Bioenvironmental industry	2	-	-	-	-	2
Bioprocess and equipment industry	4	2	2	1	1	-
Bioassay, bioinformatics and R&D service industry	2	2	1	-	-	-

< Table 1-4 > Distribution by Establishment Year(I-6)    (Unit : number of firms)

	Total	Before 1950	1951~1980	1981~1990	1991~1995	1996~2000	2001~2005	2006~2010	2011~2015	Unknown
Number of companies	978	14	137	105	78	274	214	121	29	6
▣ Sales Situation
No sales	281	4	56	32	24	63	58	37	7	-
Sales below break-even - 1 year	10	1	-	2	-	4	1	-	1	1
Sales below break-even - 2~3 years	63	2	5	6	4	14	16	13	3	-
Sales below break-even - 4~5 years	96	1	3	9	1	36	19	20	7	-
Sales below break-even - 6~9 years	91	-	4	4	4	33	35	10	1	-
Sales below break-even - 10 or more years	82	1	8	11	7	36	17	1	1	-
Sales below break-even - Unknown	1	-	-	-	-	1	-	-	-	-
Sales below break-even - 1 year	1	-	-	-	-	-	1	-	-	-
Sales below break-even - 2~3 years	15	1	-	-	-	5	3	4	2	-
Sales below break-even - 4~5 years	27	-	5	2	-	5	4	10	1	-
Sales above break-even - 6~9 years	58	1	4	1	2	13	24	12	1	-
Sales above break-even - 10 or more years	201	3	45	32	25	54	33	6	3	-
Sales - Unknown	52	-	7	6	11	10	3	8	2	5
▣ Main type of industry
Biopharmaceutical industry	330	11	63	51	31	79	50	29	13	3
Biochemical industry	206	2	25	16	10	62	45	38	6	2
Biofood industry	197	1	34	19	12	61	52	16	2	-
Bioenvironmental industry	76	-	8	7	5	21	31	3	-	1
Bioelectronics industry	22	-	-	-	2	8	6	5	1	-
Bioprocess and equipment industry	71	-	1	9	15	19	10	13	4	-
Bioenergy and bioresource industry	26	-	6	2	1	4	5	5	3	-
Bioassay, bioinformatics and R&D service industry	50	-	-	1	2	20	15	12	-	-
□ No sales
Biopharmaceutical industry	101	3	23	16	9	22	18	7	3	-
Biochemical industry	47	1	10	3	3	13	7	9	1	-
Biofood industry	60	-	18	8	4	13	13	4	-	-
Bioenvironmental industry	23	-	2	3	-	4	11	3	-	-
Bioelectronics industry	7	-	-	-	-	3	4	-	-	-
Bioprocess and equipment industry	22	-	-	1	6	5	1	7	2	-
Bioenergy and bioresource industry	11	-	3	1	-	1	2	3	1	-
Bioassay, bioinformatics and R&D service industry	10	-	-	-	2	2	2	4	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	5	1	-	2	-	1	-	-	-	1
Biofood industry	1	-	-	-	-	1	-	-	-	-
Bioenvironmental industry	1	-	-	-	-	1	-	-	-	-
Bioelectronics industry	1	-	-	-	-	-	-	-	1	-
Bioassay, bioinformatics and R&D service industry	2	-	-	-	-	1	1	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	19	1	2	3	-	6	5	1	1	-
Biochemical industry	20	1	1	1	1	4	3	7	2	-
Biofood industry	10	-	1	2	1	-	3	3	-	-
Bioenvironmental industry	3	-	-	-	-	1	2	-	-	-
Bioelectronics industry	3	-	-	-	1	-	-	2	-	-
Bioprocess and equipment industry	4	-	-	-	-	2	2	-	-	-
Bioenergy and bioresource industry	3	-	1	-	1	-	1	-	-	-
Bioassay, bioinformatics and R&D service industry	1	-	-	-	-	1	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	23	1	1	2	1	7	3	6	2	-
Biochemical industry	22	-	1	3	-	7	4	5	2	-
Biofood industry	19	-	1	1	-	11	3	2	1	-
Bioenvironmental industry	10	-	-	1	-	4	5	-	-	-
Bioelectronics industry	3	-	-	-	-	1	1	1	-	-
Bioprocess and equipment industry	10	-	-	1	-	5	-	3	1	-
Bioenergy and bioresource industry	4	-	-	-	-	1	1	1	1	-
Bioassay, bioinformatics and R&D service industry	5	-	-	1	-	-	2	2	-	-

* In case establishment year has changed by takeover, merger or divestiture etc., sales period may start earlier than the year of establishment  to maintain consistency with previous result.

	Total	Before 1950	1951~1980	1981~1990	1991~1995	1996~2000	2001~2005	2006~2010	2011~2015	Unknown
Number of companies	978	14	137	105	78	274	214	121	29	6
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	24	-	2	2	1	11	5	3	-	-
Biochemical industry	24	-	-	-	-	11	10	3	-	-
Biofood industry	24	-	1	1	1	8	11	2	-	-
Bioenvironmental industry	9	-	1	-	2	1	5	-	-	-
Bioelectronics industry	1	-	-	-	-	1	-	-	-	-
Bioprocess and equipment industry	2	-	-	1	-	-	-	-	1	-
Bioenergy and bioresource industry	1	-	-	-	-	-	1	-	-	-
Bioassay, bioinformatics and R&D service industry	6	-	-	-	-	1	3	2	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	28	1	5	6	1	9	5	-	1	-
Biochemical industry	12	-	1	-	1	8	2	-	-	-
Biofood industry	24	-	2	3	3	10	6	-	-	-
Bioenvironmental industry	6	-	-	1	-	4	1	-	-	-
Bioelectronics industry	1	-	-	-	-	1	-	-	-	-
Bioprocess and equipment industry	6	-	-	1	2	2	1	-	-	-
Bioassay, bioinformatics and R&D service industry	5	-	-	-	-	2	2	1	-	-
□ Sales below break-even - Unknown
Biofood industry	1	-	-	-	-	1	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	1	-	-	-	-	-	1	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	6	1	-	-	-	2	1	1	1	-
Biochemical industry	3	-	-	-	-	1	-	1	1	-
Biofood industry	3	-	-	-	-	2	1	-	-	-
Bioenvironmental industry	1	-	-	-	-	-	1	-	-	-
Bioelectronics industry	1	-	-	-	-	-	-	1	-	-
Bioprocess and equipment industry	1	-	-	-	-	-	-	1	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	9	-	3	1	-	2	-	3	-	-
Biochemical industry	11	-	2	1	-	2	3	3	-	-
Biofood industry	2	-	-	-	-	-	-	2	-	-
Bioenvironmental industry	1	-	-	-	-	-	1	-	-	-
Bioenergy and bioresource industry	2	-	-	-	-	1	-	-	1	-
Bioassay, bioinformatics and R&D service industry	2	-	-	-	-	-	-	2	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	11	-	1	1	1	3	4	1	-	-
Biochemical industry	17	-	2	-	-	2	7	6	-	-
Biofood industry	14	1	-	-	-	4	6	2	1	-
Bioenvironmental industry	5	-	1	-	-	1	3	-	-	-
Bioelectronics industry	1	-	-	-	-	-	-	1	-	-
Bioprocess and equipment industry	6	-	-	-	1	1	3	1	-	-
Bioenergy and bioresource industry	1	-	-	-	-	-	-	1	-	-
Bioassay, bioinformatics and R&D service industry	3	-	-	-	-	2	1	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	75	3	23	14	9	12	8	3	3	-
Biochemical industry	37	-	5	7	5	12	7	1	-	-
Biofood industry	36	-	11	4	3	9	8	1	-	-
Bioenvironmental industry	15	-	4	2	2	5	2	-	-	-
Bioelectronics industry	4	-	-	-	1	2	1	-	-	-
Bioprocess and equipment industry	16	-	-	4	5	4	3	-	-	-
Bioenergy and bioresource industry	4	-	2	1	-	1	-	-	-	-
Bioassay, bioinformatics and R&D service industry	14	-	-	-	-	9	4	1	-	-
□ Sales - Unknown
Biopharmaceutical industry	29	-	3	4	9	4	1	4	2	2
Biochemical industry	13	-	3	1	-	2	2	3	-	2
Biofood industry	2	-	-	-	-	2	-	-	-	-
Bioenvironmental industry	2	-	-	-	1	-	-	-	-	1
Bioprocess and equipment industry	4	-	1	1	1	-	-	1	-	-
Bioassay, bioinformatics and R&D service industry	2	-	-	-	-	2	-	-	-	-

* In case establishment year has changed by takeover, merger or divestiture etc., sales period may start earlier than the year of establishment  to maintain consistency with previous result.

< Table 1-5 > Distribution by total number of workers' size(Ⅱ-3) (Unit : number of firms, people)

	Total	Less than 50	50~ 299	300~ 999	More than 1,000	Un- known	Average	CEO's gender			Employees' gender
								Male	Female	Unknown	Male	Female	Unknown
Number of companies	978	574	272	75	46	11	377	870	87	21	258,329	77,275	21,018
▣ Sales Situation
No sales	281	146	85	28	19	3	318	256	16	9	56,157	19,115	10,000
Sales below break-even - 1 year	10	5	4	1	-	-	94	9	1	-	480	272	191
Sales below break-even - 2~3 years	63	46	12	3	2	-	127	53	10	-	5,454	1,768	777
Sales below break-even - 4~5 years	96	77	17	1	1	-	69	87	9	-	4,854	1,425	244
Sales below break-even - 6~9 years	91	76	11	2	2	-	140	81	10	-	7,758	4,569	438
Sales below break-even - 10 or more years	82	57	16	6	3	-	125	76	6	-	7,069	3,116	30
Sales below break-even - Unknown	1	1	-	-	-	-	43	1	-	-	-	-	-
Sales below break-even - 1 year	1	1	-	-	-	-	6	1	-	-	3	3	-
Sales below break-even - 2~3 years	15	9	6	-	-	-	60	13	2	-	478	299	64
Sales below break-even - 4~5 years	27	22	3	2	-	-	77	21	6	-	1,524	552	6
Sales above break-even - 6~9 years	58	39	14	2	3	-	127	54	4	-	4,142	1,857	1,345
Sales above break-even - 10 or more years	201	75	89	24	13	-	586	182	19	-	95,775	17,286	4,695
Sales - Unknown	52	20	15	6	3	8	2,995	36	4	12	74,635	27,013	3,185
▣ Main type of industry
Biopharmaceutical industry	330	126	133	48	17	6	235	299	24	7	45,803	17,595	11,184
Biochemical industry	206	143	39	8	14	2	1,112	180	20	6	174,525	39,141	3,201
Biofood industry	197	127	44	12	13	1	250	174	20	3	27,613	16,275	4,794
Bioenvironmental industry	76	60	13	1	1	1	65	69	6	1	3,398	746	723
Bioelectronics industry	22	15	5	2	-	-	95	18	3	1	903	551	449
Bioprocess and equipment industry	71	50	18	2	-	1	51	62	6	3	2,104	870	491
Bioenergy and bioresource industry	26	18	6	1	1	-	113	24	2	-	2,286	561	91
Bioassay, bioinformatics and R&D service industry	50	35	14	1	-	-	68	44	6	-	1,697	1,536	85
□ No sales
Biopharmaceutical industry	101	40	41	17	2	1	211	96	5	-	12,261	4,052	4,558
Biochemical industry	47	26	12	3	6	-	679	43	3	1	24,502	3,561	454
Biofood industry	60	25	17	7	10	1	535	54	3	3	16,277	10,828	3,923
Bioenvironmental industry	23	19	4	-	-	-	32	21	1	1	402	141	197
Bioelectronics industry	7	5	2	-	-	-	81	4	2	1	26	13	449
Bioprocess and equipment industry	22	17	4	-	-	1	40	18	1	3	342	160	297
Bioenergy and bioresource industry	11	7	3	-	1	-	178	10	1	-	1,637	234	85
Bioassay, bioinformatics and R&D service industry	10	7	2	1	-	-	97	10	-	-	710	126	37
□ Sales below break-even - 1 year
Biopharmaceutical industry	5	1	3	1	-	-	156	5	-	-	429	223	127
Biofood industry	1	-	1	-	-	-	64	1	-	-	-	-	-
Bioenvironmental industry	1	1	-	-	-	-	14	1	-	-	10	4	-
Bioelectronics industry	1	1	-	-	-	-	22	-	1	-	10	12	-
Bioassay, bioinformatics and R&D service industry	2	2	-	-	-	-	32	2	-	-	31	33	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	19	9	7	1	2	-	296	17	2	-	4,299	1,329	4
Biochemical industry	20	16	3	1	-	-	66	17	3	-	846	304	173
Biofood industry	10	8	1	1	-	-	73	9	1	-	104	47	580
Bioenvironmental industry	3	3	-	-	-	-	9	1	2	-	15	13	-
Bioelectronics industry	3	3	-	-	-	-	25	3	-	-	45	31	-
Bioprocess and equipment industry	4	4	-	-	-	-	19	3	1	-	56	18	-
Bioenergy and bioresource industry	3	2	1	-	-	-	38	3	-	-	89	26	-
Bioassay, bioinformatics and R&D service industry	1	1	-	-	-	-	20	-	1	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	23	15	8	-	-	-	49	22	1	-	649	422	53
Biochemical industry	22	19	1	1	1	-	177	20	2	-	2,938	563	37
Biofood industry	19	15	4	-	-	-	39	15	4	-	555	165	30
Bioenvironmental industry	10	9	1	-	-	-	18	9	1	-	65	19	98
Bioelectronics industry	3	1	2	-	-	-	110	3	-	-	268	62	-
Bioprocess and equipment industry	10	10	-	-	-	-	19	10	-	-	128	50	11
Bioenergy and bioresource industry	4	4	-	-	-	-	22	4	-	-	65	22	-
Bioassay, bioinformatics and R&D service industry	5	4	1	-	-	-	65	4	1	-	186	122	15

	Total	Less than 50	50~ 299	300~ 999	More than 1,000	Un- known	Average	CEO's gender			Employees' gender
								Male	Female	Unknown	Male	Female	Unknown
Number of companies	978	574	272	75	46	11	377	870	87	21	258,329	77,275	21,018
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	24	17	5	2	-	-	98	22	2	-	1,660	574	125
Biochemical industry	24	21	1	-	2	-	386	22	2	-	5,449	3,761	46
Biofood industry	24	23	1	-	-	-	23	21	3	-	415	116	16
Bioenvironmental industry	9	7	2	-	-	-	37	9	-	-	76	16	242
Bioelectronics industry	1	1	-	-	-	-	13	1	-	-	10	3	-
Bioprocess and equipment industry	2	1	1	-	-	-	58	2	-	-	80	35	-
Bioenergy and bioresource industry	1	1	-	-	-	-	22	-	1	-	12	10	-
Bioassay, bioinformatics and R&D service industry	6	5	1	-	-	-	20	4	2	-	56	54	9
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	28	12	8	5	3	-	298	25	3	-	5,901	2,421	30
Biochemical industry	12	11	1	-	-	-	18	12	-	-	140	80	-
Biofood industry	24	20	4	-	-	-	35	21	3	-	597	253	-
Bioenvironmental industry	6	5	1	-	-	-	18	6	-	-	90	15	-
Bioelectronics industry	1	-	-	1	-	-	334	1	-	-	160	174	-
Bioprocess and equipment industry	6	5	1	-	-	-	19	6	-	-	61	55	-
Bioassay, bioinformatics and R&D service industry	5	4	1	-	-	-	48	5	-	-	120	118	-
□ Sales below break-even - Unknown
Biofood industry	1	1	-	-	-	-	43	1	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	1	1	-	-	-	-	6	1	-	-	3	3	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	6	1	5	-	-	-	109	6	-	-	347	242	64
Biochemical industry	3	3	-	-	-	-	24	3	-	-	56	15	-
Biofood industry	3	3	-	-	-	-	11	1	2	-	22	11	-
Bioenvironmental industry	1	-	1	-	-	-	74	1	-	-	47	27	-
Bioelectronics industry	1	1	-	-	-	-	-	1	-	-	-	-	-
Bioprocess and equipment industry	1	1	-	-	-	-	10	1	-	-	6	4	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	9	6	2	1	-	-	89	8	1	-	482	322	-
Biochemical industry	11	9	1	1	-	-	105	8	3	-	973	177	-
Biofood industry	2	2	-	-	-	-	7	2	-	-	5	8	-
Bioenvironmental industry	1	1	-	-	-	-	18	-	1	-	15	3	-
Bioenergy and bioresource industry	2	2	-	-	-	-	24	2	-	-	37	4	6
Bioassay, bioinformatics and R&D service industry	2	2	-	-	-	-	25	1	1	-	12	38	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	11	4	4	1	2	-	354	9	2	-	2,625	1,267	-
Biochemical industry	17	13	3	-	1	-	129	15	2	-	634	221	1,339
Biofood industry	14	12	2	-	-	-	22	14	-	-	180	115	6
Bioenvironmental industry	5	4	-	1	-	-	80	5	-	-	341	60	-
Bioelectronics industry	1	1	-	-	-	-	6	1	-	-	4	2	-
Bioprocess and equipment industry	6	2	4	-	-	-	57	6	-	-	217	127	-
Bioenergy and bioresource industry	1	1	-	-	-	-	40	1	-	-	37	3	-
Bioassay, bioinformatics and R&D service industry	3	2	1	-	-	-	55	3	-	-	104	62	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	75	13	38	16	8	-	360	69	6	-	16,735	6,501	3,795
Biochemical industry	37	20	15	1	1	-	1,869	33	4	-	64,869	3,814	467
Biofood industry	36	15	14	4	3	-	398	32	4	-	9,454	4,729	130
Bioenvironmental industry	15	10	4	-	1	-	197	15	-	-	2,329	444	186
Bioelectronics industry	4	2	1	1	-	-	159	4	-	-	380	254	-
Bioprocess and equipment industry	16	8	7	1	-	-	96	12	4	-	1,124	301	117
Bioenergy and bioresource industry	4	1	2	1	-	-	168	4	-	-	409	262	-
Bioassay, bioinformatics and R&D service industry	14	6	8	-	-	-	104	13	1	-	475	981	-
□ Sales - Unknown
Biopharmaceutical industry	29	8	12	4	-	5	171	20	2	7	415	242	2,428
Biochemical industry	13	5	2	1	3	2	11,272	7	1	5	74,118	26,645	685
Biofood industry	2	2	-	-	-	-	2	2	-	-	1	-	-
Bioenvironmental industry	2	1	-	-	-	1	12	1	1	-	8	4	-
Bioprocess and equipment industry	4	2	1	1	-	-	92	4	-	-	90	120	66
Bioassay, bioinformatics and R&D service industry	2	2	-	-	-	-	5	2	-	-	3	2	4

< Table 1-6 > Size of Capital(Ⅱ-1)    (Unit : number of firms, million Won)

		Total	Capital
			Number of respondent companies	Sum	Average
Number of companies		978	823	12,612,142	15,325
▣ Sales Situation
No sales		281	226	3,808,191	16,850
Sales below break-even - 1 year		10	10	130,130	13,013
Sales below break-even - 2~3 years		63	56	1,107,515	19,777
Sales below break-even - 4~5 years		96	81	333,293	4,115
Sales below break-even - 6~9 years		91	76	435,271	5,727
Sales below break-even - 10 or more years		82	68	411,602	6,053
Sales below break-even - Unknown		1	1	1,940	1,940
Sales below break-even - 1 year		1	1	100	100
Sales below break-even - 2~3 years		15	10	68,941	6,894
Sales below break-even - 4~5 years		27	23	195,531	8,501
Sales above break-even - 6~9 years		58	51	947,477	18,578
Sales above break-even - 10 or more years		201	186	3,726,309	20,034
Sales - Unknown		52	34	1,445,842	42,525
▣ Main type of industry
Biopharmaceutical industry		330	291	4,028,265	13,843
Biochemical industry		206	167	5,917,787	35,436
Biofood industry		197	157	1,987,827	12,661
Bioenvironmental industry		76	69	95,138	1,379
Bioelectronics industry		22	15	42,414	2,828
Bioprocess and equipment industry		71	58	132,050	2,277
Bioenergy and bioresource industry		26	22	319,371	14,517
Bioassay, bioinformatics and R&D service industry		50	44	89,289	2,029
▣ Number of employees
Less than 50		574	452	716,485	1,585
50~299		272	257	2,115,155	8,230
300~999		75	67	1,262,895	18,849
More than 1,000		46	46	8,517,576	185,165
Unknown		11	1	30	30
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	29	103,583	3,572
	50~299	41	39	212,391	5,446
	300~999	17	16	321,907	20,119
	More than 1,000	2	2	290,718	145,359
	Unknown	1	-	-	-
Biochemical industry	Less than 50	26	17	31,492	1,852
	50~299	12	11	58,588	5,326
	300~999	3	1	31,506	31,506
	More than 1,000	6	6	1,448,447	241,408
Biofood industry	Less than 50	25	17	21,284	1,252
	50~299	17	14	127,460	9,104
	300~999	7	5	108,242	21,648
	More than 1,000	10	10	741,909	74,191
	Unknown	1	-	-	-
Bioenvironmental industry	Less than 50	19	16	15,323	958
	50~299	4	4	11,790	2,948
Bioelectronics industry	Less than 50	5	3	6,478	2,159
	50~299	2	1	6,958	6,958
Bioprocess and equipment industry	Less than 50	17	13	14,113	1,086
	50~299	4	4	50,784	12,696
	Unknown	1	-	-	-
Bioenergy and bioresource industry	Less than 50	7	5	4,173	835
	50~299	3	3	20,820	6,940
	More than 1,000	1	1	167,456	167,456
Bioassay, bioinformatics and R&D service industry	Less than 50	7	6	861	144
	50~299	2	2	9,908	4,954
	300~999	1	1	2,000	2,000
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	1	2,252	2,252
	50~299	3	3	94,232	31,411
	300~999	1	1	23,334	23,334

		Total	Capital
			Number of respondent companies	Sum	Average
Number of companies		978	823	12,612,142	15,325
Biofood industry	50~299	1	1	2,000	2,000
Bioenvironmental industry	Less than 50	1	1	176	176
Bioelectronics industry	Less than 50	1	1	1,038	1,038
Bioassay, bioinformatics and R&D service industry	Less than 50	2	2	7,098	3,549
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	8	23,110	2,889
	50~299	7	7	20,745	2,964
	300~999	1	1	48,728	48,728
	More than 1,000	2	2	953,160	476,580
Biochemical industry	Less than 50	16	12	13,878	1,157
	50~299	3	3	6,668	2,223
	300~999	1	1	10,550	10,550
Biofood industry	Less than 50	8	7	2,450	350
	50~299	1	1	1,090	1,090
	300~999	1	1	9,100	9,100
Bioenvironmental industry	Less than 50	3	3	652	217
Bioelectronics industry	Less than 50	3	3	8,255	2,752
Bioprocess and equipment industry	Less than 50	4	3	2,300	767
Bioenergy and bioresource industry	Less than 50	2	2	2,944	1,472
	50~299	1	1	3,325	3,325
Bioassay, bioinformatics and R&D service industry	Less than 50	1	1	560	560
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	12	38,130	3,178
	50~299	8	8	55,780	6,973
Biochemical industry	Less than 50	19	14	7,553	540
	50~299	1	1	3,150	3,150
	300~999	1	1	20,000	20,000
	More than 1,000	1	1	127,247	127,247
Biofood industry	Less than 50	15	12	13,843	1,154
	50~299	4	3	15,363	5,121
Bioenvironmental industry	Less than 50	9	9	7,451	828
	50~299	1	1	3,121	3,121
Bioelectronics industry	Less than 50	1	-	-	-
	50~299	2	1	3,419	3,419
Bioprocess and equipment industry	Less than 50	10	10	9,185	919
Bioenergy and bioresource industry	Less than 50	4	4	13,929	3,482
Bioassay, bioinformatics and R&D service industry	Less than 50	4	3	1,212	404
	50~299	1	1	13,908	13,908
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	14	34,532	2,467
	50~299	5	5	28,447	5,689
	300~999	2	2	76,466	38,233
Biochemical industry	Less than 50	21	19	26,331	1,386
	50~299	1	1	13,117	13,117
	More than 1,000	2	2	169,346	84,673
Biofood industry	Less than 50	23	16	37,251	2,328
	50~299	1	1	22,459	22,459
Bioenvironmental industry	Less than 50	7	5	3,126	625
	50~299	2	2	2,817	1,409
Bioelectronics industry	Less than 50	1	-	-	-
Bioprocess and equipment industry	Less than 50	1	1	120	120
	50~299	1	1	12,169	12,169
Bioenergy and bioresource industry	Less than 50	1	1	1,322	1,322
Bioassay, bioinformatics and R&D service industry	Less than 50	5	5	3,488	698
	50~299	1	1	4,280	4,280
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	10	16,266	1,627
	50~299	8	8	81,564	10,196
	300~999	5	5	67,260	13,452
	More than 1,000	3	3	127,689	42,563
Biochemical industry	Less than 50	11	7	29,932	4,276
	50~299	1	1	2,266	2,266
Biofood industry	Less than 50	20	17	23,200	1,365
	50~299	4	4	34,213	8,553
Bioenvironmental industry	Less than 50	5	3	900	300
	50~299	1	1	3,000	3,000
Bioelectronics industry	300~999	1	1	4,398	4,398

		Total	Capital
			Number of respondent companies	Sum	Average
Number of companies		978	823	12,612,142	15,325
Bioprocess and equipment industry	Less than 50	5	4	1,570	393
	50~299	1	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	3	12,132	4,044
	50~299	1	1	7,212	7,212
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	1	1,940	1,940
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	1	100	100
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	1	2,417	2,417
	50~299	5	5	59,274	11,855
Biochemical industry	Less than 50	3	3	7,150	2,383
Biofood industry	Less than 50	3	-	-	-
Bioenvironmental industry	50~299	1	1	100	100
Bioelectronics industry	Less than 50	1	-	-	-
Bioprocess and equipment industry	Less than 50	1	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	6	16,332	2,722
	50~299	2	2	63,206	31,603
	300~999	1	1	15,535	15,535
Biochemical industry	Less than 50	9	7	4,465	638
	50~299	1	1	2,900	2,900
	300~999	1	1	89,463	89,463
Biofood industry	Less than 50	2	2	480	240
Bioenvironmental industry	Less than 50	1	1	300	300
Bioenergy and bioresource industry	Less than 50	2	1	2,800	2,800
Bioassay, bioinformatics and R&D service industry	Less than 50	2	1	50	50
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	3	3,753	1,251
	50~299	4	3	8,872	2,957
	300~999	1	1	5,334	5,334
	More than 1,000	2	2	248,034	124,017
Biochemical industry	Less than 50	13	12	14,384	1,199
	50~299	3	3	38,761	12,920
	More than 1,000	1	1	576,000	576,000
Biofood industry	Less than 50	12	10	6,249	625
	50~299	2	2	9,292	4,646
Bioenvironmental industry	Less than 50	4	4	6,489	1,622
	300~999	1	1	10,846	10,846
Bioelectronics industry	Less than 50	1	1	225	225
Bioprocess and equipment industry	Less than 50	2	1	600	600
	50~299	4	4	4,985	1,246
Bioenergy and bioresource industry	Less than 50	1	1	9,672	9,672
Bioassay, bioinformatics and R&D service industry	Less than 50	2	1	1,841	1,841
	50~299	1	1	2,140	2,140
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	11	10,314	938
	50~299	38	38	346,117	9,108
	300~999	16	15	238,619	15,908
	More than 1,000	8	8	267,723	33,465
Biochemical industry	Less than 50	20	17	22,155	1,303
	50~299	15	14	338,456	24,175
	300~999	1	1	11,953	11,953
	More than 1,000	1	1	1,500,000	1,500,000
Biofood industry	Less than 50	15	12	15,349	1,279
	50~299	14	13	84,047	6,465
	300~999	4	4	85,434	21,359
	More than 1,000	3	3	625,071	208,357

		Total	Capital
			Number of respondent companies	Sum	Average
Number of companies		978	823	12,612,142	15,325
Bioenvironmental industry	Less than 50	10	10	9,533	953
	50~299	4	4	17,731	4,433
	More than 1,000	1	1	596	596
Bioelectronics industry	Less than 50	2	2	1,395	698
	50~299	1	1	3,391	3,391
	300~999	1	1	6,857	6,857
Bioprocess and equipment industry	Less than 50	8	6	2,076	346
	50~299	7	7	12,012	1,716
	300~999	1	1	14,000	14,000
Bioenergy and bioresource industry	Less than 50	1	-	-	-
	50~299	2	2	85,780	42,890
	300~999	1	1	7,150	7,150
Bioassay, bioinformatics and R&D service industry	Less than 50	6	5	3,650	730
	50~299	8	8	16,900	2,112
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	5	6,341	1,268
	50~299	12	11	83,208	7,564
	300~999	4	3	32,891	10,964
	Unknown	5	-	-	-
Biochemical industry	Less than 50	5	3	15,968	5,323
	50~299	2	1	560	560
	300~999	1	1	21,322	21,322
	More than 1,000	3	3	1,274,180	424,727
	Unknown	2	-	-	-
Biofood industry	Less than 50	2	-	-	-
Bioenvironmental industry	Less than 50	1	1	1,157	1,157
	Unknown	1	1	30	30
Bioprocess and equipment industry	Less than 50	2	2	3,756	1,878
	50~299	1	1	4,380	4,380
	300~999	1	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	2	2,049	1,024

< Table 1-7 > Ratio of Net Worth(Ⅱ-2)        (Unit : number of firms, %)

		Total	Ratio of Net worth
			Number of respondent companies	Average
Number of companies		978	748	54
▣ Sales Situation
No sales		281	203	53
Sales below break-even - 1 year		10	10	235
Sales below break-even - 2~3 years		63	49	47
Sales below break-even - 4~5 years		96	70	40
Sales below break-even - 6~9 years		91	66	45
Sales below break-even - 10 or more years		82	62	38
Sales below break-even - Unknown		1	1	20
Sales below break-even - 1 year		1	1	38
Sales below break-even - 2~3 years		15	10	55
Sales below break-even - 4~5 years		27	18	50
Sales above break-even - 6~9 years		58	48	62
Sales above break-even - 10 or more years		201	178	60
Sales - Unknown		52	32	57
▣ Main type of industry
Biopharmaceutical industry		330	272	62
Biochemical industry		206	153	48
Biofood industry		197	137	51
Bioenvironmental industry		76	61	55
Bioelectronics industry		22	12	58
Bioprocess and equipment industry		71	51	51
Bioenergy and bioresource industry		26	22	38
Bioassay, bioinformatics and R&D service industry		50	40	51
▣ Number of employees
Less than 50		574	381	51
50~299		272	253	57
300~999		75	67	62
More than 1,000		46	46	59
Unknown		11	1	95
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	24	48
	50~299	41	38	52
	300~999	17	16	59
	More than 1,000	2	2	52
	Unknown	1	-	-
Biochemical industry	Less than 50	26	12	56
	50~299	12	11	54
	300~999	3	1	59
	More than 1,000	6	6	67
Biofood industry	Less than 50	25	13	63
	50~299	17	13	52
	300~999	7	5	58
	More than 1,000	10	10	65
	Unknown	1	-	-
Bioenvironmental industry	Less than 50	19	14	54
	50~299	4	4	38
Bioelectronics industry	Less than 50	5	1	68
	50~299	2	1	24
Bioprocess and equipment industry	Less than 50	17	11	40
	50~299	4	4	75
	Unknown	1	-	-
Bioenergy and bioresource industry	Less than 50	7	5	14
	50~299	3	2	49
	More than 1,000	1	1	39
Bioassay, bioinformatics and R&D service industry	Less than 50	7	6	52
	50~299	2	2	65
	300~999	1	1	100
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	1	1,782
	50~299	3	3	76
	300~999	1	1	65

		Total	Ratio of Net worth
			Number of respondent companies	Average
Number of companies		978	748	54
Biofood industry	50~299	1	1	30
Bioenvironmental industry	Less than 50	1	1	43
Bioelectronics industry	Less than 50	1	1	78
Bioassay, bioinformatics and R&D service industry	Less than 50	2	2	60
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	6	48
	50~299	7	7	50
	300~999	1	1	48
	More than 1,000	2	2	51
Biochemical industry	Less than 50	16	10	42
	50~299	3	3	50
	300~999	1	1	67
Biofood industry	Less than 50	8	6	51
	50~299	1	1	74
	300~999	1	1	57
Bioenvironmental industry	Less than 50	3	1	57
Bioelectronics industry	Less than 50	3	3	51
Bioprocess and equipment industry	Less than 50	4	3	43
Bioenergy and bioresource industry	Less than 50	2	2	38
	50~299	1	1	-83
Bioassay, bioinformatics and R&D service industry	Less than 50	1	1	94
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	11	54
	50~299	8	8	42
Biochemical industry	Less than 50	19	14	8
	50~299	1	1	75
	300~999	1	1	66
	More than 1,000	1	1	54
Biofood industry	Less than 50	15	8	47
	50~299	4	3	49
Bioenvironmental industry	Less than 50	9	6	58
	50~299	1	1	52
Bioelectronics industry	Less than 50	1	-	-
	50~299	2	1	51
Bioprocess and equipment industry	Less than 50	10	8	45
Bioenergy and bioresource industry	Less than 50	4	4	48
Bioassay, bioinformatics and R&D service industry	Less than 50	4	2	-12
	50~299	1	1	65
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	11	31
	50~299	5	5	50
	300~999	2	2	54
Biochemical industry	Less than 50	21	18	48
	50~299	1	1	73
	More than 1,000	2	2	72
Biofood industry	Less than 50	23	14	45
	50~299	1	1	38
Bioenvironmental industry	Less than 50	7	4	35
	50~299	2	2	42
Bioelectronics industry	Less than 50	1	-	-
Bioprocess and equipment industry	Less than 50	1	1	54
	50~299	1	1	84
Bioenergy and bioresource industry	Less than 50	1	1	32
Bioassay, bioinformatics and R&D service industry	Less than 50	5	2	51
	50~299	1	1	54
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	8	51
	50~299	8	8	56
	300~999	5	5	74
	More than 1,000	3	3	51
Biochemical industry	Less than 50	11	5	-58
	50~299	1	1	69
Biofood industry	Less than 50	20	16	31
	50~299	4	4	50
Bioenvironmental industry	Less than 50	5	3	39
	50~299	1	1	58
Bioelectronics industry	300~999	1	1	69

		Total	Ratio of Net worth
			Number of respondent companies	Average
Number of companies		978	748	54
Bioprocess and equipment industry	Less than 50	5	3	61
	50~299	1	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	3	3
	50~299	1	1	53
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	1	20
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	1	38
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	1	32
	50~299	5	5	70
Biochemical industry	Less than 50	3	3	32
Biofood industry	Less than 50	3	-	-
Bioenvironmental industry	50~299	1	1	75
Bioelectronics industry	Less than 50	1	-	-
Bioprocess and equipment industry	Less than 50	1	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	4	60
	50~299	2	2	23
	300~999	1	1	82
Biochemical industry	Less than 50	9	6	43
	50~299	1	1	80
	300~999	1	1	28
Biofood industry	Less than 50	2	-	-
Bioenvironmental industry	Less than 50	1	1	45
Bioenergy and bioresource industry	Less than 50	2	1	31
Bioassay, bioinformatics and R&D service industry	Less than 50	2	1	95
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	3	55
	50~299	4	3	75
	300~999	1	1	27
	More than 1,000	2	2	59
Biochemical industry	Less than 50	13	12	64
	50~299	3	3	44
	More than 1,000	1	1	60
Biofood industry	Less than 50	12	8	57
	50~299	2	2	66
Bioenvironmental industry	Less than 50	4	4	75
	300~999	1	1	65
Bioelectronics industry	Less than 50	1	-	-
Bioprocess and equipment industry	Less than 50	2	1	86
	50~299	4	4	62
Bioenergy and bioresource industry	Less than 50	1	1	50
Bioassay, bioinformatics and R&D service industry	Less than 50	2	1	60
	50~299	1	1	70
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	10	58
	50~299	38	38	65
	300~999	16	15	65
	More than 1,000	8	8	58
Biochemical industry	Less than 50	20	14	63
	50~299	15	14	70
	300~999	1	1	63
	More than 1,000	1	1	74
Biofood industry	Less than 50	15	9	44
	50~299	14	13	60
	300~999	4	4	45
	More than 1,000	3	3	51

		Total	Ratio of Net worth
			Number of respondent companies	Average
Number of companies		978	748	54
Bioenvironmental industry	Less than 50	10	10	61
	50~299	4	4	70
	More than 1,000	1	1	54
Bioelectronics industry	Less than 50	2	2	43
	50~299	1	1	91
	300~999	1	1	79
Bioprocess and equipment industry	Less than 50	8	4	41
	50~299	7	7	54
	300~999	1	1	36
Bioenergy and bioresource industry	Less than 50	1	1	73
	50~299	2	2	84
	300~999	1	1	82
Bioassay, bioinformatics and R&D service industry	Less than 50	6	5	68
	50~299	8	8	39
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	4	62
	50~299	12	10	58
	300~999	4	3	73
	Unknown	5	-	-
Biochemical industry	Less than 50	5	3	32
	50~299	2	1	44
	300~999	1	1	41
	More than 1,000	3	3	56
	Unknown	2	-	-
Biofood industry	Less than 50	2	-	-
Bioenvironmental industry	Less than 50	1	1	42
	Unknown	1	1	95
Bioprocess and equipment industry	Less than 50	2	2	19
	50~299	1	1	87
	300~999	1	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	2	80

< Table 2 > Manpower Status of Bioindustry

< Table 2-1 > Manpower Size of Researchers(Ⅲ-2)   (Unit : number of firms, people)

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	1,797	2	5,864	6	4,053	4	1,068	1	12,782	13
▣ Sales Situation
No sales		281	5,826	21	353	1	1,124	4	823	3	177	1	2,477	9
Sales below break-even - 1 year		10	311	31	27	3	87	10	57	6	1	0	172	17
Sales below break-even - 2~3 years		63	2,536	40	83	1	268	4	146	2	49	1	546	9
Sales below break-even - 4~5 years		96	2,008	21	125	1	328	3	254	3	57	1	764	8
Sales below break-even - 6~9 years		91	2,107	23	129	1	290	3	197	2	84	1	700	8
Sales below break-even - 10 or more years		82	4,196	51	220	3	751	9	373	5	81	1	1,425	17
Sales below break-even - Unknown		1	43	43	3	3	14	14	8	8	2	2	27	27
Sales below break-even - 1 year		1	6	6	1	1	-	-	-	-	2	2	3	3
Sales below break-even - 2~3 years		15	466	31	18	1	59	4	42	3	6	0	125	8
Sales below break-even - 4~5 years		27	897	33	46	2	126	5	133	5	7	0	312	12
Sales above break-even - 6~9 years		58	2,860	49	121	2	418	7	322	6	143	2	1,004	17
Sales above break-even - 10 or more years		201	18,151	90	634	3	2,328	12	1,610	8	450	2	5,022	25
Sales - Unknown		52	279	5	37	1	71	2	88	3	9	0	205	4
▣ Main type of industry
Biopharmaceutical industry		330	20,818	63	929	3	3,002	10	1,700	6	526	2	6,157	19
Biochemical industry		206	5,015	24	307	2	1,105	6	637	3	119	1	2,168	11
Biofood industry		197	6,519	33	264	1	818	4	478	2	99	1	1,659	8
Bioenvironmental industry		76	1,214	16	35	0	135	2	160	2	27	0	357	5
Bioelectronics industry		22	1,185	54	32	2	126	6	125	6	20	1	303	14
Bioprocess and equipment industry		71	1,514	21	50	1	152	2	187	3	39	1	428	6
Bioenergy and bioresource industry		26	1,149	44	48	2	107	4	95	4	121	5	371	14
Bioassay, bioinformatics and R&D service industry		50	2,272	45	132	3	419	9	671	14	117	2	1,339	27
▣ Number of employees
Less than 50		574	7,205	13	496	1	1,166	2	1,034	2	159	0	2,855	5
50~299		272	17,085	63	528	2	1,807	7	1,880	7	379	1	4,594	17
300~999		75	5,435	72	254	4	946	14	509	8	206	3	1,915	26
More than 1,000		46	9,961	217	519	11	1,945	42	630	14	324	7	3,418	74
Unknown		11	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	479	12	31	1	86	2	90	2	17	0	224	6
	50~299	41	779	19	29	1	96	2	138	3	25	1	288	7
	300~999	17	1,179	69	111	7	363	21	222	13	35	2	731	43
	More than 1,000	2	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	26	216	8	8	0	27	1	29	1	5	0	69	3
	50~299	12	438	37	12	1	40	4	37	3	12	1	101	8
	300~999	3	3	1	1	1	2	2	-	-	-	-	3	1
	More than 1,000	6	160	27	54	9	71	12	20	3	10	2	155	26
Biofood industry	Less than 50	25	208	8	13	1	34	1	30	1	1	0	78	3
	50~299	17	560	33	16	1	49	3	66	4	22	1	153	9
	300~999	7	451	64	12	2	59	8	31	4	13	2	115	16
	More than 1,000	10	413	41	23	2	166	17	33	3	8	1	230	23
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	94	5	4	0	15	1	13	1	3	0	35	2
	50~299	4	199	50	3	1	7	2	16	4	3	1	29	7
Bioelectronics industry	Less than 50	5	28	6	4	1	8	2	12	3	1	0	25	5
	50~299	2	18	9	1	1	7	4	5	3	-	-	13	7
Bioprocess and equipment industry	Less than 50	17	166	10	3	0	18	1	26	2	9	1	56	3
	50~299	4	81	20	4	1	15	4	11	3	3	1	33	8
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	56	8	2	0	6	1	13	2	5	1	26	4
	50~299	3	87	29	-	-	6	2	14	5	-	-	20	7
	More than 1,000	1	76	76	10	10	20	20	6	6	5	5	41	41
Bioassay, bioinformatics and R&D service industry	Less than 50	7	14	2	1	0	5	1	7	1	-	-	13	2
	50~299	2	99	50	4	2	13	7	3	2	-	-	20	10
	300~999	1	22	22	7	7	11	11	1	1	-	-	19	19

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	1,797	2	5,864	6	4,053	4	1,068	1	12,782	13
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	9	9	-	-	4	4	5	5	-	-	9	9
	50~299	3	108	36	4	2	10	5	24	12	1	1	39	13
	300~999	1	66	66	13	13	47	47	6	6	-	-	66	66
Biofood industry	50~299	1	28	28	1	1	5	5	5	5	-	-	11	11
Bioenvironmental industry	Less than 50	1	14	14	-	-	7	7	-	-	-	-	7	7
Bioelectronics industry	Less than 50	1	22	22	3	3	6	6	-	-	-	-	9	9
Bioassay, bioinformatics and R&D service industry	Less than 50	2	64	32	6	3	8	4	17	9	-	-	31	16
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	131	15	12	1	44	5	9	1	-	-	65	7
	50~299	7	485	69	8	1	27	4	14	2	7	1	56	8
	300~999	1	21	21	2	2	8	8	-	-	-	-	10	10
	More than 1,000	2	1,185	593	20	10	38	19	10	5	10	5	78	39
Biochemical industry	Less than 50	16	105	7	6	0	24	2	20	1	2	0	52	3
	50~299	3	42	14	4	1	8	3	16	5	5	2	33	11
	300~999	1	180	180	3	3	44	44	17	17	7	7	71	71
Biofood industry	Less than 50	8	72	9	4	1	15	2	10	1	3	0	32	4
	50~299	1	27	27	-	-	4	4	4	4	1	1	9	9
	300~999	1	30	30	2	2	21	21	6	6	1	1	30	30
Bioenvironmental industry	Less than 50	3	16	5	-	-	2	1	4	1	2	1	8	3
Bioelectronics industry	Less than 50	3	76	25	6	2	13	4	11	4	4	1	34	11
Bioprocess and equipment industry	Less than 50	4	57	14	10	3	1	0	3	1	3	1	17	4
Bioenergy and bioresource industry	Less than 50	2	53	27	4	2	9	5	15	8	2	1	30	15
	50~299	1	50	50	1	1	8	8	6	6	2	2	17	17
Bioassay, bioinformatics and R&D service industry	Less than 50	1	6	6	1	1	2	2	1	1	-	-	4	4
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	286	19	30	2	60	4	20	1	8	1	118	8
	50~299	8	457	57	14	2	62	8	73	9	15	2	164	21
Biochemical industry	Less than 50	19	240	13	10	1	29	2	46	3	7	0	92	5
	50~299	1	33	33	1	1	9	9	2	2	-	-	12	12
	300~999	1	53	53	4	4	22	22	11	11	-	-	37	37
	More than 1,000	1	30	30	2	2	6	6	2	2	2	2	12	12
Biofood industry	Less than 50	15	132	9	13	1	28	2	25	2	1	0	67	4
	50~299	4	259	65	8	2	17	4	12	3	5	1	42	11
Bioenvironmental industry	Less than 50	9	71	8	4	0	16	2	11	1	5	1	36	4
	50~299	1	24	24	3	3	5	5	-	-	-	-	8	8
Bioelectronics industry	Less than 50	1	7	7	1	1	2	2	2	2	-	-	5	5
	50~299	2	50	25	4	2	14	7	14	7	4	2	36	18
Bioprocess and equipment industry	Less than 50	10	164	16	7	1	17	2	23	2	4	0	51	5
Bioenergy and bioresource industry	Less than 50	4	47	12	2	1	3	1	1	0	5	1	11	3
Bioassay, bioinformatics and R&D service industry	Less than 50	4	67	17	13	3	25	6	9	2	1	0	48	12
	50~299	1	88	88	9	9	13	13	3	3	-	-	25	25
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	292	17	40	2	76	4	29	2	5	0	150	9
	50~299	5	406	81	4	1	19	5	33	8	58	12	114	23
	300~999	2	20	10	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	286	14	21	1	46	2	45	2	7	0	119	6
	50~299	1	215	215	7	7	40	40	4	4	5	5	56	56
	More than 1,000	2	51	26	13	7	20	10	2	1	1	1	36	18
Biofood industry	Less than 50	23	241	10	19	1	28	1	25	1	5	0	77	3
	50~299	1	102	102	2	2	4	4	2	2	-	-	8	8
Bioenvironmental industry	Less than 50	7	32	5	3	0	9	1	6	1	-	-	18	3
	50~299	2	237	119	1	1	3	2	6	3	2	1	12	6
Bioelectronics industry	Less than 50	1	13	13	1	1	2	2	4	4	-	-	7	7
Bioprocess and equipment industry	Less than 50	1	8	8	-	-	1	1	1	1	1	1	3	3
	50~299	1	107	107	4	4	14	14	24	24	-	-	42	42
Bioenergy and bioresource industry	Less than 50	1	22	22	2	2	6	6	10	10	-	-	18	18
Bioassay, bioinformatics and R&D service industry	Less than 50	5	37	7	5	1	10	2	4	1	-	-	19	4
	50~299	1	38	38	7	7	12	12	2	2	-	-	21	21

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	1,797	2	5,864	6	4,053	4	1,068	1	12,782	13
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	268	22	27	2	52	4	49	4	5	0	133	11
	50~299	8	563	70	66	8	120	15	42	5	5	1	233	29
	300~999	5	155	31	13	3	46	9	21	4	6	1	86	17
	More than 1,000	3	1,538	513	73	24	331	110	75	25	24	8	503	168
Biochemical industry	Less than 50	11	94	9	7	1	14	1	13	1	1	0	35	3
	50~299	1	77	77	2	2	15	15	8	8	-	-	25	25
Biofood industry	Less than 50	20	294	15	15	1	35	2	26	1	1	0	77	4
	50~299	4	422	106	2	1	30	8	19	5	-	-	51	13
Bioenvironmental industry	Less than 50	5	28	6	-	-	6	1	3	1	-	-	9	2
	50~299	1	73	73	-	-	2	2	8	8	-	-	10	10
Bioelectronics industry	300~999	1	334	334	2	2	31	31	31	31	1	1	65	65
Bioprocess and equipment industry	Less than 50	5	59	12	1	0	5	1	7	1	1	0	14	3
	50~299	1	53	53	-	-	7	7	2	2	-	-	9	9
Bioassay, bioinformatics and R&D service industry	Less than 50	4	55	14	5	1	14	4	5	1	1	0	25	6
	50~299	1	183	183	7	7	43	43	64	64	36	36	150	150
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	43	43	3	3	14	14	8	8	2	2	27	27
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	6	6	1	1	-	-	-	-	2	2	3	3
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	38	38	1	1	3	3	1	1	-	-	5	5
	50~299	5	333	67	14	3	49	10	31	6	3	1	97	19
Biochemical industry	Less than 50	3	29	10	3	1	4	1	3	1	1	0	11	4
Biofood industry	Less than 50	3	16	5	-	-	1	0	4	1	-	-	5	2
Bioenvironmental industry	50~299	1	41	41	-	-	-	-	3	3	2	2	5	5
Bioelectronics industry	Less than 50	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	9	9	-	-	2	2	-	-	-	-	2	2
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	93	16	6	1	11	2	18	3	-	-	35	6
	50~299	2	245	123	3	2	15	8	47	24	-	-	65	33
	300~999	1	149	149	4	4	12	12	2	2	-	-	18	18
Biochemical industry	Less than 50	9	117	13	8	1	11	1	15	2	-	-	34	4
	50~299	1	74	74	3	3	5	5	1	1	-	-	9	9
	300~999	1	91	91	19	19	49	49	18	18	5	5	91	91
Biofood industry	Less than 50	2	13	7	-	-	1	1	2	1	1	1	4	2
Bioenvironmental industry	Less than 50	1	18	18	-	-	-	-	7	7	-	-	7	7
Bioenergy and bioresource industry	Less than 50	2	47	24	1	1	3	2	4	2	1	1	9	5
Bioassay, bioinformatics and R&D service industry	Less than 50	2	50	25	2	1	19	10	19	10	-	-	40	20
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	58	15	8	2	25	6	4	1	1	0	38	10
	50~299	4	206	52	8	2	26	7	8	2	1	0	43	11
	300~999	1	29	29	1	1	6	6	-	-	-	-	7	7
	More than 1,000	2	1,476	738	54	27	229	115	186	93	80	40	549	275
Biochemical industry	Less than 50	13	292	22	18	2	50	4	34	3	5	0	107	8
	50~299	3	96	32	1	0	4	1	20	7	-	-	25	8
	More than 1,000	1	17	17	2	2	2	2	2	2	-	-	6	6
Biofood industry	Less than 50	12	127	11	11	1	11	1	21	2	1	0	44	4
	50~299	2	154	77	5	3	26	13	9	5	-	-	40	20
Bioenvironmental industry	Less than 50	4	55	14	2	1	2	1	7	2	-	-	11	3
	300~999	1	7	7	1	1	6	6	-	-	-	-	7	7
Bioelectronics industry	Less than 50	1	6	6	1	1	3	3	-	-	-	-	4	4
Bioprocess and equipment industry	Less than 50	2	27	14	1	1	3	2	3	2	3	2	10	5
	50~299	4	133	33	3	1	14	4	17	4	-	-	34	9
Bioenergy and bioresource industry	Less than 50	1	40	40	-	-	-	-	3	3	2	2	5	5
Bioassay, bioinformatics and R&D service industry	Less than 50	2	17	9	5	3	6	3	3	2	-	-	14	7
	50~299	1	120	120	-	-	5	5	5	5	50	50	60	60

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	1,797	2	5,864	6	4,053	4	1,068	1	12,782	13
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	328	25	14	1	30	2	50	4	4	0	98	8
	50~299	38	4,528	119	122	3	411	11	214	6	45	1	792	21
	300~999	16	931	58	27	2	108	8	58	4	24	2	217	14
	More than 1,000	8	3,777	472	148	19	538	67	158	20	144	18	988	124
Biochemical industry	Less than 50	20	303	15	12	1	47	2	34	2	4	0	97	5
	50~299	15	1,200	80	27	2	140	9	133	9	16	1	316	21
	300~999	1	42	42	3	3	29	29	7	7	3	3	42	42
	More than 1,000	1	475	475	45	45	330	330	85	85	15	15	475	475
Biofood industry	Less than 50	15	258	17	16	1	24	2	32	2	3	0	75	5
	50~299	14	1,307	93	25	2	76	5	80	6	3	0	184	13
	300~999	4	710	178	7	2	16	4	21	5	4	1	48	12
	More than 1,000	3	645	215	65	22	154	51	7	2	22	7	248	83
Bioenvironmental industry	Less than 50	10	130	13	9	1	16	2	23	2	1	0	49	5
	50~299	4	79	20	3	1	9	2	10	3	9	2	31	8
	More than 1,000	1	96	96	2	2	30	30	43	43	-	-	75	75
Bioelectronics industry	Less than 50	2	20	10	2	1	4	2	3	2	-	-	9	5
	50~299	1	92	92	1	1	5	5	4	4	-	-	10	10
	300~999	1	519	519	6	6	31	31	39	39	10	10	86	86
Bioprocess and equipment industry	Less than 50	8	233	29	5	1	19	2	11	1	9	1	44	6
	50~299	7	398	57	10	1	33	5	47	7	6	1	96	14
	300~999	1	2	2	-	-	-	-	2	2	-	-	2	2
Bioenergy and bioresource industry	Less than 50	1	26	26	3	3	5	5	2	2	1	1	11	11
	50~299	2	212	106	7	4	8	4	5	3	4	4	24	12
	300~999	1	433	433	16	16	33	33	16	16	94	94	159	159
Bioassay, bioinformatics and R&D service industry	Less than 50	6	93	16	11	2	21	4	22	4	3	1	57	10
	50~299	8	1,314	164	48	6	211	26	504	63	26	3	789	99
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	40	5	2	1	4	1	3	1	-	-	9	1
	50~299	12	160	13	20	3	46	8	60	10	3	1	129	11
	300~999	4	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	26	5	3	1	5	1	12	2	-	-	20	4
	50~299	2	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	8	8	-	-	2	2	-	-	3	3	5	5
	More than 1,000	3	22	7	8	3	10	3	1	0	3	1	22	7
	Unknown	2	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	1	1	1	1	-	-	-	-	-	-	1	1
Bioenvironmental industry	Less than 50	1	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	12	6	2	1	3	2	5	3	-	-	10	5
	50~299	1	5	5	-	-	-	-	5	5	-	-	5	5
	300~999	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	5	3	1	1	1	1	2	1	-	-	4	2

< Table 2-2 > Manpower Size of Production Workers  (Unit : number of firms, people)

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	133	0	1,009	1	4,491	5	7,931	9	13,564	14
▣ Sales Situation
No sales		281	5,826	21	26	0	139	1	845	3	1,063	4	2,073	7
Sales below break-even - 1 year		10	311	31	1	0	5	1	26	3	28	3	60	6
Sales below break-even - 2~3 years		63	2,536	40	25	0	132	2	471	7	480	8	1,108	18
Sales below break-even - 4~5 years		96	2,008	21	6	0	65	1	231	2	414	4	716	7
Sales below break-even - 6~9 years		91	2,107	23	15	0	66	1	228	3	233	3	542	6
Sales below break-even - 10 or more years		82	4,196	51	13	0	71	1	434	5	789	10	1,307	16
Sales below break-even - Unknown		1	43	43	1	1	3	3	7	7	5	5	16	16
Sales below break-even - 1 year		1	6	6	-	-	-	-	1	1	-	-	1	1
Sales below break-even - 2~3 years		15	466	31	10	1	10	1	34	2	42	3	96	6
Sales below break-even - 4~5 years		27	897	33	1	0	30	1	208	8	93	3	332	12
Sales above break-even - 6~9 years		58	2,860	49	7	0	134	2	344	6	665	11	1,150	20
Sales above break-even - 10 or more years		201	18,151	90	28	0	352	2	1,656	8	4,111	21	6,147	31
Sales - Unknown		52	279	5	-	-	2	0	6	0	8	0	16	0
▣ Main type of industry
Biopharmaceutical industry		330	20,818	63	73	0	711	2	2,380	8	3,983	13	7,147	22
Biochemical industry		206	5,015	24	8	0	63	0	538	3	844	4	1,453	7
Biofood industry		197	6,519	33	31	0	128	1	988	5	1,882	10	3,029	15
Bioenvironmental industry		76	1,214	16	4	0	16	0	198	3	151	2	369	5
Bioelectronics industry		22	1,185	54	1	0	17	1	97	5	461	23	576	26
Bioprocess and equipment industry		71	1,514	21	12	0	36	1	130	2	332	5	510	7
Bioenergy and bioresource industry		26	1,149	44	3	0	19	1	117	5	270	10	409	16
Bioassay, bioinformatics and R&D service industry		50	2,272	45	1	0	19	0	43	1	8	0	71	1
▣ Number of employees
Less than 50		574	7,205	13	51	0	143	0	847	2	1,078	2	2,119	4
50~299		272	17,085	63	38	0	381	1	1,791	7	3,892	15	6,102	22
300~999		75	5,435	72	10	0	120	2	780	12	994	15	1,904	25
More than 1,000		46	9,961	217	34	1	365	8	1,073	23	1,967	43	3,439	75
Unknown		11	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	479	12	-	-	6	0	41	1	61	2	108	3
	50~299	41	779	19	-	-	7	0	105	3	181	5	293	7
	300~999	17	1,179	69	1	0	19	1	39	2	93	5	152	9
	More than 1,000	2	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	26	216	8	-	-	5	0	23	1	61	3	89	3
	50~299	12	438	37	1	0	6	1	45	4	153	14	205	17
	300~999	3	3	1	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	160	27	-	-	-	-	-	-	5	1	5	1
Biofood industry	Less than 50	25	208	8	16	1	4	0	19	1	28	1	67	3
	50~299	17	560	33	1	0	25	2	88	6	162	10	276	16
	300~999	7	451	64	3	0	16	2	232	33	85	12	336	48
	More than 1,000	10	413	41	3	0	23	2	56	6	100	10	182	18
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	94	5	-	-	2	0	7	0	24	1	33	2
	50~299	4	199	50	-	-	3	1	84	21	38	10	125	31
Bioelectronics industry	Less than 50	5	28	6	-	-	-	-	1	0	-	-	1	0
	50~299	2	18	9	-	-	2	1	3	2	-	-	5	3
Bioprocess and equipment industry	Less than 50	17	166	10	-	-	6	0	28	2	22	1	56	3
	50~299	4	81	20	-	-	3	1	9	2	19	5	31	8
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	56	8	-	-	2	0	7	1	11	2	20	3
	50~299	3	87	29	-	-	-	-	43	14	-	-	43	14
	More than 1,000	1	76	76	1	1	5	5	10	10	19	19	35	35
Bioassay, bioinformatics and R&D service industry	Less than 50	7	14	2	-	-	-	-	-	-	-	-	-	-
	50~299	2	99	50	-	-	5	3	5	3	1	1	11	6
	300~999	1	22	22	-	-	-	-	-	-	-	-	-	-

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	133	0	1,009	1	4,491	5	7,931	9	13,564	14
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	9	9	-	-	-	-	-	-	-	-	-	-
	50~299	3	108	36	1	1	3	2	16	8	16	8	36	12
	300~999	1	66	66	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	28	28	-	-	1	1	8	8	8	8	17	17
Bioenvironmental industry	Less than 50	1	14	14	-	-	1	1	2	2	2	2	5	5
Bioelectronics industry	Less than 50	1	22	22	-	-	-	-	-	-	2	2	2	2
Bioassay, bioinformatics and R&D service industry	Less than 50	2	64	32	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	131	15	1	0	9	1	23	3	3	0	36	4
	50~299	7	485	69	2	0	6	1	73	10	166	24	247	35
	300~999	1	21	21	1	1	1	1	8	8	1	1	11	11
	More than 1,000	2	1,185	593	7	4	96	48	225	113	240	120	568	284
Biochemical industry	Less than 50	16	105	7	-	-	1	0	11	1	15	1	27	2
	50~299	3	42	14	-	-	1	0	5	2	3	1	9	3
	300~999	1	180	180	-	-	-	-	82	82	10	10	92	92
Biofood industry	Less than 50	8	72	9	1	0	-	-	2	0	5	1	8	1
	50~299	1	27	27	-	-	1	1	5	5	10	10	16	16
	300~999	1	30	30	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	16	5	3	1	1	0	-	-	-	-	4	1
Bioelectronics industry	Less than 50	3	76	25	-	-	1	0	6	2	12	4	19	6
Bioprocess and equipment industry	Less than 50	4	57	14	9	2	10	3	16	4	-	-	35	9
Bioenergy and bioresource industry	Less than 50	2	53	27	1	1	4	2	5	3	6	3	16	8
	50~299	1	50	50	-	-	1	1	8	8	9	9	18	18
Bioassay, bioinformatics and R&D service industry	Less than 50	1	6	6	-	-	-	-	2	2	-	-	2	2
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	286	19	2	0	15	1	48	3	39	3	104	7
	50~299	8	457	57	1	0	16	2	15	2	86	12	118	15
Biochemical industry	Less than 50	19	240	13	1	0	3	0	26	2	48	3	78	4
	50~299	1	33	33	-	-	2	2	10	10	9	9	21	21
	300~999	1	53	53	-	-	-	-	16	16	-	-	16	16
	More than 1,000	1	30	30	-	-	3	3	6	6	9	9	18	18
Biofood industry	Less than 50	15	132	9	-	-	1	0	16	1	20	1	37	2
	50~299	4	259	65	-	-	2	1	29	7	121	30	152	38
Bioenvironmental industry	Less than 50	9	71	8	-	-	2	0	17	2	14	2	33	4
	50~299	1	24	24	-	-	1	1	12	12	-	-	13	13
Bioelectronics industry	Less than 50	1	7	7	-	-	-	-	-	-	1	1	1	1
	50~299	2	50	25	1	1	2	1	8	4	3	2	14	7
Bioprocess and equipment industry	Less than 50	10	164	16	1	0	6	1	12	1	39	4	58	6
Bioenergy and bioresource industry	Less than 50	4	47	12	-	-	-	-	7	2	20	5	27	7
Bioassay, bioinformatics and R&D service industry	Less than 50	4	67	17	-	-	1	0	-	-	5	1	6	2
	50~299	1	88	88	-	-	11	11	9	9	-	-	20	20
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	292	17	2	0	8	0	40	2	17	1	67	4
	50~299	5	406	81	3	1	28	7	49	12	22	6	102	20
	300~999	2	20	10	1	1	3	3	12	12	1	1	17	9
Biochemical industry	Less than 50	21	286	14	1	0	2	0	39	2	32	2	74	4
	50~299	1	215	215	-	-	3	3	7	7	15	15	25	25
	More than 1,000	2	51	26	1	1	5	3	1	1	8	4	15	8
Biofood industry	Less than 50	23	241	10	4	0	6	0	18	1	40	2	68	3
	50~299	1	102	102	-	-	1	1	30	30	54	54	85	85
Bioenvironmental industry	Less than 50	7	32	5	-	-	1	0	4	1	2	0	7	1
	50~299	2	237	119	-	-	-	-	3	2	10	5	13	7
Bioelectronics industry	Less than 50	1	13	13	-	-	2	2	4	4	-	-	6	6
Bioprocess and equipment industry	Less than 50	1	8	8	-	-	-	-	-	-	3	3	3	3
	50~299	1	107	107	1	1	4	4	12	12	29	29	46	46
Bioenergy and bioresource industry	Less than 50	1	22	22	1	1	1	1	2	2	-	-	4	4
Bioassay, bioinformatics and R&D service industry	Less than 50	5	37	7	-	-	-	-	-	-	-	-	-	-
	50~299	1	38	38	1	1	2	2	7	7	-	-	10	10

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	133	0	1,009	1	4,491	5	7,931	9	13,564	14
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	268	22	1	0	4	0	37	3	27	2	69	6
	50~299	8	563	70	-	-	16	2	53	7	74	9	143	18
	300~999	5	155	31	-	-	10	2	27	5	21	4	58	12
	More than 1,000	3	1,538	513	11	4	31	10	181	60	276	92	499	166
Biochemical industry	Less than 50	11	94	9	-	-	4	0	11	1	16	1	31	3
	50~299	1	77	77	-	-	-	-	25	25	20	20	45	45
Biofood industry	Less than 50	20	294	15	1	0	3	0	49	2	75	4	128	6
	50~299	4	422	106	-	-	-	-	21	5	129	32	150	38
Bioenvironmental industry	Less than 50	5	28	6	-	-	1	0	3	1	-	-	4	1
	50~299	1	73	73	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	334	334	-	-	2	2	9	9	118	118	129	129
Bioprocess and equipment industry	Less than 50	5	59	12	-	-	-	-	6	1	10	2	16	3
	50~299	1	53	53	-	-	-	-	2	2	21	21	23	23
Bioassay, bioinformatics and R&D service industry	Less than 50	4	55	14	-	-	-	-	10	3	2	1	12	3
	50~299	1	183	183	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	43	43	1	1	3	3	7	7	5	5	16	16
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	6	6	-	-	-	-	1	1	-	-	1	1
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	38	38	1	1	5	5	11	11	1	1	18	18
	50~299	5	333	67	8	2	5	1	18	4	13	3	44	9
Biochemical industry	Less than 50	3	29	10	-	-	-	-	2	1	11	4	13	4
Biofood industry	Less than 50	3	16	5	1	0	-	-	1	0	-	-	2	1
Bioenvironmental industry	50~299	1	41	41	-	-	-	-	2	2	17	17	19	19
Bioelectronics industry	Less than 50	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	9	9	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	93	16	1	0	-	-	27	5	9	2	37	6
	50~299	2	245	123	-	-	-	-	84	42	-	-	84	42
	300~999	1	149	149	-	-	29	29	52	52	35	35	116	116
Biochemical industry	Less than 50	9	117	13	-	-	1	0	27	3	10	1	38	4
	50~299	1	74	74	-	-	-	-	10	10	19	19	29	29
	300~999	1	91	91	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	13	7	-	-	-	-	2	1	5	3	7	4
Bioenvironmental industry	Less than 50	1	18	18	-	-	-	-	2	2	-	-	2	2
Bioenergy and bioresource industry	Less than 50	2	47	24	-	-	-	-	4	2	15	8	19	10
Bioassay, bioinformatics and R&D service industry	Less than 50	2	50	25	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	58	15	-	-	-	-	-	-	-	-	-	-
	50~299	4	206	52	-	-	9	2	23	6	19	5	51	13
	300~999	1	29	29	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	1,476	738	5	3	113	57	183	92	430	215	731	366
Biochemical industry	Less than 50	13	292	22	1	0	3	0	50	4	49	4	103	8
	50~299	3	96	32	-	-	-	-	18	6	20	7	38	13
	More than 1,000	1	17	17	-	-	2	2	1	1	5	5	8	8
Biofood industry	Less than 50	12	127	11	-	-	-	-	11	1	23	2	34	3
	50~299	2	154	77	-	-	3	2	34	17	45	23	82	41
Bioenvironmental industry	Less than 50	4	55	14	-	-	-	-	3	1	9	2	12	3
	300~999	1	7	7	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	6	6	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	27	14	-	-	-	-	-	-	12	6	12	6
	50~299	4	133	33	1	0	4	1	11	3	44	11	60	15
Bioenergy and bioresource industry	Less than 50	1	40	40	-	-	-	-	10	10	9	9	19	19
Bioassay, bioinformatics and R&D service industry	Less than 50	2	17	9	-	-	-	-	-	-	-	-	-	-
	50~299	1	120	120	-	-	-	-	-	-	-	-	-	-

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	133	0	1,009	1	4,491	5	7,931	9	13,564	14
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	328	25	1	0	5	0	43	3	37	3	86	7
	50~299	38	4,528	119	13	0	153	4	484	13	1,306	35	1,956	51
	300~999	16	931	58	4	0	25	2	169	12	174	12	372	23
	More than 1,000	8	3,777	472	6	1	87	11	289	36	630	79	1,012	127
Biochemical industry	Less than 50	20	303	15	-	-	6	0	34	2	47	2	87	4
	50~299	15	1,200	80	3	0	16	1	88	6	276	18	383	26
	300~999	1	42	42	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	475	475	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	258	17	-	-	2	0	21	1	94	6	117	8
	50~299	14	1,307	93	-	-	33	2	176	13	512	37	721	52
	300~999	4	710	178	-	-	4	1	62	16	116	29	182	46
	More than 1,000	3	645	215	-	-	-	-	100	33	245	82	345	115
Bioenvironmental industry	Less than 50	10	130	13	-	-	1	0	20	2	11	1	32	3
	50~299	4	79	20	1	0	3	1	18	5	24	6	46	12
	More than 1,000	1	96	96	-	-	-	-	21	21	-	-	21	21
Bioelectronics industry	Less than 50	2	20	10	-	-	-	-	3	2	-	-	3	2
	50~299	1	92	92	-	-	1	1	8	8	55	55	64	64
	300~999	1	519	519	-	-	7	7	55	55	270	270	332	332
Bioprocess and equipment industry	Less than 50	8	233	29	-	-	3	0	6	1	60	8	69	9
	50~299	7	398	57	-	-	-	-	28	4	73	10	101	14
	300~999	1	2	2	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	26	26	-	-	-	-	5	5	3	3	8	8
	50~299	2	212	106	-	-	2	1	-	-	110	55	112	56
	300~999	1	433	433	-	-	4	4	16	16	68	68	88	88
Bioassay, bioinformatics and R&D service industry	Less than 50	6	93	16	-	-	-	-	10	2	-	-	10	2
	50~299	8	1,314	164	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	40	5	-	-	2	1	5	2	5	2	12	2
	50~299	12	160	13	-	-	-	-	-	-	-	-	-	-
	300~999	4	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	26	5	-	-	-	-	-	-	1	0	1	0
	50~299	2	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	8	8	-	-	-	-	1	1	2	2	3	3
	More than 1,000	3	22	7	-	-	-	-	-	-	-	-	-	-
	Unknown	2	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	1	1	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	12	6	-	-	-	-	-	-	-	-	-	-
	50~299	1	5	5	-	-	-	-	-	-	-	-	-	-
	300~999	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	5	3	-	-	-	-	-	-	-	-	-	-

< Table 2-3 > Manpower Size of Others such as sales/administrative(Ⅲ-2)

(Unit : number of firms, people)

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	412	0	1,267	1	8,174	9	3,487	4	13,340	14
▣ Sales Situation
No sales		281	5,826	21	21	0	84	0	854	3	317	1	1,276	5
Sales below break-even - 1 year		10	311	31	3	0	2	0	63	7	11	1	79	8
Sales below break-even - 2~3 years		63	2,536	40	16	0	94	1	529	8	243	4	882	14
Sales below break-even - 4~5 years		96	2,008	21	22	0	54	1	373	4	79	1	528	6
Sales below break-even - 6~9 years		91	2,107	23	31	0	98	1	554	6	182	2	865	10
Sales below break-even - 10 or more years		82	4,196	51	68	1	126	2	1,014	12	256	3	1,464	18
Sales below break-even - Unknown		1	43	43	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	6	6	1	1	-	-	-	-	1	1	2	2
Sales below break-even - 2~3 years		15	466	31	100	7	22	2	92	7	31	2	245	16
Sales below break-even - 4~5 years		27	897	33	8	0	24	1	193	7	28	1	253	9
Sales above break-even - 6~9 years		58	2,860	49	14	0	59	1	493	9	140	2	706	12
Sales above break-even - 10 or more years		201	18,151	90	128	1	703	4	3,962	20	2,189	11	6,982	35
Sales - Unknown		52	279	5	-	-	1	0	47	1	10	0	58	1
▣ Main type of industry
Biopharmaceutical industry		330	20,818	63	250	1	623	2	4,578	15	2,063	7	7,514	23
Biochemical industry		206	5,015	24	30	0	153	1	951	5	260	1	1,394	7
Biofood industry		197	6,519	33	46	0	185	1	995	5	605	3	1,831	9
Bioenvironmental industry		76	1,214	16	4	0	30	0	350	5	104	1	488	6
Bioelectronics industry		22	1,185	54	14	1	42	2	191	10	59	3	306	14
Bioprocess and equipment industry		71	1,514	21	16	0	50	1	339	5	171	3	576	8
Bioenergy and bioresource industry		26	1,149	44	10	0	31	1	226	9	102	4	369	14
Bioassay, bioinformatics and R&D service industry		50	2,272	45	42	1	153	3	544	11	123	3	862	17
▣ Number of employees
Less than 50		574	7,205	13	104	0	238	0	1,486	3	403	1	2,231	4
50~299		272	17,085	63	223	1	625	2	3,990	16	1,551	6	6,389	23
300~999		75	5,435	72	38	1	153	2	1,111	17	314	5	1,616	22
More than 1,000		46	9,961	217	47	1	251	5	1,587	35	1,219	27	3,104	67
Unknown		11	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	479	12	9	0	11	0	96	3	31	1	147	4
	50~299	41	779	19	2	0	12	0	148	4	36	1	198	5
	300~999	17	1,179	69	8	0	24	1	230	14	34	2	296	17
	More than 1,000	2	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	26	216	8	-	-	2	0	33	1	23	1	58	2
	50~299	12	438	37	1	0	8	1	105	10	18	2	132	11
	300~999	3	3	1	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	160	27	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	208	8	-	-	10	0	50	2	3	0	63	3
	50~299	17	560	33	-	-	1	0	19	1	111	7	131	8
	300~999	7	451	64	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	413	41	-	-	-	-	-	-	1	0	1	0
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	94	5	-	-	-	-	13	1	13	1	26	1
	50~299	4	199	50	-	-	1	0	33	8	11	3	45	11
Bioelectronics industry	Less than 50	5	28	6	-	-	-	-	2	1	-	-	2	0
	50~299	2	18	9	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	166	10	1	0	5	0	33	2	15	1	54	3
	50~299	4	81	20	-	-	-	-	-	-	17	4	17	4
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	56	8	-	-	2	0	6	1	2	0	10	1
	50~299	3	87	29	-	-	-	-	24	8	-	-	24	8
	More than 1,000	1	76	76	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	14	2	-	-	-	-	1	0	-	-	1	0
	50~299	2	99	50	-	-	8	4	58	29	2	1	68	34
	300~999	1	22	22	-	-	-	-	3	3	-	-	3	3

		Total	Bioindustry Workers		Researcher: Doctor		Researcher: Master		Researcher: Bachelor		Researcher: Others		Researcher: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	412	0	1,267	1	8,174	9	3,487	4	13,340	14
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	9	9	-	-	-	-	-	-	-	-	-	-
	50~299	3	108	36	-	-	-	-	23	12	10	5	33	11
	300~999	1	66	66	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	28	28	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	14	14	-	-	1	1	-	-	1	1	2	2
Bioelectronics industry	Less than 50	1	22	22	-	-	1	1	10	10	-	-	11	11
Bioassay, bioinformatics and R&D service industry	Less than 50	2	64	32	3	2	-	-	30	15	-	-	33	17
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	131	15	-	-	4	0	24	3	2	0	30	3
	50~299	7	485	69	-	-	-	-	150	21	32	5	182	26
	300~999	1	21	21	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	1,185	593	8	4	79	40	259	130	193	97	539	270
Biochemical industry	Less than 50	16	105	7	1	0	1	0	22	1	2	0	26	2
	50~299	3	42	14	-	-	-	-	-	-	-	-	-	-
	300~999	1	180	180	-	-	-	-	17	17	-	-	17	17
Biofood industry	Less than 50	8	72	9	-	-	6	1	22	3	4	1	32	4
	50~299	1	27	27	-	-	-	-	2	2	-	-	2	2
	300~999	1	30	30	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	16	5	1	0	-	-	2	1	1	0	4	1
Bioelectronics industry	Less than 50	3	76	25	1	0	3	1	18	6	1	0	23	8
Bioprocess and equipment industry	Less than 50	4	57	14	5	1	-	-	-	-	-	-	5	1
Bioenergy and bioresource industry	Less than 50	2	53	27	-	-	-	-	7	4	-	-	7	4
	50~299	1	50	50	-	-	1	1	6	6	8	8	15	15
Bioassay, bioinformatics and R&D service industry	Less than 50	1	6	6	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	286	19	9	1	9	1	41	3	5	0	64	4
	50~299	8	457	57	1	0	15	2	127	18	32	5	175	22
Biochemical industry	Less than 50	19	240	13	3	0	3	0	54	3	10	1	70	4
	50~299	1	33	33	-	-	-	-	-	-	-	-	-	-
	300~999	1	53	53	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	30	30	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	132	9	1	0	1	0	18	1	8	1	28	2
	50~299	4	259	65	1	0	4	1	48	12	12	3	65	16
Bioenvironmental industry	Less than 50	9	71	8	-	-	-	-	2	0	-	-	2	0
	50~299	1	24	24	-	-	-	-	3	3	-	-	3	3
Bioelectronics industry	Less than 50	1	7	7	-	-	-	-	1	1	-	-	1	1
	50~299	2	50	25	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	164	16	1	0	-	-	44	4	10	1	55	6
Bioenergy and bioresource industry	Less than 50	4	47	12	-	-	-	-	8	2	1	0	9	2
Bioassay, bioinformatics and R&D service industry	Less than 50	4	67	17	-	-	2	1	10	3	1	0	13	3
	50~299	1	88	88	6	6	20	20	17	17	-	-	43	43
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	292	17	7	0	8	0	48	3	12	1	75	4
	50~299	5	406	81	3	1	24	6	135	34	28	7	190	38
	300~999	2	20	10	-	-	1	1	2	2	-	-	3	2
Biochemical industry	Less than 50	21	286	14	5	0	6	0	63	3	19	1	93	4
	50~299	1	215	215	7	7	27	27	36	36	64	64	134	134
	More than 1,000	2	51	26	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	241	10	5	0	12	1	63	3	16	1	96	4
	50~299	1	102	102	-	-	-	-	9	9	-	-	9	9
Bioenvironmental industry	Less than 50	7	32	5	-	-	3	0	2	0	2	0	7	1
	50~299	2	237	119	1	1	8	4	164	82	39	20	212	106
Bioelectronics industry	Less than 50	1	13	13	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	8	8	-	-	-	-	1	1	1	1	2	2
	50~299	1	107	107	2	2	3	3	13	13	1	1	19	19
Bioenergy and bioresource industry	Less than 50	1	22	22	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	37	7	-	-	5	1	13	3	-	-	18	4
	50~299	1	38	38	1	1	1	1	5	5	-	-	7	7

		Total	Bioindustry Workers		Others: Doctor		Others: Master		Others: Bachelor		Others: Others		Others: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	412	0	1,267	1	8,174	9	3,487	4	13,340	14
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	268	22	7	1	6	1	40	3	13	1	66	6
	50~299	8	563	70	13	2	19	2	123	15	32	4	187	23
	300~999	5	155	31	2	0	4	1	5	1	-	-	11	2
	More than 1,000	3	1,538	513	26	9	40	13	441	147	29	10	536	179
Biochemical industry	Less than 50	11	94	9	2	0	3	0	17	2	6	1	28	3
	50~299	1	77	77	-	-	-	-	7	7	-	-	7	7
Biofood industry	Less than 50	20	294	15	9	0	10	1	45	2	25	1	89	4
	50~299	4	422	106	2	1	16	4	112	28	91	23	221	55
Bioenvironmental industry	Less than 50	5	28	6	1	0	3	1	6	1	5	1	15	3
	50~299	1	73	73	-	-	-	-	63	63	-	-	63	63
Bioelectronics industry	300~999	1	334	334	4	4	17	17	82	82	37	37	140	140
Bioprocess and equipment industry	Less than 50	5	59	12	-	-	2	0	23	5	4	1	29	6
	50~299	1	53	53	1	1	-	-	16	16	4	4	21	21
Bioassay, bioinformatics and R&D service industry	Less than 50	4	55	14	-	-	2	1	12	3	4	1	18	5
	50~299	1	183	183	1	1	4	4	22	22	6	6	33	33
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	43	43	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	6	6	1	1	-	-	-	-	1	1	2	2
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	38	38	-	-	1	1	12	12	2	2	15	15
	50~299	5	333	67	100	20	13	3	61	12	18	4	192	38
Biochemical industry	Less than 50	3	29	10	-	-	-	-	4	1	1	0	5	2
Biofood industry	Less than 50	3	16	5	-	-	1	0	7	2	1	0	9	3
Bioenvironmental industry	50~299	1	41	41	-	-	-	-	8	8	9	9	17	17
Bioelectronics industry	Less than 50	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	9	9	-	-	7	7	-	-	-	-	7	7
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	93	16	1	0	2	0	15	3	3	1	21	4
	50~299	2	245	123	2	1	5	3	82	41	7	4	96	48
	300~999	1	149	149	1	1	5	5	8	8	1	1	15	15
Biochemical industry	Less than 50	9	117	13	2	0	6	1	25	3	12	1	45	5
	50~299	1	74	74	-	-	3	3	30	30	3	3	36	36
	300~999	1	91	91	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	13	7	-	-	-	-	2	1	-	-	2	1
Bioenvironmental industry	Less than 50	1	18	18	-	-	-	-	9	9	-	-	9	9
Bioenergy and bioresource industry	Less than 50	2	47	24	-	-	1	1	16	8	2	1	19	10
Bioassay, bioinformatics and R&D service industry	Less than 50	2	50	25	2	1	2	1	6	3	-	-	10	5
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	58	15	-	-	2	1	13	3	5	1	20	5
	50~299	4	206	52	2	1	5	1	92	23	13	3	112	28
	300~999	1	29	29	-	-	-	-	21	21	1	1	22	22
	More than 1,000	2	1,476	738	5	3	30	15	131	66	30	15	196	98
Biochemical industry	Less than 50	13	292	22	2	0	9	1	65	5	6	0	82	6
	50~299	3	96	32	-	-	-	-	31	10	2	1	33	11
	More than 1,000	1	17	17	-	-	-	-	3	3	-	-	3	3
Biofood industry	Less than 50	12	127	11	1	0	3	0	42	4	3	0	49	4
	50~299	2	154	77	2	1	4	2	22	11	4	2	32	16
Bioenvironmental industry	Less than 50	4	55	14	-	-	1	0	21	5	10	3	32	8
	300~999	1	7	7	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	6	6	-	-	-	-	2	2	-	-	2	2
Bioprocess and equipment industry	Less than 50	2	27	14	-	-	-	-	4	2	1	1	5	3
	50~299	4	133	33	1	0	4	1	34	9	-	-	39	10
Bioenergy and bioresource industry	Less than 50	1	40	40	-	-	-	-	12	12	4	4	16	16
Bioassay, bioinformatics and R&D service industry	Less than 50	2	17	9	1	1	1	1	-	-	1	1	3	2
	50~299	1	120	120	-	-	-	-	-	-	60	60	60	60

		Total	Bioindustry Workers		Others: Doctor		Others: Master		Others: Bachelor		Others: Others		Others: Total
			Total	Average	Total	Average	Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	39,686	41	412	0	1,267	1	8,174	9	3,487	4	13,340	14
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	328	25	5	0	11	1	112	9	16	1	144	11
	50~299	38	4,528	119	33	1	184	5	1,063	29	500	14	1,780	47
	300~999	16	931	58	3	0	20	1	299	21	20	1	342	21
	More than 1,000	8	3,777	472	3	0	88	11	735	92	951	119	1,777	222
Biochemical industry	Less than 50	20	303	15	2	0	18	1	79	4	20	1	119	6
	50~299	15	1,200	80	5	0	67	4	358	24	71	5	501	33
	300~999	1	42	42	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	475	475	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	258	17	8	1	11	1	34	2	13	1	66	4
	50~299	14	1,307	93	5	0	47	3	232	17	118	8	402	29
	300~999	4	710	178	6	2	45	11	250	63	179	45	480	120
	More than 1,000	3	645	215	5	2	14	5	18	6	15	5	52	17
Bioenvironmental industry	Less than 50	10	130	13	1	0	13	1	24	2	11	1	49	5
	50~299	4	79	20	-	-	-	-	-	-	2	1	2	1
	More than 1,000	1	96	96	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	20	10	-	-	2	1	3	2	3	2	8	4
	50~299	1	92	92	1	1	4	4	9	9	4	4	18	18
	300~999	1	519	519	8	8	15	15	64	64	14	14	101	101
Bioprocess and equipment industry	Less than 50	8	233	29	4	1	25	3	58	7	33	4	120	15
	50~299	7	398	57	1	0	4	1	111	16	85	12	201	29
	300~999	1	2	2	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	26	26	1	1	-	-	4	4	2	2	7	7
	50~299	2	212	106	3	2	5	3	13	7	55	28	76	38
	300~999	1	433	433	6	6	22	22	130	130	28	28	186	186
Bioassay, bioinformatics and R&D service industry	Less than 50	6	93	16	2	0	1	0	20	3	3	1	26	4
	50~299	8	1,314	164	26	3	107	13	346	43	46	6	525	66
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	40	5	-	-	-	-	12	4	7	2	19	2
	50~299	12	160	13	-	-	1	0	30	5	-	-	31	3
	300~999	4	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	26	5	-	-	-	-	2	0	3	1	5	1
	50~299	2	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	8	8	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	22	7	-	-	-	-	-	-	-	-	-	-
	Unknown	2	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	1	1	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	12	6	-	-	-	-	2	1	-	-	2	1
	50~299	1	5	5	-	-	-	-	-	-	-	-	-	-
	300~999	1	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	5	3	-	-	-	-	1	1	-	-	1	1

< Table 3 > Investment Status of Bioindustry   (Unit : number of firms, million Won)

		Total	Total R&D Investment		R&D Investment in Bioindustry		Total Facility Investment		Facility Investment in Bioindustry
			Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	4,884,873	4,995	1,312,560	1,342	776,933	794	411,962	421
▣ Sales Situation
No sales		281	674,243	2,399	235,598	838	225,176	801	18,665	66
Sales below break-even - 1 year		10	28,410	2,841	17,550	1,755	5,923	592	3,846	385
Sales below break-even - 2~3 years		63	118,609	1,883	68,112	1,081	241,180	3,828	228,176	3,622
Sales below break-even - 4~5 years		96	55,976	583	35,914	374	29,988	312	11,851	123
Sales below break-even - 6~9 years		91	150,938	1,659	73,116	803	30,679	337	5,770	63
Sales below break-even - 10 or more years		82	289,774	3,534	164,711	2,009	18,676	228	10,685	130
Sales below break-even - Unknown		1	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	524	524	50	50	3	3	3	3
Sales below break-even - 2~3 years		15	11,974	798	10,515	701	16,059	1,071	5,806	387
Sales below break-even - 4~5 years		27	31,676	1,173	12,506	463	4,837	179	2,615	97
Sales above break-even - 6~9 years		58	283,291	4,884	224,653	3,873	45,383	782	23,932	413
Sales above break-even - 10 or more years		201	3,215,703	15,999	446,610	2,222	156,974	781	99,018	493
Sales - Unknown		52	23,755	457	23,225	447	2,055	40	1,595	31
▣ Main type of industry
Biopharmaceutical industry		330	1,784,494	5,408	996,423	3,019	490,471	1,486	353,457	1,071
Biochemical industry		206	2,568,681	12,469	118,190	574	58,554	284	18,457	90
Biofood industry		197	280,658	1,425	86,500	439	41,768	212	13,219	67
Bioenvironmental industry		76	24,847	327	9,183	121	3,401	45	1,793	24
Bioelectronics industry		22	27,793	1,263	22,764	1,035	3,677	167	1,087	49
Bioprocess and equipment industry		71	90,926	1,281	21,038	296	2,614	37	1,553	22
Bioenergy and bioresource industry		26	63,417	2,439	21,064	810	155,309	5,973	4,056	156
Bioassay, bioinformatics and R&D service industry		50	44,057	881	37,398	748	21,139	423	18,340	367
▣ Number of employees
Less than 50		574	181,686	317	117,982	206	37,537	65	29,281	51
50~299		272	404,516	1,487	306,572	1,127	147,782	543	63,762	234
300~999		75	633,526	8,447	325,096	4,335	69,453	926	17,783	237
More than 1,000		46	3,665,145	79,677	562,910	12,237	522,161	11,351	301,136	6,546
Unknown		11	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	5,869	147	4,913	123	152	4	152	4
	50~299	41	15,081	368	5,510	134	1,975	48	998	24
	300~999	17	283,164	16,657	192,101	11,300	27,331	1,608	8,462	498
	More than 1,000	2	27,276	13,638	100	50	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	26	4,543	175	2,071	80	421	16	206	8
	50~299	12	7,307	609	2,841	237	1,150	96	280	23
	300~999	3	7,658	2,553	400	133	1,000	333	40	13
	More than 1,000	6	212,054	35,342	7,500	1,250	19,000	3,167	3,200	533
Biofood industry	Less than 50	25	2,996	120	1,582	63	907	36	307	12
	50~299	17	4,928	290	1,960	115	5,030	296	910	54
	300~999	7	14,856	2,122	2,536	362	320	46	275	39
	More than 1,000	10	33,300	3,330	3,900	390	15,500	1,550	2,100	210
	Unknown	1	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	1,461	77	120	6	100	5	50	3
	50~299	4	168	42	93	23	-	-	-	-
Bioelectronics industry	Less than 50	5	100	20	10	2	100	20	10	2
	50~299	2	1,750	875	500	250	500	250	300	150
Bioprocess and equipment industry	Less than 50	17	1,274	75	750	44	750	44	445	26
	50~299	4	2,689	672	2,489	622	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	920	131	620	89	350	50	350	50
	50~299	3	5,091	1,697	400	133	-	-	-	-
	More than 1,000	1	39,491	39,491	3,000	3,000	150,500	150,500	500	500
Bioassay, bioinformatics and R&D service industry	Less than 50	7	95	14	30	4	40	6	30	4
	50~299	2	172	86	172	86	-	-	-	-
	300~999	1	2,000	2,000	2,000	2,000	50	50	50	50

		Total	Total R&D Investment		R&D Investment in Bioindustry		Total Facility Investment		Facility Investment in Bioindustry
			Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	4,884,873	4,995	1,312,560	1,342	776,933	794	411,962	421
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	400	400	400	400	200	200	200	200
	50~299	3	3,000	1,000	3,000	1,000	3,330	1,110	2,030	677
	300~999	1	22,101	22,101	11,600	11,600	1,261	1,261	484	484
Biofood industry	50~299	1	80	80	10	10	-	-	-	-
Bioenvironmental industry	Less than 50	1	412	412	412	412	12	12	12	12
Bioelectronics industry	Less than 50	1	420	420	420	420	200	200	200	200
Bioassay, bioinformatics and R&D service industry	Less than 50	2	1,997	999	1,708	854	920	460	920	460
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	8,319	924	6,638	738	94	10	94	10
	50~299	7	5,188	741	2,405	344	4,435	634	2,195	314
	300~999	1	15,000	15,000	11,000	11,000	1,800	1,800	800	800
	More than 1,000	2	54,366	27,183	20,000	10,000	231,350	115,675	223,350	111,675
Biochemical industry	Less than 50	16	1,428	89	1,332	83	398	25	300	19
	50~299	3	5,250	1,750	1,200	400	112	37	51	17
	300~999	1	21,347	21,347	21,347	21,347	2,500	2,500	1,000	1,000
Biofood industry	Less than 50	8	1,720	215	1,670	209	6	1	6	1
	50~299	1	380	380	150	150	-	-	-	-
	300~999	1	1,850	1,850	20	20	100	100	10	10
Bioenvironmental industry	Less than 50	3	306	102	306	102	30	10	30	10
Bioelectronics industry	Less than 50	3	1,060	353	1,020	340	200	67	200	67
Bioprocess and equipment industry	Less than 50	4	1,264	316	564	141	45	11	30	8
Bioenergy and bioresource industry	Less than 50	2	587	294	200	100	100	50	100	50
	50~299	1	294	294	10	10	10	10	10	10
Bioassay, bioinformatics and R&D service industry	Less than 50	1	250	250	250	250	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	11,185	746	10,912	727	2,140	143	2,140	143
	50~299	8	12,717	1,590	6,961	870	11,174	1,397	3,428	429
Biochemical industry	Less than 50	19	3,332	175	2,198	116	472	25	172	9
	50~299	1	450	450	80	80	-	-	-	-
	300~999	1	3,540	3,540	500	500	1,541	1,541	621	621
	More than 1,000	1	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	4,395	293	3,669	245	2,683	179	2,666	178
	50~299	4	3,067	767	758	190	6,429	1,607	90	23
Bioenvironmental industry	Less than 50	9	1,134	126	964	107	195	22	170	19
	50~299	1	419	419	419	419	-	-	-	-
Bioelectronics industry	Less than 50	1	150	150	100	100	-	-	-	-
	50~299	2	8,000	4,000	4,500	2,250	2,500	1,250	200	100
Bioprocess and equipment industry	Less than 50	10	2,854	285	1,399	140	481	48	281	28
Bioenergy and bioresource industry	Less than 50	4	100	25	100	25	210	53	210	53
Bioassay, bioinformatics and R&D service industry	Less than 50	4	1,299	325	949	237	504	126	504	126
	50~299	1	3,334	3,334	2,405	2,405	1,659	1,659	1,369	1,369
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	13,829	813	12,619	742	1,450	85	630	37
	50~299	5	14,141	2,828	13,073	2,615	16,396	3,279	627	125
	300~999	2	3,283	1,642	3,283	1,642	6,374	3,187	188	94
Biochemical industry	Less than 50	21	13,848	659	12,948	617	2,977	142	2,627	125
	50~299	1	6,792	6,792	6,792	6,792	-	-	-	-
	More than 1,000	2	83,167	41,584	14,000	7,000	300	150	300	150
Biofood industry	Less than 50	23	5,029	219	3,136	136	480	21	336	15
	50~299	1	632	632	632	632	-	-	-	-
Bioenvironmental industry	Less than 50	7	354	51	148	21	102	15	62	9
	50~299	2	1,000	500	1,000	500	-	-	-	-
Bioelectronics industry	Less than 50	1	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	200	200	10	10	-	-	-	-
	50~299	1	3,500	3,500	3,500	3,500	100	100	100	100
Bioenergy and bioresource industry	Less than 50	1	750	750	550	550	350	350	250	250
Bioassay, bioinformatics and R&D service industry	Less than 50	5	1,578	316	1,275	255	150	30	150	30
	50~299	1	2,835	2,835	150	150	2,000	2,000	500	500

		Total	Total R&D Investment		R&D Investment in Bioindustry		Total Facility Investment		Facility Investment in Bioindustry
			Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	4,884,873	4,995	1,312,560	1,342	776,933	794	411,962	421
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	10,173	848	7,463	622	106	9	106	9
	50~299	8	67,503	8,438	62,835	7,854	3,729	466	3,152	394
	300~999	5	38,658	7,732	13,018	2,604	1,680	336	833	167
	More than 1,000	3	151,444	50,481	63,839	21,280	8,822	2,941	3,111	1,037
Biochemical industry	Less than 50	11	1,300	118	1,257	114	90	8	90	8
	50~299	1	1,929	1,929	300	300	200	200	100	100
Biofood industry	Less than 50	20	4,769	238	3,447	172	1,027	51	751	38
	50~299	4	3,118	780	2,768	692	2,101	525	2,101	525
Bioenvironmental industry	Less than 50	5	620	124	610	122	50	10	50	10
	50~299	1	400	400	-	-	50	50	-	-
Bioelectronics industry	300~999	1	5,773	5,773	5,773	5,773	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	857	171	597	119	150	30	150	30
	50~299	1	715	715	715	715	35	35	14	14
Bioassay, bioinformatics and R&D service industry	Less than 50	4	1,599	400	1,173	293	419	105	10	3
	50~299	1	916	916	916	916	217	217	217	217
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	524	524	50	50	3	3	3	3
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	396	396	396	396	-	-	-	-
	50~299	5	9,649	1,930	9,649	1,930	14,500	2,900	5,500	1,100
Biochemical industry	Less than 50	3	1,600	533	300	100	1,282	427	217	72
Biofood industry	Less than 50	3	30	10	20	7	-	-	-	-
Bioenvironmental industry	50~299	1	239	239	150	150	277	277	89	89
Bioelectronics industry	Less than 50	1	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	60	60	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	1,510	252	1,100	183	1,856	309	954	159
	50~299	2	1,683	842	1,254	627	-	-	-	-
	300~999	1	1,169	1,169	1,169	1,169	29	29	29	29
Biochemical industry	Less than 50	9	1,010	112	658	73	530	59	365	41
	50~299	1	332	332	332	332	106	106	106	106
	300~999	1	24,914	24,914	7,000	7,000	-	-	-	-
Biofood industry	Less than 50	2	730	365	715	358	10	5	8	4
Bioenvironmental industry	Less than 50	1	100	100	50	50	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	178	89	178	89	2,306	1,153	1,153	577
Bioassay, bioinformatics and R&D service industry	Less than 50	2	50	25	50	25	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	2,247	562	2,247	562	3,884	971	3,884	971
	50~299	4	6,812	1,703	6,812	1,703	25,000	6,250	300	75
	300~999	1	5,408	5,408	2,400	2,400	200	200	170	170
	More than 1,000	2	235,937	117,969	200,921	100,461	8,852	4,426	14,359	7,180
Biochemical industry	Less than 50	13	6,134	472	4,214	324	4,765	367	4,600	354
	50~299	3	5,369	1,790	410	137	183	61	20	7
	More than 1,000	1	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	1,199	100	1,122	94	191	16	181	15
	50~299	2	4,301	2,151	1,150	575	2,000	1,000	150	75
Bioenvironmental industry	Less than 50	4	528	132	211	53	-	-	-	-
	300~999	1	9,794	9,794	358	358	40	40	-	-
Bioelectronics industry	Less than 50	1	100	100	100	100	50	50	50	50
Bioprocess and equipment industry	Less than 50	2	456	228	406	203	6	3	6	3
	50~299	4	4,253	1,063	3,549	887	212	53	212	53
Bioenergy and bioresource industry	Less than 50	1	393	393	393	393	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	360	180	360	180	-	-	-	-
	50~299	1	-	-	-	-	-	-	-	-

		Total	Total R&D Investment		R&D Investment in Bioindustry		Total Facility Investment		Facility Investment in Bioindustry
			Total	Average	Total	Average	Total	Average	Total	Average
Number of companies		978	4,884,873	4,995	1,312,560	1,342	776,933	794	411,962	421
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	4,634	356	4,198	323	421	32	406	31
	50~299	38	75,377	1,984	71,377	1,878	20,819	548	18,801	495
	300~999	16	88,743	5,546	15,010	938	14,609	913	2,213	138
	More than 1,000	8	565,327	70,666	205,395	25,674	74,947	9,368	52,306	6,538
Biochemical industry	Less than 50	20	4,829	241	3,462	173	427	21	382	19
	50~299	15	15,598	1,040	15,598	1,040	2,100	140	2,080	139
	300~999	1	4,800	4,800	4,800	4,800	9,000	9,000	1,000	1,000
	More than 1,000	1	2,130,000	2,130,000	6,500	6,500	10,000	10,000	700	700
Biofood industry	Less than 50	15	2,815	188	2,456	164	1,740	116	1,735	116
	50~299	14	38,235	2,731	12,010	858	2,341	167	1,380	99
	300~999	4	20,921	5,230	6,484	1,621	10	3	-	-
	More than 1,000	3	130,783	43,594	36,255	12,085	890	297	210	70
Bioenvironmental industry	Less than 50	10	1,702	170	1,492	149	45	5	30	3
	50~299	4	4,210	1,053	1,350	338	500	125	300	75
	More than 1,000	1	2,000	2,000	1,500	1,500	2,000	2,000	1,000	1,000
Bioelectronics industry	Less than 50	2	322	161	223	112	-	-	-	-
	50~299	1	537	537	537	537	-	-	-	-
	300~999	1	9,581	9,581	9,581	9,581	127	127	127	127
Bioprocess and equipment industry	Less than 50	8	31,061	3,883	791	99	260	33	200	25
	50~299	7	6,243	892	5,468	781	73	10	73	10
	300~999	1	35,000	35,000	750	750	2	2	2	2
Bioenergy and bioresource industry	Less than 50	1	800	800	800	800	-	-	-	-
	50~299	2	847	424	847	424	4	2	4	2
	300~999	1	13,966	13,966	13,966	13,966	1,479	1,479	1,479	1,479
Bioassay, bioinformatics and R&D service industry	Less than 50	6	2,712	452	1,100	183	700	117	110	18
	50~299	8	24,660	3,083	24,660	3,083	14,480	1,810	14,480	1,810
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	80	10	-	-	-	-	-	-
	50~299	12	22,825	1,902	22,825	1,902	1,555	130	1,555	130
	300~999	4	-	-	-	-	-	-	-	-
	Unknown	5	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	150	30	150	30	-	-	-	-
	50~299	2	-	-	-	-	-	-	-	-
	300~999	1	-	-	-	-	-	-	-	-
	More than 1,000	3	-	-	-	-	-	-	-	-
	Unknown	2	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	-	-	-	-	-	-	-	-
	Unknown	1	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	-	-	-	-	-	-	-	-
	50~299	1	500	500	50	50	500	500	40	40
	300~999	1	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	200	100	200	100	-	-	-	-

< Table4 > Cooperation in Bioindustry

III. Statistical Tables

< Table4-1 > Domestic Scale of Joint Investment Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	30	21	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	18	14	4	-	-	-	-	-	-	-	-	-
▣ Sales Situation
No sales		281	3	3	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	1	0	0	0	0	1	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		96	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 10 or more years		201	24	16	6	0	2	0	7	4	2	-	1	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	16	12	4	-	-	-	-	-	-	-	-	-
Sales - Unknown		52	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	29	20	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	17	13	4	-	-	-	-	-	-	-	-	-
Biochemical industry		206	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry		197	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry		76	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry		22	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry		71	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry		26	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
50~299		272	20	18	0	0	2	0	4	3	-	-	1	-	-	-	-	-	-	-	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	13	13	-	-	-	-	-	-	-	-	-	-
300~999		75	8	2	6	0	0	0	4	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	-	4	-	-	-	-	-	-	-	-	-
More than 1,000		46	1	0	0	0	0	1	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	41	3	3	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	300~999	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	30	21	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	18	14	4	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	26	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	1	0	0	0	0	1	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	30	21	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	18	14	4	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	30	21	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	18	14	4	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	30	21	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	18	14	4	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	15	13	0	0	2	0	3	2	-	-	1	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	11	11	-	-	-	-	-	-	-	-	-	-
	300~999	16	8	2	6	0	0	0	4	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	-	4	-	-	-	-	-	-	-	-	-
	More than 1,000	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	14	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	30	21	6	0	2	1	8	5	2	-	1	-	1	-	-	-	-	1	1	-	-	-	1	-	1	1	-	-	-	-	1	1	-	-	-	-	18	14	4	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4-2 > Overseas Scale of Joint Investment Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	9	1	5	0	1	2	5	1	2	-	1	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Sales Situation
No sales		281	3	1	1	0	1	0	3	1	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		96	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 10 or more years		201	5	0	3	0	0	2	1	-	-	-	-	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales - Unknown		52	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	6	1	5	0	0	0	3	1	2	-	-	-	-	-	-	-	-	-	3	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry		206	1	0	0	0	1	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry		197	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry		76	1	0	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry		22	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry		71	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry		26	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	2	0	0	0	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
50~299		272	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
300~999		75	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
More than 1,000		46	5	0	4	0	0	1	1	-	1	-	-	-	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	41	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	17	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	9	1	5	0	1	2	5	1	2	-	1	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	26	1	0	0	0	1	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	9	1	5	0	1	2	5	1	2	-	1	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	9	1	5	0	1	2	5	1	2	-	1	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	9	1	5	0	1	2	5	1	2	-	1	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	8	3	0	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	3	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	14	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	9	1	5	0	1	2	5	1	2	-	1	1	-	-	-	-	-	-	4	-	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	10	1	0	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4 > Cooperation in Bioindustry

< Table4-3 > Domestic Scale of Joint R&D Contract Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	798	246	284	115	102	51	173	56	47	34	30	6	69	6	43	4	3	13	23	8	10	2	3	-	154	52	39	22	24	17	34	19	6	5	4	-	287	91	110	38	36	12	58	14	29	10	2	3
▣ Sales Situation
No sales		281	95	44	37	9	3	2	19	8	6	5	-	-	1	1	-	-	-	-	4	2	1	-	1	-	23	12	7	3	-	1	2	2	-	-	-	-	42	19	19	1	2	1	4	-	4	-	-	-
Sales below break-even - 1 year		10	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1
Sales below break-even - 2~3 years		63	54	16	14	13	6	5	14	2	3	3	3	3	1	-	-	-	1	-	3	2	1	-	-	-	10	2	3	4	-	1	1	1	-	-	-	-	19	7	5	4	2	1	6	2	2	2	-	-
Sales below break-even - 4~5 years		96	55	13	26	8	8	0	13	4	2	4	3	-	5	2	2	-	1	-	3	-	3	-	-	-	7	4	2	-	1	-	2	1	-	1	-	-	25	2	17	3	3	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	66	40	15	3	8	0	22	15	3	-	4	-	2	-	1	1	-	-	-	-	-	-	-	-	14	9	5	-	-	-	6	4	1	1	-	-	20	11	4	1	4	-	2	1	1	-	-	-
Sales below break-even - 10 or more years		82	118	29	46	27	14	2	29	7	8	7	6	1	1	-	-	1	-	-	4	1	3	-	-	-	22	8	8	1	4	1	5	1	1	3	-	-	53	12	22	15	4	-	4	-	4	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	9	1	1	1	5	1	6	1	1	1	2	1	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	1	-	-	-	1	-	1	-	-	-	1	-
Sales below break-even - 4~5 years		27	50	28	10	2	4	6	11	11	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-	15	4	-	2	4	5	3	2	1	-	-	-	7	3	3	-	-	1	12	6	6	-	-	-
Sales above break-even - 6~9 years		58	59	26	7	11	9	6	7	2	1	1	2	1	-	-	-	-	-	-	7	2	2	1	2	-	17	7	-	7	3	-	5	5	-	-	-	-	19	9	3	1	2	4	4	1	1	1	-	1
Sales above break-even - 10 or more years		201	288	49	126	41	44	28	50	6	21	13	10	-	57	1	40	2	1	13	2	1	-	1	-	-	45	6	14	5	11	9	10	3	3	-	4	-	100	28	37	13	17	5	24	4	11	7	1	1
Sales - Unknown		52	3	0	2	0	1	0	2	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	263	69	99	56	33	6	64	18	15	19	11	1	4	-	1	2	-	1	14	3	8	1	2	-	37	14	11	6	6	-	5	5	-	-	-	-	100	23	43	19	12	3	39	6	21	9	2	1
Biochemical industry		206	145	34	36	19	23	33	21	7	5	1	6	2	14	1	-	1	-	12	5	3	1	1	-	-	53	9	10	7	12	15	10	4	2	4	-	-	42	10	18	5	5	4	-	-	-	-	-	-
Biofood industry		197	229	60	109	20	35	5	58	12	23	9	12	2	41	-	40	-	1	-	1	-	-	-	1	-	22	6	8	4	3	1	7	2	1	-	4	-	93	39	31	7	14	2	7	1	6	-	-	-
Bioenvironmental industry		76	14	6	3	3	0	2	1	1	-	-	-	-	3	2	-	1	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	1	-	-	-	7	1	2	2	-	2	-	-	-	-	-	-
Bioelectronics industry		22	33	20	2	7	2	2	6	1	1	3	1	-	-	-	-	-	-	-	-	-	-	-	-	-	6	5	-	-	-	1	5	5	-	-	-	-	13	8	1	3	1	-	3	1	-	1	-	1
Bioprocess and equipment industry		71	29	8	9	4	6	2	4	2	-	2	-	-	1	1	-	-	-	-	-	-	-	-	-	-	5	-	3	-	2	-	5	3	1	1	-	-	11	2	3	1	4	1	3	-	2	-	-	1
Bioenergy and bioresource industry		26	16	6	6	2	1	1	5	2	2	-	-	1	1	-	-	-	1	-	3	2	1	-	-	-	3	-	1	2	-	-	-	-	-	-	-	-	3	1	2	-	-	-	1	1	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	69	43	20	4	2	0	14	13	1	-	-	-	5	2	2	-	1	-	-	-	-	-	-	-	26	16	6	3	1	-	1	-	1	-	-	-	18	7	10	1	-	-	5	5	-	-	-	-
▣ Number of employees
Less than 50		574	348	123	109	41	56	19	77	29	16	9	18	5	12	5	3	2	2	-	9	1	7	1	-	-	70	27	20	10	10	3	16	10	2	1	3	-	145	44	52	17	23	9	19	7	9	1	-	2
50~299		272	245	69	85	43	36	12	65	20	16	18	10	1	4	-	1	1	1	1	5	3	2	-	-	-	38	9	9	4	10	6	13	5	3	4	1	-	95	28	43	9	12	3	25	4	11	7	2	1
300~999		75	65	22	15	18	6	4	10	4	3	2	1	-	-	-	-	-	-	-	-	-	-	-	-	-	27	10	6	3	4	4	3	3	-	-	-	-	18	3	3	11	1	-	7	2	3	2	-	-
More than 1,000		46	140	32	75	13	4	16	21	3	12	5	1	-	53	1	39	1	-	12	9	4	1	1	3	-	19	6	4	5	-	4	2	1	1	-	-	-	29	16	12	1	-	-	7	1	6	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	17	8	5	2	1	1	2	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	8	4	1	1	1	-	-	-	-	-	-
	50~299	41	11	3	8	0	0	0	3	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-	6	-	6	-	-	-	-	-	-	-	-	-
	300~999	17	9	4	4	1	0	0	4	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	1	1	-	-	-	-	1	1	-	-	-	-	1	-	1	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	798	246	284	115	102	51	173	56	47	34	30	6	69	6	43	4	3	13	23	8	10	2	3	-	154	52	39	22	24	17	34	19	6	5	4	-	287	91	110	38	36	12	58	14	29	10	2	3
Biochemical industry	Less than 50	26	3	1	1	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	11	11	0	0	0	0	3	3	-	-	-	-	1	1	-	-	-	-	2	2	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-	3	3	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	12	4	6	0	1	1	2	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	-	-	1	1	1	-	-	-	-	6	3	2	-	1	-	1	-	1	-	-	-
	50~299	17	6	3	1	2	0	0	3	1	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	2	1	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	7	0	5	1	1	0	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	1	-	-	1	-	-	-	-	-	-	-	-	3	-	3	-	-	-	2	-	2	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	3	0	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
	300~999	1	11	6	3	2	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	6	3	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	7	1	5	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	3	1	2	-	-	-	2	-	2	-	-	-
	50~299	7	3	1	2	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	300~999	1	2	0	0	2	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	1	-	-	1	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	798	246	284	115	102	51	173	56	47	34	30	6	69	6	43	4	3	13	23	8	10	2	3	-	154	52	39	22	24	17	34	19	6	5	4	-	287	91	110	38	36	12	58	14	29	10	2	3
Biochemical industry	Less than 50	16	4	1	0	1	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	1	-	-	-	-	-	-	-	-
	50~299	3	5	2	1	1	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	11	3	3	1	2	2	5	-	2	1	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	3	1	-	1	1	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	3	2	0	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	7	0	0	5	2	0	3	-	-	2	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	-	2	1	-	1	-	-	1	-	-
Bioprocess and equipment industry	Less than 50	4	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	3	0	2	0	0	1	2	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	1	7	5	0	1	1	0	1	1	-	-	-	-	1	-	-	-	1	-	2	2	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	1	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	8	0	7	0	1	0	1	-	1	-	-	-	-	-	-	-	-	-	3	-	3	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	3	-	2	-	1	-	-	-	-	-	-	-
	50~299	8	3	0	0	0	3	0	2	-	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	6	1	3	2	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	1	-	-	4	-	3	1	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	9	2	3	2	2	0	4	1	1	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	1	2	1	1	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	3	3	0	0	0	0	1	1	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	5	2	1	2	0	0	4	2	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	20	5	12	1	2	0	-	-	-	-	-	-	3	-	2	-	1	-	-	-	-	-	-	-	6	4	1	-	1	-	-	-	-	-	-	-	11	1	9	1	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	6	3	3	0	0	0	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	2	1	1	-	-	-
	50~299	5	11	11	0	0	0	0	10	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	9	0	5	2	2	0	1	-	1	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	3	-	3	-	-	-	-	-	-	-	-	-	4	-	1	1	2	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	19	8	5	0	6	0	8	2	2	-	4	-	-	-	-	-	-	-	-	-	-	-	-	-	3	2	1	-	-	-	-	-	-	-	-	-	8	4	2	-	2	-	-	-	-	-	-	-
	50~299	1	5	5	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	798	246	284	115	102	51	173	56	47	34	30	6	69	6	43	4	3	13	23	8	10	2	3	-	154	52	39	22	24	17	34	19	6	5	4	-	287	91	110	38	36	12	58	14	29	10	2	3
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	3	3	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	3	0	2	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	1	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	10	10	0	0	0	0	3	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	6	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	18	7	11	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	7	4	3	-	-	-	-	-	-	-	-	-	6	2	4	-	-	-	3	-	3	-	-	-
	50~299	8	17	6	7	2	2	0	1	-	-	-	1	-	-	-	-	-	-	-	2	-	2	-	-	-	2	2	-	-	-	-	1	1	-	-	-	-	11	3	5	2	1	-	-	-	-	-	-	-
	300~999	5	11	0	0	9	2	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	-	-	9	1	-	-	-	-	-	-	-
	More than 1,000	3	7	1	3	3	0	0	3	-	-	3	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	1	-	1	-	-	-
Biochemical industry	Less than 50	11	13	2	3	1	5	2	4	1	1	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	4	-	-	-	3	1	-	-	-	-	-	-	5	1	2	1	1	-	-	-	-	-	-	-
	50~299	1	5	1	1	3	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	-	3	-	-	2	1	1	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	19	8	6	1	4	0	8	5	1	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	5	2	1	1	1	-	-	-	-	-	-	-	6	1	4	-	1	-	-	-	-	-	-	-
	50~299	4	17	3	7	6	1	0	10	-	5	4	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	3	2	2	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	2	0	0	2	0	0	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	4	0	4	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	3	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	1	4	0	4	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	1	-	1	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	9	1	1	1	5	1	6	1	1	1	2	1	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	1	-	-	-	1	-	1	-	-	-	1	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	7	1	6	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	1	6	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	798	246	284	115	102	51	173	56	47	34	30	6	69	6	43	4	3	13	23	8	10	2	3	-	154	52	39	22	24	17	34	19	6	5	4	-	287	91	110	38	36	12	58	14	29	10	2	3
Biochemical industry	Less than 50	9	6	3	2	1	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	1	-	-	-	-	-	-	-	-	3	1	2	-	-	-	-	-	-	-	-	-
	50~299	1	4	0	2	0	0	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	1	-	1	-	-	-	2	-	1	-	-	1	-	-	-	-	-	-
	300~999	1	13	5	0	0	4	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	3	-	-	4	4	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	1	0	0	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	19	19	0	0	0	0	10	10	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	5	5	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	300~999	1	2	0	1	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	1	-	-
	More than 1,000	2	11	3	1	5	2	0	-	-	-	-	-	-	-	-	-	-	-	-	5	1	1	1	2	-	6	2	-	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	9	1	1	3	3	1	2	-	-	-	2	-	-	-	-	-	-	-	2	1	1	-	-	-	4	-	-	3	1	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	7	0	2	1	2	2	2	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	4	-	2	-	1	1	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-
	300~999	1	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	21	20	1	0	0	0	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	-	-	-	-	5	5	-	-	-	-	8	8	-	-	-	-	1	1	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	4	0	0	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	-	1	1	1	1	-	-	-	-	1
	50~299	4	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	4	0	1	1	2	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	2	-	1	1	-	-	-	-	-	-	-	-
	50~299	38	78	15	22	23	14	4	17	1	3	10	3	-	2	-	-	1	-	1	1	1	-	-	-	-	11	3	3	1	4	-	2	2	-	-	-	-	30	6	12	4	6	2	15	2	4	7	1	1
	300~999	16	9	3	5	1	0	0	4	1	2	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	1	2	-	-	-	2	1	1	-	-	-
	More than 1,000	8	10	1	4	4	1	0	5	-	2	2	1	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	1	-	-	2	1	1	-	-	-
Biochemical industry	Less than 50	20	22	2	10	3	5	2	4	-	2	-	2	-	-	-	-	-	-	-	1	-	-	1	-	-	7	-	5	1	1	-	1	-	1	-	-	-	9	2	2	1	2	2	-	-	-	-	-	-
	50~299	15	17	3	6	1	3	4	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	1	-	1	3	4	-	-	-	-	-	-	6	1	5	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	16	0	0	0	0	16	-	-	-	-	-	-	12	-	-	-	-	12	-	-	-	-	-	-	4	-	-	-	-	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	18	0	3	4	11	0	2	-	-	-	2	-	1	-	-	-	1	-	-	-	-	-	-	-	2	-	1	1	-	-	3	-	-	-	3	-	10	-	2	3	5	-	-	-	-	-	-	-
	50~299	14	19	7	6	1	5	0	4	3	-	-	1	-	1	-	1	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	1	-	-	-	1	-	11	4	4	1	2	-	1	-	1	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	77	15	62	0	0	0	10	-	10	-	-	-	39	-	39	-	-	-	-	-	-	-	-	-	5	1	4	-	-	-	2	1	1	-	-	-	19	13	6	-	-	-	2	-	2	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	798	246	284	115	102	51	173	56	47	34	30	6	69	6	43	4	3	13	23	8	10	2	3	-	154	52	39	22	24	17	34	19	6	5	4	-	287	91	110	38	36	12	58	14	29	10	2	3
Bioenvironmental industry	Less than 50	10	4	0	2	1	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	3	-	1	1	-	1	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	2	0	1	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	1	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	7	2	2	0	3	0	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	3	1	-	-	2	-	2	-	2	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	2	0	1	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	2	0	2	0	0	0	2	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4-4 > Overseas Scale of Joint R&D Contract Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	58	9	19	16	9	5	26	4	5	9	5	3	3	1	-	2	-	-	10	-	5	3	2	-	3	1	1	-	1	-	2	1	1	-	-	-	11	1	6	1	1	2	3	1	1	1	-	-
▣ Sales Situation
No sales		281	5	3	0	1	1	0	2	1	-	1	-	-	1	1	-	-	-	-	-	-	-	-	-	-	2	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	14	3	3	5	3	0	10	1	1	5	3	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	2	1	1	-	-	-
Sales below break-even - 4~5 years		96	3	1	1	1	0	0	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	5	1	0	4	0	0	1	1	-	-	-	-	2	-	-	2	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	5	0	4	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	5	-	4	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 10 or more years		201	22	1	8	4	4	5	8	-	-	3	2	3	-	-	-	-	-	-	3	-	1	-	2	-	-	-	-	-	-	-	2	1	1	-	-	-	8	-	6	-	-	2	1	-	-	1	-	-
Sales - Unknown		52	3	0	3	0	0	0	3	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	39	0	15	13	6	5	19	-	4	9	3	3	-	-	-	-	-	-	10	-	5	3	2	-	2	-	1	-	1	-	1	-	1	-	-	-	6	-	4	-	-	2	1	-	-	1	-	-
Biochemical industry		206	2	1	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
Biofood industry		197	7	3	2	1	1	0	3	2	-	-	1	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	2	1	-	-	-	-	-	-	-	-
Bioenvironmental industry		76	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry		22	2	0	1	0	1	0	2	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry		71	2	0	0	2	0	0	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry		26	4	3	1	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	2	1	1	-	-	-
Bioassay, bioinformatics and R&D service industry		50	2	2	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	25	5	7	7	6	0	14	3	2	5	4	-	1	1	-	-	-	-	5	-	4	1	-	-	3	1	1	-	1	-	-	-	-	-	-	-	2	-	-	1	1	-	-	-	-	-	-	-
50~299		272	28	4	10	6	3	5	11	1	3	3	1	3	2	-	-	2	-	-	3	-	1	-	2	-	-	-	-	-	-	-	2	1	1	-	-	-	7	1	4	-	-	2	3	1	1	1	-	-
300~999		75	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
More than 1,000		46	4	0	2	2	0	0	-	-	-	-	-	-	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	41	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	17	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	58	9	19	16	9	5	26	4	5	9	5	3	3	1	-	2	-	-	10	-	5	3	2	-	3	1	1	-	1	-	2	1	1	-	-	-	11	1	6	1	1	2	3	1	1	1	-	-
Biochemical industry	Less than 50	26	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	2	2	0	0	0	0	1	1	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	8	0	1	5	2	0	7	-	-	5	2	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	58	9	19	16	9	5	26	4	5	9	5	3	3	1	-	2	-	-	10	-	5	3	2	-	3	1	1	-	1	-	2	1	1	-	-	-	11	1	6	1	1	2	3	1	1	1	-	-
Biochemical industry	Less than 50	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	2	0	1	0	1	0	2	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	4	3	1	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	2	1	1	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	1	0	0	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	58	9	19	16	9	5	26	4	5	9	5	3	3	1	-	2	-	-	10	-	5	3	2	-	3	1	1	-	1	-	2	1	1	-	-	-	11	1	6	1	1	2	3	1	1	1	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	2	0	0	2	0	0	-	-	-	-	-	-	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	2	0	0	2	0	0	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	58	9	19	16	9	5	26	4	5	9	5	3	3	1	-	2	-	-	10	-	5	3	2	-	3	1	1	-	1	-	2	1	1	-	-	-	11	1	6	1	1	2	3	1	1	1	-	-
Biochemical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	5	0	4	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	5	-	4	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	18	0	6	4	3	5	7	-	-	3	1	3	-	-	-	-	-	-	3	-	1	-	2	-	-	-	-	-	-	-	1	-	1	-	-	-	6	-	4	-	-	2	1	-	-	1	-	-
	300~999	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	1	0	0	0	1	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	14	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	2	0	2	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	58	9	19	16	9	5	26	4	5	9	5	3	3	1	-	2	-	-	10	-	5	3	2	-	3	1	1	-	1	-	2	1	1	-	-	-	11	1	6	1	1	2	3	1	1	1	-	-
Bioenvironmental industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	3	0	3	0	0	0	3	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4 > Cooperation in Bioindustry

< Table4-5 > Domestic Scale of Technical Tie-up (Licensing) Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	112	35	34	17	16	10	44	11	9	10	9	5	5	3	2	-	-	-	6	3	3	-	-	-	10	1	7	-	2	-	4	1	2	1	-	-	42	16	11	6	5	4	1	-	-	-	-	1
▣ Sales Situation
No sales		281	27	13	4	5	4	1	16	4	3	5	3	1	2	2	-	-	-	-	2	2	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-	5	4	-	-	1	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	10	0	5	0	2	3	6	-	2	-	2	2	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	2	-	-	1	-	-	-	-	-	-
Sales below break-even - 4~5 years		96	10	3	6	0	1	0	1	1	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	3	-	3	-	-	-	-	-	-	-	-	-	5	2	2	-	1	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	10	4	2	2	1	1	5	1	-	2	1	1	2	1	1	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	13	5	3	4	1	0	7	4	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	-	1	-	1	1	-	-	-	-	3	-	2	1	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	8	0	1	2	1	4	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	4	-	1	1	-	2	1	-	-	-	-	1
Sales above break-even - 10 or more years		201	30	9	10	4	6	1	5	1	2	-	2	-	1	-	1	-	-	-	1	-	1	-	-	-	3	-	2	-	1	-	2	-	2	-	-	-	18	8	2	4	3	1	-	-	-	-	-	-
Sales - Unknown		52	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	67	23	18	14	8	4	27	5	6	8	5	3	4	3	1	-	-	-	6	3	3	-	-	-	2	1	1	-	-	-	2	1	-	1	-	-	26	10	7	5	3	1	-	-	-	-	-	-
Biochemical industry		206	23	6	7	2	6	2	12	2	3	2	3	2	-	-	-	-	-	-	-	-	-	-	-	-	3	-	2	-	1	-	2	-	2	-	-	-	6	4	-	-	2	-	-	-	-	-	-	-
Biofood industry		197	5	1	3	0	1	0	1	1	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	2	-	1	-	1	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Bioenvironmental industry		76	9	3	2	1	1	2	4	3	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	-	2	1	-	2	-	-	-	-	-	-
Bioelectronics industry		22	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry		71	3	0	1	0	0	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	1	-	-	-	-	1
Bioenergy and bioresource industry		26	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	3	0	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	44	9	17	3	9	6	15	2	3	2	6	2	2	1	1	-	-	-	3	1	2	-	-	-	5	-	4	-	1	-	1	-	1	-	-	-	17	5	6	1	2	3	1	-	-	-	-	1
50~299		272	58	20	15	12	7	4	28	8	6	8	3	3	3	2	1	-	-	-	3	2	1	-	-	-	4	1	2	-	1	-	2	1	1	-	-	-	18	6	4	4	3	1	-	-	-	-	-	-
300~999		75	8	5	2	1	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	6	4	1	1	-	-	-	-	-	-	-	-
More than 1,000		46	2	1	0	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	41	21	10	3	5	2	1	14	3	3	5	2	1	2	2	-	-	-	-	2	2	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
	300~999	17	2	1	1	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	112	35	34	17	16	10	44	11	9	10	9	5	5	3	2	-	-	-	6	3	3	-	-	-	10	1	7	-	2	-	4	1	2	1	-	-	42	16	11	6	5	4	1	-	-	-	-	1
Biochemical industry	Less than 50	26	2	0	0	0	2	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
	50~299	12	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	2	0	1	0	1	0	1	-	-	-	1	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	6	0	4	0	0	2	3	-	2	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	2	-	-	1	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	112	35	34	17	16	10	44	11	9	10	9	5	5	3	2	-	-	-	6	3	3	-	-	-	10	1	7	-	2	-	4	1	2	1	-	-	42	16	11	6	5	4	1	-	-	-	-	1
Biochemical industry	Less than 50	16	2	0	0	0	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	3	1	2	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	2	1	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	-	1	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	1	1	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	3	0	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	7	3	2	0	1	1	3	1	-	-	1	1	2	1	1	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	5	2	0	0	2	0	0	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	112	35	34	17	16	10	44	11	9	10	9	5	5	3	2	-	-	-	6	3	3	-	-	-	10	1	7	-	2	-	4	1	2	1	-	-	42	16	11	6	5	4	1	-	-	-	-	1
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	4	1	1	2	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	2	-	1	1	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	3	1	0	2	0	0	3	1	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	2	0	1	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	3	3	0	0	0	0	3	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	1	0	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	112	35	34	17	16	10	44	11	9	10	9	5	5	3	2	-	-	-	6	3	3	-	-	-	10	1	7	-	2	-	4	1	2	1	-	-	42	16	11	6	5	4	1	-	-	-	-	1
Biochemical industry	Less than 50	9	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	1	0	0	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	2	0	0	0	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	3	0	1	1	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	1	1	-	1	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	2	0	0	0	0	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	1	-	-	-	-	1
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	1	0	0	0	1	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	11	3	2	3	3	0	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	3	1	3	3	-	-	-	-	-	-	-
	300~999	16	4	2	1	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	2	1	1	-	-	-	-	-	-	-	-
	More than 1,000	8	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	4	0	4	0	0	0	2	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	4	1	2	0	1	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	1	-	1	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	14	1	0	1	0	0	0	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	112	35	34	17	16	10	44	11	9	10	9	5	5	3	2	-	-	-	6	3	3	-	-	-	10	1	7	-	2	-	4	1	2	1	-	-	42	16	11	6	5	4	1	-	-	-	-	1
Bioenvironmental industry	Less than 50	10	2	0	0	0	1	1	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	1	0	1	0	0	0	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4-6 > Overseas Scale of Technical Tie-up (Licensing) Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	41	4	8	22	2	5	21	2	4	9	2	4	2	-	-	1	-	1	7	-	4	3	-	-	8	-	-	8	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
▣ Sales Situation
No sales		281	3	0	0	1	0	2	3	-	-	1	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	7	0	0	5	2	0	7	-	-	5	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		96	2	1	1	0	0	0	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	1	0	0	1	0	0	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	8	0	0	8	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	-	-	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	6	1	4	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	5	-	4	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 10 or more years		201	11	2	0	6	0	3	6	1	-	3	-	2	1	-	-	-	-	1	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	-	-	1	-	-
Sales - Unknown		52	3	0	3	0	0	0	3	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	28	3	8	13	2	2	18	2	4	9	2	1	1	-	-	-	-	1	7	-	4	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	-	-	1	-	-
Biochemical industry		206	1	0	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry		197	3	1	0	0	0	2	2	-	-	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry		76	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry		22	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry		71	1	0	0	1	0	0	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry		26	8	0	0	8	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	-	-	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	25	1	5	16	2	1	12	1	1	7	2	1	-	-	-	-	-	-	5	-	4	1	-	-	8	-	-	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
50~299		272	12	3	3	2	0	4	7	1	3	-	-	3	2	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
300~999		75	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
More than 1,000		46	3	0	0	3	0	0	1	-	-	1	-	-	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	41	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	17	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	41	4	8	22	2	5	21	2	4	9	2	4	2	-	-	1	-	1	7	-	4	3	-	-	8	-	-	8	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
Biochemical industry	Less than 50	26	1	0	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	1	0	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	7	0	0	5	2	0	7	-	-	5	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	41	4	8	22	2	5	21	2	4	9	2	4	2	-	-	1	-	1	7	-	4	3	-	-	8	-	-	8	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
Biochemical industry	Less than 50	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	2	1	1	0	0	0	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	41	4	8	22	2	5	21	2	4	9	2	4	2	-	-	1	-	1	7	-	4	3	-	-	8	-	-	8	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	1	0	0	1	0	0	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	41	4	8	22	2	5	21	2	4	9	2	4	2	-	-	1	-	1	7	-	4	3	-	-	8	-	-	8	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
Biochemical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	8	0	0	8	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	-	-	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	5	0	4	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	5	-	4	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	2	0	0	2	0	0	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	5	2	0	1	0	2	2	1	-	-	-	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	-	-	1	-	-
	300~999	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	8	3	0	0	3	0	0	1	-	-	1	-	-	-	-	-	-	-	-	2	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	14	1	0	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	41	4	8	22	2	5	21	2	4	9	2	4	2	-	-	1	-	1	7	-	4	3	-	-	8	-	-	8	-	-	-	-	-	-	-	-	2	2	-	-	-	-	1	-	-	1	-	-
Bioenvironmental industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	3	0	3	0	0	0	3	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4 > Cooperation in Bioindustry

< Table4-7 > Domestic Scale of Domestic/International Technical Manpower Exchange Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	63	37	19	0	5	2	17	3	11	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	9	7	1	-	1	-	8	6	-	-	2	-	27	20	6	-	1	-	2	1	1	-	-	-
▣ Sales Situation
No sales		281	2	2	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	11	4	5	0	0	2	3	-	1	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	4	3	-	-	-	1	-	1	-	-	-
Sales below break-even - 4~5 years		96	4	2	0	0	2	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	3	1	1	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	1	1	-	1	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	3	2	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	-	1	-	1	1	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	21	21	0	0	0	0	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	-	-	-	-	5	5	-	-	-	-	8	8	-	-	-	-	1	1	-	-	-	-
Sales above break-even - 10 or more years		201	17	3	13	0	1	0	10	-	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	1	-	-	-	1	-	4	2	2	-	-	-	-	-	-	-	-	-
Sales - Unknown		52	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	8	5	3	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	2	1	-	-	-	-	-	-	-	-	-	4	2	2	-	-	-	-	-	-	-	-	-
Biochemical industry		206	8	5	1	0	1	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	-	1	-	5	4	1	-	-	-	-	-	-	-	-	-
Biofood industry		197	6	2	3	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	2	2	-	1	-	1	-	1	-	-	-
Bioenvironmental industry		76	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry		22	21	21	0	0	0	0	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	-	-	-	-	5	5	-	-	-	-	8	8	-	-	-	-	1	1	-	-	-	-
Bioprocess and equipment industry		71	3	0	0	0	3	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry		26	4	1	2	0	0	1	2	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	12	2	10	0	0	0	10	-	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	43	32	6	0	3	2	6	2	1	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	6	5	-	-	1	-	5	5	-	-	-	-	24	19	4	-	1	-	2	1	1	-	-	-
50~299		272	15	2	12	0	1	0	11	1	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	1	-	-	-	1	-	2	-	2	-	-	-	-	-	-	-	-	-
300~999		75	5	3	1	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	2	1	-	-	1	-	1	1	-	-	-	-	-	-	-	-	-	-
More than 1,000		46	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	41	2	2	0	0	0	0	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	63	37	19	0	5	2	17	3	11	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	9	7	1	-	1	-	8	6	-	-	2	-	27	20	6	-	1	-	2	1	1	-	-	-
Biochemical industry	Less than 50	26	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	63	37	19	0	5	2	17	3	11	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	9	7	1	-	1	-	8	6	-	-	2	-	27	20	6	-	1	-	2	1	1	-	-	-
Biochemical industry	Less than 50	16	3	2	0	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	3	0	3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	1	-	1	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	3	0	2	0	0	1	2	-	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	2	0	0	0	2	0	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	2	2	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	2	1	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	63	37	19	0	5	2	17	3	11	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	9	7	1	-	1	-	8	6	-	-	2	-	27	20	6	-	1	-	2	1	1	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	63	37	19	0	5	2	17	3	11	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	9	7	1	-	1	-	8	6	-	-	2	-	27	20	6	-	1	-	2	1	1	-	-	-
Biochemical industry	Less than 50	9	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	2	1	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	21	21	0	0	0	0	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	5	-	-	-	-	5	5	-	-	-	-	8	8	-	-	-	-	1	1	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	2	0	2	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	2	-	-	-	-	-	-	-	-	-
	300~999	16	2	1	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
	50~299	14	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Domestic
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	63	37	19	0	5	2	17	3	11	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	9	7	1	-	1	-	8	6	-	-	2	-	27	20	6	-	1	-	2	1	1	-	-	-
Bioenvironmental industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	1	0	0	0	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	10	0	10	0	0	0	10	-	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

< Table4-8 > Overseas Scale of Domestic/ International Technical Manpower Exchange Cooperation (Ⅲ-4) (Unit : Cases, Count)

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	8	1	1	2	1	3	4	-	-	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	-	-	-	-	-	-
▣ Sales Situation
No sales		281	2	0	0	0	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		63	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		96	3	1	0	1	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	1	-	1	-	1	-	-	-	-	-	-
Sales below break-even - 6~9 years		91	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 10 or more years		82	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - Unknown		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 1 year		1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 2~3 years		15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales below break-even - 4~5 years		27	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 6~9 years		58	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales above break-even - 10 or more years		201	2	0	1	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
Sales - Unknown		52	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Main type of industry
Biopharmaceutical industry		330	3	1	1	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-
Biochemical industry		206	2	0	0	0	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry		197	2	0	0	2	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-
Bioenvironmental industry		76	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry		22	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry		71	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry		26	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry		50	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
▣ Number of employees
Less than 50		574	4	0	0	1	1	2	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	-	-	1	-	1	-	-	-	-	-	-
50~299		272	4	1	1	1	0	1	2	-	-	1	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	1	1	-	-	-	-	-	-	-	-	-
300~999		75	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
More than 1,000		46	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unknown		11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales situation - No sales
Biopharmaceutical industry	Less than 50	40	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	41	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	8	1	1	2	1	3	4	-	-	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	-	-	-	-	-	-
Biochemical industry	Less than 50	26	2	0	0	0	1	1	2	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	25	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	8	1	1	2	1	3	4	-	-	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	-	-	-	-	-	-
Biochemical industry	Less than 50	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	1	1	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	19	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	1	0	0	1	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	4	1	0	0	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-	1	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 6~9 years
Biopharmaceutical industry	Less than 50	17	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	21	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	23	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	8	1	1	2	1	3	4	-	-	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 10 or more years
Biopharmaceutical industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	11	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - Unknown
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 1 year
Biofood industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 2~3 years
Biopharmaceutical industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales below break-even - 4~5 years
Biopharmaceutical industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	8	1	1	2	1	3	4	-	-	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	-	-	-	-	-	-
Biochemical industry	Less than 50	9	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 6~9 years
Biopharmaceutical industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	1	0	0	1	0	0	1	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales above break-even - 10 or more years
Biopharmaceutical industry	Less than 50	13	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	38	2	0	1	0	0	1	1	-	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	1	-	-	-	-	-	-	-	-	-
	300~999	16	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	20	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	15	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	14	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

		Total	Overseas
			Sub Total						Business Entities																		Research Institutes
									1~299						300~999						1,000 or more						Government-invested						Private						Universities						Medical Institutes
			Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial	Total	Basic	Experimental	Prototype	Product	Commercial
Number of companies		978	8	1	1	2	1	3	4	-	-	1	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	1	1	1	-	1	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	10	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioelectronics industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	7	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenergy and bioresource industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	6	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
□ Sales - Unknown
Biopharmaceutical industry	Less than 50	8	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	12	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	4	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biochemical industry	Less than 50	5	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	More than 1,000	3	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Biofood industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioenvironmental industry	Less than 50	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	Unknown	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioprocess and equipment industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	50~299	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
	300~999	1	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bioassay, bioinformatics and R&D service industry	Less than 50	2	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

III. Statistical Tables

< Table 5 > Size of Sales and Import in Bioindustry

< Table 5-1 > Size of Domestic Sales and Export by Category among

Classification Scheme of Bioindustry (Ⅲ-6)        (Unit : million Won)

Industry	Industry Name	Category No.	Category Name	Domestic Sales	Export	Total
1	Biopharmaceutical industry	1010	Antibiotics	23,706	81,907	105,613
		1020	Anticancer medications	48,078	79,960	128,038
		1030	Vaccines	289,707	235,257	524,964
		1040	Hormones	113,401	80,065	193,466
		1050	Immunotherapeutics	38,416	514,228	552,644
		1060	Hemotherapeutics	266,156	95,309	361,465
		1070	Growth factors	2,367	568	2,935
		1080	New therapeutics	54,908	9,530	64,438
		1090	Diagnostic kits	24,754	203,730	228,484
		1100	Animal medications	101,869	25,647	127,516
		1000	Other biopharmaceuticals	567,339	568,214	1,135,553
		Subtotal		1,530,701	1,894,416	3,425,116
2	Biochemical industry	2010	Biopolymers	35,485	30,899	66,384
		2020	Industrial enzymes and reagents	280	15,170	15,450
		2030	Enzymes and reagents for research	37,291	43,074	80,365
		2040	Biocosmetics and home & personal care chemicals	315,392	41,556	356,948
		2050	Biological agrochemicals and fertilizers	21,003	111	21,114
		2000	Other biochemicals	26,755	4,394	31,149
		Subtotal		436,206	135,203	571,409
3	Biofood industry	3010	Functional health foods	319,109	36,943	356,052
		3020	Amino acids	34,422	52,368	86,790
		3030	Food additives	166,587	377,648	544,235
		3040	Fermented foods	89,762	-	89,762
		3050	Feed additives	665,750	1,453,657	2,119,407
		3000	Other biofoods	15,781	5,347	21,128
		Subtotal		1,291,411	1,925,962	3,217,373
4	Bioenvironmental industry	4010	Microbial treatment agents	17,170	72	17,242
		4020	Microbe-immobilized materials and equipments	3,207	18	3,225
		4030	Bioenvironmental agents and systems	6,859	113	6,972
		4040	Measuring apparatus for environmental pollution(service for pollution assessment)	800	-	800
		4000	Other bioenvironmental productions and services	2,275	100	2,375
		Subtotal		30,311	303	30,614

Industry	Industry Name	Category No.	Category Name	Domestic Sales	Export	Total
5	Bioelectronics industry	5010	DNA chips	4,228	647	4,875
		5020	Protein chips	-	-	-
		5030	Cell chips	-	-	-
		5040	Biosensors	26,381	128,121	154,502
		5050	BioMEMS	-	-	-
		5000	Other bioelectronics	165	656	821
		Subtotal		30,774	129,425	160,199
6	Bioprocess and equipment industry	6010	Bioreactors	1,514	341	1,855
		6020	Biomedical and diagnostic apparatuses	23,543	16,634	40,177
		6030	Bioprocess and analysis equipments	33,937	26,859	60,796
		6040	Plant and process design	25,000	-	25,000
		6000	Other bioprocess and equipments	5,050	29,715	34,765
		Subtotal		89,044	73,548	162,592
7	Bioenergy and bioresource industry	7010	Biofuel	402,803	20,814	423,617
		7020	Artificial seeds and seedlings	126,731	25,927	152,658
		7030	Experimental animals	24,181	-	24,181
		7040	Transgenic animals and plants	1,504	-	1,504
		7000	Other bioenergy and bioresources	44,854	-	44,854
		Subtotal		600,073	46,741	646,814
8	Bioassay, bioinformatics and R&D service industry	8010	Bioinformatics services	238	16	254
		8020	Gene analysis services	47,212	31,436	78,648
		8030	Protein analysis services	2,025	300	2,325
		8040	R&D services	21,113	6,611	27,724
		8050	Biosafety and efficacy evaluation services	92,781	7,363	100,144
		8060	Diagnosis and preservation services	37,391	23	37,414
		8000	Other bioassays, bioinformatics services	80	-	80
		Subtotal		200,840	45,749	246,589
Total				4,209,360	4,251,346	8,460,706

< Table 5-2 > Size of Import by Category among

Classification Scheme of Bioindustry (Ⅲ-7) (Unit : million Won)

Industry	Industry Name	Category No.	Category Name	Import
1	Biopharmaceutical industry	1010	Antibiotics	16,243
		1020	Anticancer medications	170,144
		1030	Vaccines	270,708
		1040	Hormones	231,750
		1050	Immunotherapeutics	62,733
		1060	Hemotherapeutics	199,641
		1070	Growth factors	-
		1080	New therapeutics	12,441
		1090	Diagnostic kits	30,714
		1100	Animal medications	10,610
		1000	Other biopharmaceuticals	215,701
		Subtotal		1,220,685
2	Biochemical industry	2010	Biopolymers	-
		2020	Industrial enzymes and reagents	16,984
		2030	Enzymes and reagents for research	44,189
		2040	Biocosmetics and home & personal care chemicals	4,128
		2050	Biological agrochemicals and fertilizers	482
		2000	Other biochemicals	21,927
		Subtotal		87,710
3	Biofood industry	3010	Functional health foods	16,651
		3020	Amino acids	10,374
		3030	Food additives	2,885
		3040	Fermented foods	-
		3050	Feed additives	5,940
		3000	Other biofoods	226
		Subtotal		36,076
4	Bioenvironmental industry	4010	Microbial treatment agents	-
		4020	Microbe-immobilized materials and equipments	-
		4030	Bioenvironmental agents and systems	-
		4040	Measuring apparatus for environmental pollution(service for pollution assessment)	119
		4000	Other bioenvironmental productions and services	-
		Subtotal		119

Industry	Industry Name	Category No.	Category Name	Import
5	Bioelectronics industry	5010	DNA chips	270
		5020	Protein chips	-
		5030	Cell chips	-
		5040	Biosensors	500
		5050	BioMEMS	-
		5000	Other bioelectronics	-
		Subtotal		770
6	Bioprocess and equipment industry	6010	Bioreactors	300
		6020	Biomedical and diagnostic apparatuses	1,620
		6030	Bioprocess and analysis equipments	50,519
		6040	Plant and process design	-
		6000	Other bioprocess and equipments	1,342
		Subtotal		53,781
7	Bioenergy and bioresource industry	7010	Biofuel	1,697
		7020	Artificial seeds and seedlings	6,445
		7030	Experimental animals	-
		7040	Transgenic animals and plants	52
		7000	Other bioenergy and bioresources	-
		Subtotal		8,194
8	Bioassay, bioinformatics and R&D service industry	8010	Bioinformatics services	400
		8020	Gene analysis services	-
		8030	Protein analysis services	-
		8040	R&D services	964
		8050	Biosafety and efficacy evaluation services	-
		8060	Diagnosis and preservation services	-
		8000	Other bioassays, bioinformatics services	-
		Subtotal		1,364
Total				1,408,699

Appendix : Explanation on             Classification Scheme

Appendix : Explanation

1. Bioindustry

1. Biopharmaceutical industry

Field of study concerning biopharmaceuticals, medical drugs or medical equipment produced using biotechnology in the R&D or production process to diagnosis, prevent and cure diverse diseases of human or animals. It is an industry that produces the following products.

1010 Antibiotics

Base material or related medicine that inhibits or kills the growth and proliferation of microorganisms

1110) Animal medications

Exception

1020 Anticancer medications

Base material or medicine that is used in cure for malignant tumor

1030 Vaccines

Antigen used to automatically increase immunity of a person or animal in the prevention of infectious diseases (Substance that prevents or cures diseases selectively by artificially stimulating the immune system)

1040 Hormones

Base material and related medicine that is made of hormones, its variants or analogs to cure special diseases using physiological characteristics of hormones

1050 Immunotherapeutics

Base material and related medicine that is used to adjust bioimmune acitivities such as protein substances

1060 Hemotherapeutics

Serum protein products which were separated from blood or biotechnologically manufactured materials and medical products, which are used to treat pathologic conditions of patients (symptoms caused by deficiency in serum protein, etc.)

1070 Growth factors

Polypeptides which facilitate cell division, growth or differentiation, and their modified substances or analogues (including their mimicking agents or peptides which have only the active fraction)

1080 New therapeutics(ex. gene therapeutics, cell therapy, cloned organs, etc.)

New therapeutic agents which have different way of treatment compared to existing agents (Gene therapeutics, cell therapy products, cloned organs and therapeutic antibodies are included in this category at present.)

<Reference>

Gene therapeutics - Agents of normal genes which are transduced in patients to treat diseases caused by genetic abnormalities

Cell therapyproducts - Medical products of living autologous, allogenic or xenogenic cells which are processed to be modified their biological characteristics by in vitro proliferation, selection or other methods

Cloned organs - Artificial organ substitutes which are not mechanical attachments or implants but organs produced by cell culture

Therapeutic antibodies- Antibodies of major immunologic mechanisms which are produced in vitro to protect human body from foreign pathogenic organisms

1090 Diagnostic kits

Kits and reagents which are used to diagnose the actual condition of diseases

Reagents used in research are classified as '2030) Enzymes and reagents for research'

Exception

1100 Animal medications

Therapeutic products which are used to diagnose, treat and prevent diseases of animals (including probiotics)

3050) Feed additives

Exception

1000 Other biopharmaceuticals

Other biomedical products which are not classified above (including ingredients and intermediates which are not classified above)

3020) Amino acids

Exception

2. Biochemical industry

Industrial activities which produce compounds or substitutes of existing chemical products using bio-purification technology or biotechnology in R&D or manufacturing process [excluding products which are used mainly in medical purpose]

2010 Biopolymers

Materials (structural constituents), biocompatible polymers and biodegradable resins (functional packaging materials) which are made from proteins, nucleic acids or polyssacharides

1090) New therapeutics

Exception

2020 Industrial enzymes and reagents

Enzymes which are extracted from industrially valuable organisms or produced by biotechnology, and other industrial reagents

2030 Enzymes and reagents for research

Reagents, buffer solutions, polymerases, reagent kits, DNA vectors and gene expression systems

2040 Biocosmetics and home & personal care chemicals

Household items such as a soap, detergents and functional cosmetics

2050 Biological agrochemicals and fertilizers

Microbial agents which are used to exterminate or control weeds, pests or microorganisms which inhibit growth of crops, and microbial agents which enrich nutrients in soil to enhance growth of crops

For agricultural pesticides and fertilizers produced by a bioprocess using non-microbial or non-biological agents, refer to '2000) Other biochemicals'.

Exception

2000 Other biochemicals

Other biochemicals which are not classified above (including macromolecular monomers, solvents and others)

3. Biofood industry

Industrial activities which produce foods, beverages, animal foods and animal/vegetable fat and oil using bio-purification technology or biotechnology in R&D or manufacturing process [excluding products which are used mainly in medical purpose]

3010 Functional health foods

which functionally useful ingredients for human body and biotechnology are used in its manufacturing (limited to foods which Commissioner of Korea Food and Drug Administration admitted that they have functionality according to 「The Law for Functional Health Foods」)

3020 Amino acids

Aminoacids used in drugs, foods and feed additives

3030 Food additives

Substances which are added in foods such as seasonings, food preservatives, nucleotides, peptides and lipids (including starch, organic acids and functional sugar, etc.)

3010) Functional health foods

Exception

3020) Amino acids

3040 Fermented foods

Products which went through fermentation process such as fermented sauces, alcoholic beverages, pickled vegetables and fermented livestock foods

3010) Functional health foods

Exception

3050 Feed additives

Various kinds of feed additives, nutrients and feedstuffs for animal raising or fish farming

For animal drugs including probiotics, refer to '1100) animal drugs'.

Exception

3000 Other biofoods

Other biofoods which were not classified above (including ingredients and intermediates which were not classified above)

4. Bioenvironmental industry

Industrial activities which produce substances or systems for environmental cleanup, environmental remediation and reducing/preventing environmental pollution using bioderivatives or biotechnology in R&D or manufacturing process, or industrial activities which build up pollution diagnosis and assessment services or facilities using these products, providing following products or services

4010 Microbial treatment agents

Microorganism agents for the purpose of environmental cleanup (waste/wastewater treatment, etc.), reducing/preventing environmental pollution (biodesulfurization, biocracking, biocollection, biopulping, etc.) and environmental remediation, including construction and installation services associated with selling such products

4020 Microbe-immobilized materials and equipments

Immobilized materials and equipments for the purpose of environmental cleanup (waste/wastewater treatment, foul smell/VOC treatment, etc.) such as a microorganism-utilizing filter, including construction and installation services associated with selling such products

4030 Bioenvironmental agents and systems

Materials, equipments and systems for the purpose of waste/wastewater treatment, foul smell/VOC treatment, environmental remediation and resource recycling, including construction and installation services associated with selling such products

4010) Microbial treatment agents

Exception

4020) Microbe-immobilized materials and equipments

4040 Measuring apparatus for environmental pollution(service for pollution assessment)

Equipments which measure water quality, soil pollution level and air pollution level (including construction and installation services associated with selling such products), and pollution source diagnosis and pollution level measuring services on demand of customers

5040) Biosensors

Exception

4000 Other bioenvironmental productions and services

Other bioenvironmental products which were not classified above (including ingredients and intermediates which were not classified above) and associates services

5. Bioelectronics industry

Industrial activities which produce components/materials of medical or analytical purpose using     nano/electronic technology, bio information or biotechnology in R&D or manufacturing process, producing following products

5010 DNA chips

Detecting devices which fix DNAs

5020 Protein chips

Detecting devices which fix proteins

5030 Cell chips

Detecting devices which fix cells and devices which analyze cellular phenomena

5040 Biosensors

Detecting devices which utilize various kinds of biofunctions

5050 BioMEMS

Micro electromechanical systems(MEMS) for the purpose of medical or R&D use such as biotechnology, health examination or drug administration

5000 Other bioelectronics

Other bioelectronic components/materials which are not classified above

Biocomputers, nerochips, carbohydrate chips

Example

6. Bioprocess and equipment industry

Industrial activities which produce devices, equipments and plants for the purpose of using bioderivatives or biotechnologies in R&D or manufacturing process, providing following products or services [including biomedical devices and diagnostic devices]

6010 Bioreactors

Devices which produce valuable substances using biological reactions

Fermentation bath, cell incubators, enzyme reaction incubators

Example

6020 Biomedical and diagnostic apparatuses

Devices which examine and diagnose physical or physiologic functions for medical purpose

1080) Newtherapeutics, diagnostic reagents and kits

Exception

2010) Biopolymers

5040) Biosensors, BioMEMS

6030 Bioprocess and analysis equipments

Experimental and R&D devices such as separation/purification devices, synthesis/cloning devices, sequence analyzing devices, and other interpretation/analysis devices

6040 Plant and process design

System constructing and plant designing services using bioprocess technology and devices, equipments

6000 Other bioprocess and equipments

Bioprocess devices and experimental devices which are not classified above (including ingredients and components which are not classified above)

7. Bioenergy and bioresource industry

Industrial activities which develop energyby utilizing organisms or biotechnology in R&D or manufacturing process, and industrial activities which dig out and produce organisms which have novel functions and then cultivate or raise them

7010 Biofuel

Alternative fuel materials which are produced under conversion process from biomass

7020 Artificial seeds and seedlings

Seeds, improved seeds, mushroom strains and energy crops for forestry or agricultural use

7030 Experimental animals

Experimental animals including transgenic animals such as insects, mice and rats

7040 Transgenic animals and plants

Transgenic animals and plants

7020) Artificial seeds and seedlings

Exception

7030) Experimental animals

7000 Other bioenergy and bioresources

Other bioenergy (biogas) and organisms (including microbial strains and cell strains)

For developmental services, refer to subsections of
"8. Bioassay, bioinformatics and R&D service industry"

Exception

8. Bioassay, bioinformatics and R&D service industry

Industrial activities of biotechnology which conduct R&D by proxy or provide analysis/assessment consulting services and associated bioinformations, providing services described below [Activities manufacturing class 1~7 products on consignment of other companies are referred to as production activities of relevant products]

8010 Bioinformatics services

Services which provide customers with solutions based on bioinformatics and predictions

Bioinformatics database services, statistical analysis of bioexperimental data, oligomer designing, antibody designing and cell strain designing

Example

8020 Gene analysis services

Services which utilize genetic analysis

Genetic sequence analysis, parentage test, GMO diagnosis, microorganism identification, DNA genotyping, SNP analysis

Example

8030 Protein analysis services

Services which utilize protein analysis

Protein sequence/structure analysis, protein expression pattern analysis

Example

8040 R&D services(ex. drug development services, etc.)

Activities which conduct R&D essential for product development by proxy using biotechnology. Services and technical consulting excluding providing bioinformations (In sales survey of a company, sales which come from technology transfer in biotechnological field correspond to this category)

New drug development

Example

8050 Biosafety and efficacy evaluation services

Preclinical study or clinical study services

8060 Diagnosis and preservation services

Disease diagnosis services and cell line preservation services using biotechnology

Cord blood preservation service

Example

8010) Bioinformatics services

Exception

8020) Gene analysis services

8030) Disease diagnosis services which utilize one of protein analysis services

8000 Other bioassays, bioinformatics services

Other bioassays, bioinformatics services which are not classified above

Services which provide information on standardization (GMP, FDA certification, IQ, OQ, PQ), technology and management consulting services

Example

2. Biotechnology

A. Genetic engineering

Technology which changes the genetic characteristics of target organisms by gene manipulation or transplantation

A1. Gene manupulation

Technology which directly deal with genes such as gene identification, modification, separation, recombination, synthesis, amplification and transfer

A101. Genetic material development

Corresponding List

A102. Gene separation

A103. Gene cloning

A104. Gene transformation

A105. Gene screening

A106. Genetic mutation

A107. Gene targeting

A108. DNA synthesis

A109. DNA amplification

A2. Gene expression and regulation

Technologies which modify the mode, degree or rate of expression of genetic information by intervening in replication, transcription and translation of genetic information

A201. Host cell development

Corresponding List

A202. Gene overexpression

A203. Secretory expression

A204. Gene replication and transcriptional regulation

A205. Signal transduction analysis

A206. Oncogenesis

A207. Gene expression profile analysis

A208. High throughput gene expression

A209. RNA interference

A3. Gene application

Technologies which develop new molecules, nuclei or individuals

A301. Transgenic animals

Corresponding List

A302. Transgenic plants

A303. Transgenic microorganisms

A304. Molecular evolution

A305. Genome shuffling

A4. Gene therapy

Technologies which are used in the whole therapeutic process from development of therapeutic genes to transferring them into human body and expression

A401. Ex vivo therapy

Corresponding List

A402. Gene therapy vector development and production

A403. Evaluation of gene transfer and expression

A404. Therapeutic gene development

A405. Germline gene therapy

A406. In vivo model for gene therapy

A407. Oncolytic virus therapy

A408. RNA interference

A409. DNA vaccine

A0. Genetic engineering, n.e.s.

B. Protein engineering

Technologies which analyze structure and function of proteins and design, create or apply specific proteins

B1. Protein structure analysis

Technologies which analyze sequence, mass, planar structure and conformation of proteins

B101. Protein mass spectrometry

Corresponding List

B102. Protein sequence analysis

B103. Protein 3D structure analysis

B104. High throughput structural determination

B105. Protein linkage maps

B106. Protein-protein interaction mapping

B2. Protein function analysis

Technologies which analyze functions of proteins such as their stability, recognition and response

B201. Protein stability analysis

Corresponding List

B202. Protein folding analysis

B203. Protein recognition mechanism analysis

B204. Protein reaction analysis

B205. Inhibitor screening and development

B206. Protein linkage map analysis

B207. Protein-protein interaction mapping

B3. Complex protein engineering

Technologies which are utilized in protein modification, manipulation of antibodies and receptors, and protein designing

B301. Antibody engineering

Corresponding List

B302. Protein modification

B303. Receptor engineering

B304. Protein design

B305. Complex protein formation

B4. Peptide engineering

Technologies which are utilized in synthesis, purification, designing, analysis of structure and function of peptides

B401. Peptide synthesis and purification

Corresponding List

B402. Peptide design

B403. Peptide structure and function analysis

B404. Activated peptide utilization

B405. Multidimensional peptide separation

B5. Protein application

Technologies which develop or utilize enzymes or combinatorial biocatalysts using proteins

B501. Novel enzyme screening

Corresponding List

B502. Artificial enzyme production and utilization

B503. Protein refolding

B504. Combinatorial biocatalysis

B505. Enzyme therapy

B0. Protein engineering, n.e.s.

C. Other macromolecule engineering

Technologies which analyze structure and functions of biomacromolecules such as carbohydrate or lipid, and which develop valuable materials by modifying or utilizing these biomacromolecules

C1. Lipid engineering

Technologies which artificially synthesize lipids or separate them from its natural state, analyze their structure and functions, and develop valuable materials such as functional lipids by physically or biochemically modifying or processing them

C101. Functional lipid development

Corresponding List

C2. Carbohydrate engineering

Technologies which artificially synthesize carbohydrates or separate them from its natural state, analyze their structure and functions, and develop valuable materials such as functional carbohydrates by physically or biochemically modifying or processing them

C201. Polysaccharide chemistry

Corresponding List

C202. Neoglycan technology

C203. Functional carbohydrate development

C0. Other macromolecule engineering, n.e.s.

D. Cell and tissue engineering

Technologies which are utilized to maintain, improve and recover organic functions by manufacturing and using new cells which can express valuable genetic characteristics or by producing artificial tissues or organs

D1. Stem cell therapy

Technologies which induce undifferentiated stem cells to differentiate into specific cells or tissues in appropriate in vitro condition and utilize them to treat injured tissues or organs

D101. Embryonic stem cell utilization

Corresponding List

D102. Adult stem cell utilization

D103. Stem cell differentiation induction

D104. Regenerative medicine

D2. Bioenvironment regulation

Technologies which create in vitro conditions physically and chemically similar to conditions of living bodies to maximize specific functions of cells or organs

D201. Biological and chemical bioenvironment

Corresponding List

D202. Physical, mechanical bioenvironment mimics

D203. Cell and biomaterials interface

D204. Hybrid tissue engineering

D3. Functional biomaterial development

Technologies which develop structurally and chemically modified functional biocompatible materials which can induce specific activities by interaction with cells and tissues in organisms

D301. New biomaterial development

Corresponding List

D302. Biocompatibility enhancing technology

D303. Functional supporter development

D304. Biocompatibility material development

D4. Cell engineering

Comprehensive cellular technologies including technologies which create new cells such as hybrid cells or recombinant cells, and cell separating and culturing technologies

D401. Cell assays

Corresponding List

D402. Cell microencapsulation

D403. Cell manipulation

D404. Nuclear transfer

D5. Tissue engineering

Technologies which are utilized in maintaining, developing and recovering biofunctions by manufacturing artificial tissues or organs using cells, organs and biocompatible materials

D501. Tissue assays

Corresponding List

D502. Tissue microencapsulation

D503. Tissue manipulation

D504. Tissue culture

D0. Cell and tissue engineering, n.e.s.

E. System biology and bioinformatics

Technologies which study on comprehensive characteristics of living organisms by analyzing and integrating their constituents and interactions, and technologies which obtain and utilize valuable information by processing and handling living organism-originated information

E1. Gene sequence analysis

Technologies which analyze the whole genetic information of an individual by using DNA sequencer or other devices

E101. SNP(single nucleotide polymorphism) analysis

Corresponding List

E102. cDNA library construction

E103. Gene-expression profile analysis

E104. DNA chip development and application

E105. High throughput screening

E106. Full-length cDNA cloning

E107. Whole genome sequence technology

E2. Functional genomics

Technologies which investigate genetic functions to obtain information required for diagnosis and prognosis prediction of diseases and for developing medicines

E201. Proteome related technology

Corresponding List

E202. Genetic functional network analysis

E203. Comparative genomics

E204. Pharmacogenomics

E205. Toxicogenomics

E206. Gene targeting

E207. Transcriptomics

E208. Genotyping

E209. Haplotype profiling

E210. Genome-wide gene trapping

E211. Inverse genomics

E3. Proteomics

Technologies which investigate structure and function of specific proteins and interaction between proteins to understand cellular behavior and gene expression

E301. Protein display

Corresponding List

E302. Protein informatics

E303. Cellular proteomics

E304. Disease-related expression profiling

E305. Pharmacoproteomics

E306. Protein chip development and application

E4. Bioinformatics

Technologies which obtain and utilize valuable information by analyzing and processing bioinformation of organisms using computer

E401. Biological database construction

Corresponding List

E402. Data mining system development

E403. Biological system modeling and simulation

E404. Base sequence analysis and design

E405. Structure/function prediction

E406. Biological network analysis

E0. System biology and bioinformatics, n.e.s.

F. Metabolic engineering

Technologies which improve production of target metabolites or produce new metabolites by analyzing and modifying the metabolism pathway or its regulatory system

F1. Metabolite production

Technologies which industrially produce primary metabolites essential for cell growth (nucleic acids, aminoacids, vitamins, etc.) and secondary metabolites which are biosynthesized after cell growth (antibiotics, dyes, etc.)

F101. Primary metabolite production (amino acid, organic acid, alcohol, etc.)

Corresponding List

F102. Secondary metabolite production(antibiotics, etc.)

F103. Production of other bioproducts (nucleic acid, lipid, protein, carbohydrate, etc.)

F2. Applications of metabolic engineering

Technologies which are utilized in improving production of target metabolites, producing new metabolites or biological degradation of non-organic materials by analyzing, modifying and redesigning the metabolic pathways and their regulatory systems

F201. Enhanced production of existing metabolites

Corresponding List

F202. Production of novel metabolites

F203. Optimizing the substrate utilization

F204. Designing pathways for degradation of xenobiotics

F205. Engineering of metabolic pathways and cellular  system for improving mid and downstream bioprocesses

F3. Understanding the metabolism and metabolic pathway

Technologies which analyze and informationize metabolic flux, metabolic regulatory system and metabolic networks

F301. Metabolic flux analysis

Corresponding List

F302. Metabolic flux regulation analysis

F303. Metabolic network analysis

F304. Metabolic profiling

F305. Isotopomer analysis

F0. Metabolic engineering, n.e.s.

F001. Integration of genome, transcriptome, proteome, metabolome

Corresponding List

and fluxome

F002. In silico metabolic engineering

G. Bioprocess

Processing technologies such as culturing, biotransformation, recovery and purification which utilize organisms or bioderivatives for production of valuable materials or products

G1. Fermentation engineering

Microbial culturing technologies which are utilized to maximize the production of valuable materials

G101. Strain improvement

Corresponding List

G102. High cell density culture

G103. Recombinant microorganism culture engineering

G104. Algae cell culture engineering

G105. Cell immobilization

G2. Cell culture engineering

Technologies utilized in optimal culturing of cell strains derived from animals, plants and insects

G201. Plant cell culture engineering

Corresponding List

G202. Animal cell culture engineering

G203. Cell line development

G204. Plant tissue culture engineering

G205. Insect cell culture

G206. Media optimization

G3. Biotransformation

Technologies which convert precursor materials to other valuable materials by utilizing biocatalysts

G301. Enzyme reaction engineering

Corresponding List

G302. Enzyme stabilization

G303. Enzyme immobilization

G304. Chirotechnology

G4. Bioseparation engineering

Technologies which are utilized to optimally recover and purify valuable materials produced by bioprocesses

G401. Filtration

Corresponding List

G402. Centrifugation

G403. Extraction

G404. Adsorption

G405. Chromatography

G406. Membrane separation

G407. Precipitation / crystallization

G408. Freeze drying

G409. Electrophoresis

G410. Cell separation

G5. Industrialization

Technologies which design, analyze, optimize and manage manufacturing processes to produce living organisms or bioderivatives in industrial scale

G501. Scaleup technology

Corresponding List

G502. Bioreactor design and fabrication

G503. Process design

G504. Process control and optimization

G505. Sterilization

G506. Cost analysis

G507. Process validation

G508. Quality assurance / control

G509. cGMP(current Good Manufacturing Practices)

G510. GLP(Good Laboratory Practice)

G0. Bioprocess, n.e.s.

G001. Bioleaching

Corresponding List

G002. Cryopreservation

H. Bioresource production and utilization

Technologies which produce and preserve bioresources such as animals, plants and microorganisms efficiently, and produce valuable products by separating and processing materials obtained from these bioresources

H1. Plant resource utilization technology

Technologies associated with genetic resource preserving, genetic modification, molecular breeding, cultivation, pest control, and processing and storage of agricultural products, for efficient production of plant resources

H101. Nuclear fusion

Corresponding List

H102. Cultivation and breeding

H103. Transgenic plant development and molecular breeding

H104. Plant transformation analysis and detection

H105. Plant cell differentiation

H106. Plant gene resources analysis and preservation

H107. Disease and parasite protection

H108. Farm product quality control and storage

H2. Animal resource utilization technology

Technologies which produce products which assist preservation, breeding, growth and efficient production of animal resources, or technologies which produce valuable products by utilizing byproducts of animal resource production

H201. Nuclear fusion

Corresponding List

H202. Animal resource utilization

H203. Animal breeding, development and proliferation

H204. Transgenic animal development

H205. Animal disease control

H206. Experimental animal development and production

H207. Experimental animal management and utilization

H208. Animal feed production

H209. Animal byproduct processing technology

H210. Animal cell cloning technology

H3. Microbial resource utilization technology

Technologies which separate, identify and manage valuable microorganic resources or technologies which produce valuable materials by using these resources

H301. Nuclear fusion

Corresponding List

H302. Screening and Identification of microbial resource

H303. isolation

H304. Probiotic development and utilization

H4. Insect resource utilization technology

Technologies which produce valuable materials by preserving or utilizing insect resources such as insect bodies, insect cells or insect-associated microorganisms

H401. Functional insect and its material utilization

Corresponding List

H402. Utilization of insect organ and insect cell line

H403. Preservation of insect resource and search for its application

H404. Utilization of insect based microorganism

H5. Marine/fresh water organism technology

Technologies which are utilized in producing valuable materials or environmental conservation by preserving, separating, breeding and utilizing bioresources associated with marine lives or limnobios

H501. Aquatic animal breeding and development

Corresponding List

H502. Aquatic farming

H503. Excellent individual preservation

H504. Aquatic microorganism utilization

H505. Aquatic plant breeding and utilization

H506. Aquatic organism resources screening

H507. Aquatic environment preservation

H6. Food engineering

Technologies which produce and manage foods or food materials by discovering, assessing, processing and packaging bioresources which can be utilized as general foods or functional health foods.

H601. Food processing and packaging

Corresponding List

H602. Functional food material production

H603. Food pollutant detection and management

H604. Fermentation foods and enzyme utilization

H605. Food quality and nutrition evaluation

H606. Food additives development

H7. Biomaterializing technology

Technologies which produce valuable materials or assess their functions by discovering, assessing, separating, purifying, biocatalyzing and biomimicking biomaterials derived from bioresources

H701. Metabolism enhancing biomaterial screening

Corresponding List

H702. Biomaterial production and utilization

H703. Biomaterial functionality evaluation

H704. Biomaterial separation and purification

H705. Biomimetry

H706. Molecular high throughput screening

H8. Biodiversity conservation

Technologies which preserve and manage genetic, species and ecosystemic diversity

H801. Genetic diversity preservation and management

Corresponding List

H802. Species diversity preservation and management

H803. Ecosystem diversity preservation and management

H804. Cryopreservation

H0. Bioresource production and utilization, n.e.s.

H001. Bioproduct engineering

Corresponding List

H002. Life support system for closed environment

I. Environmental biotechnology and bioenergy technology

Biotechnologies which are applied to environmental area and bioenergy area such as measuring, processing and remedying pollution

I1. Clean technology

Technologies of production and management which utilize eco-friendly alternative materials and processes which can reduce energy or resource consumption or discharge of reduce environmental pollutants

I101. Process-related clean technology

Corresponding List

I102. Biological agrochemicals development

I103. Biodegradable material production

I104. Bio-based solvent technology

I2. Environmental pollution control and management technology

Management and reducing technologies which can reduce discharge of environmental pollutants to natural environments such as water, air and earth, or can restore polluted natural environment

I201. Air pollution control and treatment

Corresponding List

I202. Water pollution control and treatment

I203. Soil pollution control and remediation

I204. Waste treatment

I205. Environmental pollutants measurement and analysis

I206. Environmental assessment and control

I207. Ecosystem restoration

I3. Bioenergy technology

Technologies which produce and utilize energy-related products including electricity, fuel (liquid, solid and gaseous), heat, chemicals and other materials by using renewable resources such as biomass

I301. Bioethanol production using starch biomass

Corresponding List

I302. Bioethanol production using lignocellulosic biomass

I303. Biodiesel production

I304. Biogas production

I305. Biogas utilization

I306. Biohydrogen production

I307. Biobutanol production

I0. Environmental biotechnology and bioenergy technology, n.e.s.

J. Nanobiotechnology

Technologies which control and apply biomolecules by fusing nanotechnology and biotechnology in nano scale

J1. Nano-biodevice fabrication

Technologies which compose and produce biodevices by controlling organisms or bioderivatives in nano scale

J101. Nano-DNA chip fabrication

Corresponding List

J102. Nano-protein chip fabrication

J103. Nano chip production and application

J104. Nano-bioelectronic device fabrication

J105. Nano-biosensor system

J106. Nano-bioactuator fabrication

J107. Nano-biosignal analysis

J2. Nanobiomaterial technology

Technologies which produce medical and industrial materials by controlling, designing and processing organisms or bioderivatives in nano scale to utilize their biocontrol functions

J201. Biomaterial self-assembly

Corresponding List

J202. Biomaterial production for

nanobiochip

J203. Hybrid nanomaterial

manufacturing

J204. Bio-nanoparticle manufacturing

J205. Bio-nanomaterial thin film fabrication

J3. Nano drug delivery system

Technologies and systems which regulate drug releasing rate by controlling particles in nano scale or improve drug delivery to target area

J301. Nanomaterial for drug delivery

Corresponding List

J302. Nanostructure manipulation and property analysis

J303. Nano-carrier macufacturing

J304. Molecular target discovery

J4. BioNEMS(Nanoelectromechanical systems), nano-LOC(lab-on-a-chip)

Technologies which produce biochips by utilizing microprocessing techniques in nano scale, and technologies which design, fabricate and produce biochips which materialize various kinds of laboratory procedures such as combination, reaction, separation and analysis

J401. Nano-fluidic

Corresponding List

J402. Nano-processing

J403. Nano-lithography

J404. Surface, interface control

J405. Nanoscale particle manipulation

J406.  Nanoflow visualization & diagnosis

J0. Nanobiotechnology, n.e.s.

K. Bioelectronics engineering

Technologies which construct, produce and utilize biodevices on the basis of detecting functions of organisms or bioderivatives

K1. Biosensor fabrication

Technologies which design, construct and produce devices which detect and quantify specific materials by artificially materializing detecting functions of organisms or bioderivatives

K101. Biomaterial immobilization

Corresponding List

K102. Sensor array fabrication

K103. Biomolecule recognition analysis

K104. Sensor system design

K105. Signal detection and transducing

K106. Remote transmission

K2. Bioelectronic device fabrication

Technologies which design, construct and produce devices which detect specific materials and have data processing and storing functions by artificially materializing electron delivery and storage functions of organisms or bioderivatives

K201. Biofilm fabrication

Corresponding List

K202. Device fabrication

K203. Biomemory fabrication

K204. Biocomputing

K3. Biochip fabrication

Technologies which fabricate chips which analyze functions of genes, proteins and cells by immobilization of organisms or bioderivatives on solid board with high density

K301. DNA chip fabrication and application

Corresponding List

K302. Protein chip fabrication and application

K303. Cell chip fabrication and application

K304. High throughput screening

K305. Array fabrication

K306. Biodata mining

K307. Instrument manufacturing for biochip

K4. Microfluidics

Technologies which investigate the fluidic phenomenon in microstructures related to collecting, treating, separating and transferring materials in biochips and lab-on-a-chip

K401. Plastic microfabrication

Corresponding List

K402. Microfluidic transport

K403. Low Reynolds number flow

K404. Multiscale flow simulation

K405. Microflow driving & manipulation

K406. Micro/nanoscale particle manipulation

K407. Microflow visualization & diagnosis

K0. Bioelectronics, n.e.s.

L. Biosafety and efficacy evaluation

Technologies which evaluate potential risks or biologic efficacy of biotechnologies and biotechnological products

L1. Safety evaluation

Technologies related to evaluation methods and tools of risks of biotechnologies and biotechnological products

L101. Medicine, cosmetics safety evaluation

Corresponding List

L102. Food and food additives safety evaluation

L103. Chemical material safety evaluation

L104. Biological agrochemicals safety evaluation

L105. Microbiological safety evaluation

L106. GMO safety evaluation

L107. Clinical trial

L108. Toxicity evaluation

L2. Safety management

Management technologies which reduce or block potential risks of biotechnologies and biotechnological products

L201. Safety management

Corresponding List

L202. HACCP(hazard analysis critical control points)

L203. Safety management of GMO

L3. Environmental assessment

Technologies related to establishment and evaluation of methods for minimizing or avoiding influence on environment and technologies related to evaluation of influence on natural/life environment, social/economic environment and culture before initiating works which have potential influence on environment

L301. Environmental assessment of natural disaster

Corresponding List

L302. Environmental assessment of chemicals

L303. Environmental assessment of radioactive materials

L304. Environmental assessment of synthetic resins and petroleum products

L305. Environmental assessment of magnetism

L306. Evaluation and management of GMO

L307. Biodegradability evaluation

L4. Biohazard management

Technologies which prevent, manage and restore disasters which are caused by leakage of toxic materials, pathogens and biotechnological organisms or man-made changes on ecosystem to cause serious influence on mankind and ecosystem

L401. Safety management of chemicals

Corresponding List

L402. Safety management of radioactive materials

L403. Biohazard management caused by natural disaster

L404. Biological remediation restoration using microorganisms

L405. Biohazard management caused by bio-weapons

L5. Efficacy evaluation

Technologies which evaluate efficacy of materials which enhance or inhibit activities of human body, organisms or bioderivatives

L501. In vitro assay

Corresponding List

L502. In vivo assay

L503. Pharmacokinetic evaluation

L504. Preclinical trial

L505. Clinical trial I

L506. Clinical trial II

L507. Clinical trial Ⅲ

L508. Clinical trial Ⅳ

L0. Biosafety and efficacy evaluation, n.e.s.

M. Other biotechnology

M1. Combinational biology

Technologies which secure molecular diversity from genetic information on the basis of genetic recombination and select potential candidate materials of specific activities, and secure their genetic information

M101. Shape library construction

Corresponding List

M102. Hybrid polyketide antibiotics development

M2. Drug delivery

Technologies which minimize adverse reactions of drugs and maximize effects and efficacy of drugs by regulating drug release rate or facilitating drug delivery to target area

M201. Controlled release formulation

Corresponding List

M202. Biomaterials for drug delivery

M203. Structure manipulation and property analysis

M204. Carrier development

M205. Molecular target discovery

M3. Immunotherapy

Technologies which treat diseases using in vivo immune system by producing, modifying and activating materials and cells related to in vivo immunity

M301. Immunomodulator

Corresponding List

M302. Immunotherapeutics

M303. Targeted immunotherapy

M0. Biotechnology, n.e.s.

Report on Survey of Domestic Bioindustry

Issued Date : January, 2017

Issued by : Ministry of Trade, Industry and Energy · Korea Biotechnology Industry Organization

Address : 1F. #C, Korea Bio Park, 700, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea (13488)

Phone：(031) 628-0040, 0019

Fax  ：(031) 628-0054